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ABSTRACT 
According their empirical relevance in traditional medicine and diets, six wild species 
from the Portuguese medicinal flora were selected as important sources of phenolic 
compounds, namely flavonoids. The present study aimed to characterize the phenolic 
composition and evaluate bioactive properties (antioxidant, antitumor and 
antiangiogenic) of methanolic extracts, infusions and decoctions prepared from 
Chamaemelum nobile and Matricaria recutita, and Prunus spinosa, Arbutus unedo, Rosa 
micrantha and Rosa canina fruits; and to synthesize derivatives/metabolites of some 
flavonoids present in the studied samples. The main phenolic compounds in C. nobile 
extract, decoction and infusion were flavonols, flavones, phenolic acids and derivatives. 
The extract gave the highest antioxidant activity in the β-carotene bleaching and TBARS 
formation inhibition assays. The highest radical scavenging activity and reducing power 
were observed in the infusion. The extract showed the highest antitumor (in different 
human tumor cell lines) and antiangiogenic (phosphorylation inhibition of VEGFR-2) 
activities. M. recutita infusion and decoction showed better results than the extract in the 
radical scavenging activity and β-carotene bleaching inhibition assays. The antitumor 
activity of the extract and infusion showed to be selective for HCT-15 and HeLa cell lines. 
Luteolin-O-acylhexoside was the most abundant flavonoid in the three preparations. 3-
O-Caffeoylquinic acid was the most abundant phenolic compound in P. spinosa, 
quercetin 3-O-glucoside in A. unedo, and taxifolin in R. micrantha and R. canina. P. 
spinosa revealed to be the most rich in anthocyanins. Two different enriched phenolic 
extracts were prepared, in order to compare their bioactivity: non-anthocyanin phenolic 
compounds enriched extract (PE) and anthocyanins enriched extract (AE). A. unedo (PE) 
and R. canina (AE) presented the highest antioxidant activity in all the assays, and the 
highest antitumor activity was observed in A. unedo (PE and AE). The synthesis of 
derivatives/metabolites of flavonoids was performed using quercetin or quercetin 3-O-
rutinoside (rutin) (identified in the studied samples) affording O-tri and different O-tetra 
protected (benzyl or methyl) quercetins that were submitted to glucuronidation attempts 
using acetobromo-α-ᴅ-glucuronic acid methyl ester in order to obtain possible precursors 
of human metabolites. As complex mixtures were obtained, further studies are needed to 
allow the formation of higher amounts of the required glucuronide derivatives to enable 
their isolation in a pure form. 
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RESUMO 
De acordo com a sua relevância empírica na medicina tradicional e utilização em dietas, 
foram selecionadas seis espécies silvestres da flora medicinal Portuguesa, como fontes 
importantes de compostos fenólicos, nomeadamente flavonoides. O presente estudo teve 
como objetivo caracterizar a composição fenólica e avaliar as propriedades bioativas 
(antioxidante, antitumoral e antiangiogénica) de extratos, infusões e decocções 
preparadas a partir de Chamaemelum nobile e Matricaria recutita, e frutos de Prunus 
spinosa, Arbutus unedo, Rosa micrantha e Rosa canina; e sintetizar derivados/ 
metabolitos de alguns flavonoides presentes nas espécies estudadas. Os compostos 
fenólicos mais abundantes no extrato, decocção e infusão de C. nobile foram flavonóis, 
flavonas, ácidos fenólicos e derivados. O extrato mostrou a maior atividade antioxidante 
nos ensaios de inibição da descoloração do β-caroteno e da formação de TBARS. A maior 
atividade captadora de radicais livres e o maior poder redutor foram observados na 
infusão. O extrato mostrou maior atividade antitumoral (nas diferentes linhas celulares 
tumorais) e antiangiogénica (inibição da fosforilação do VEGFR-2). A infusão e a 
decocção de M. recutita mostraram maior atividade captadora de radicais livres e inibição 
da descoloração do β-caroteno do que o extrato. Os efeitos antitumorais do extrato e da 
infusão mostraram ser seletivos para as linhas celulares HeLa e HCT-15. A luteolina-O-
acil-hexósido foi o flavonoide mais abundante nas três preparações. O ácido 3-O-
cafeoilquínico foi o composto fenólico mais abundante em P. spinosa, enquanto que a 
quercetina 3-O-glucósido foi o maioritário em A. unedo, e a taxifolina foi o mais 
abundante em R. canina e R. micrantha. P. spinosa revelou o maior teor em antocianinas. 
Prepararam-se dois extratos fenólicos diferentes de forma a comparar a sua bioatividade: 
um extrato enriquecido em compostos fenólicos sem antocianinas (PE) e um extrato 
enriquecido em antocianinas (AE). A. unedo (PE) e R. canina (AE) apresentaram a maior 
atividade antioxidante em todos os ensaios, e a maior atividade antitumoral foi observada 
em A. unedo (PE e AE). A síntese de derivados/metabolitos dos flavonoides foram 
realizados usando a quercetina e rutina (quercetina 3-O-rutinósido) (identificados nas 
amostras estudadas) obtendo-se O-tri e diferentes O-tetra (benzil ou metil) quercetinas 
protegidas, que foram submetidas a tentativas de glucuronidação usando o éster metílico 
do ácido acetobromo-α-ᴅ-glucurónico a fim de obter possíveis precursores de metabolitos 
humanos. Tendo-se obtido misturas complexas, são necessários mais estudos para 
permitir a formação de quantidades mais elevadas dos glucuronidos requeridos, que 
possibilitem o isolamento dos compostos numa forma pura.  
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Chapter 1. Introduction 
Ethnobotany is an interdisciplinary science which investigates the relationships between 
plants and human societies. The knowledge of plant use was widespread in ancient 
civilizations. The folk knowledge about medicinal use of plants has been transmitted for 
centuries primarily orally (Pieroni & Privitiera, 2014). The traditional use of medicinal 
plants seems to have survived across generations relatively intact, some of these traditions 
have changed or disappeared, and new interests in the use of medicinal and aromatic 
plants have emerged (Quave et al., 2012). Until the middle of the 19th century, plants 
were the main therapeutic agents used by humans, and even today their role in medicine 
is still relevant (Camejo-Rodrigues et al., 2003, Pieroni & Privitiera, 2014). 
Ethnopharmacology focuses on the understanding of local and indigenous use of the 
bioactive natural products (Staub et al., 2015). In recent years, much of the 
ethnopharmaceutical research has been focused to more specific approaches in order to 
evaluate and better understanding the biological and pharmacological effects of the 
medicinal plants (Heinrich, 2003) Phytochemical studies on medicinal plants are 
relatively abundant in the last years (Delgado, 1992). Studies that combine a 
phytochemical and a detailed pharmacological approach, or studies that explored their 
effects on health has increased. Considering the increasing interest in the chemical nature 
and the mechanisms of action of antioxidants from commonly used medicinal plants, the 
species selected in this work are certainly important sources of flavonoids. To study 
pharmacological effects that confirm the relevance of empirical uses of some wild species 
and their contribution to a good health condition is important. The plants involved in this 
work, were chosen according to data provided by ethnobotanical surveys. It is based on 
consented interviews carried out in Trás-os-Montes, Portugal, and these plants are some 
of the most mentioned and used in this region. This work aims at providing knowledge 
of the mechanisms involved in health-promoting properties of such species through their 
flavonoids and/or metabolites. 
 
1.1 Flowers heads of Chamaemelum nobile and Matricaria recutita 
1.1.1 Botanical characterization 
Roman chamomile, Chamaemelum nobile L. is a perennial herb found in wild and 
cultivated habitats in western Europe, North America and Northern Africa. In traditional 
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medicine, chamomile flowers are used as an anti-inflammatory and spasmolytic beverage 
for stomach disorders (Melegari et al., 1988; Rossi et al., 1988). German chamomile, 
Matricaria recutita L., is an annual herbaceous flowering plant native to Europe. Both 
from the botanical family Asteraceae, these herbs have been used as herbal remedies for 
thousands of years (Crevin, 1990). 
German chamomile (also known as Matricaria recutita L., Chamomilla recutita [L.] 
Rauschert, Matricaria chamomilla L., Matricaria suaveolens L.), is one of the most 
popular and widely used medicinal plants in the world. The plant has a long history of 
application in herbal medicine, which dates back to ancient Greece and Rome where it 
was referenced by Hippocrates, Galen and Asclepius (Tolouee et al., 2010). 
 
1.1.2 Bioactive properties 
Different classes of bioactive constituents are present in Roman chamomile (C. nobile), 
including phenolic compounds (Carnat et al., 2004; Tschan et al., 1996). Otherwise, C. 
nobile is tradicionally considered to be an antiseptic, antibiotic, disinfectant, bactericidal, 
fungicidal and vermifuge. It has been used for centuries as anti-inflammatory, 
antioxidant, mild astringent, mild sedative, antispasmodic, antibacterial and healing 
medicine (Ma et al., 2007). Oral dosage forms (decoctions and infusions) are used for the 
symptomatic treatment of gastrointestinal disorders and of the painful component of 
functional digestive symptoms. External applications of extracts and lotions are 
recommended as repellent and emollient, in the treatment of skin disorders and for eye 
irritation or discomfort of various etiologies. Furthermore, it is used as an analgesic in 
diseases of the oral cavity, oropharynx or both and as a mouthwash for oral hygiene 
(Srivastava et al., 2010). In this work some studies of Roman chamomile (C. nobile) will 
be presented, focusing in nutritional composition, phytochemicals whitin the herb and its 
infusion and decoction, and, antioxidant and antitumor activity (SubChapter 3.1) 
(Guimarães et al., 2013). 
German chamomile (M. recutita) contains several classes of biologically active 
compounds including essential oils (Granzera et al., 2006; Petronilho et al., 2012) and 
several polyphenols (McKay & Blumberg, 2006; Nováková et al., 2010). It has also been 
used traditionally as a medicinal and pharmaceutical preparation, due to its anti-
inflammatory, anti-spasmodic, analgesic, antibacterial, anti-allergic antioxidant and mild 
astringent properties, and healing characteristics (Maschi et al., 2008; McKay & 
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Blumberg, 2006; Weiss, 1988). Externally, German chamomile has been used to treat 
diaper rash, cracked nipples, chicken pox, ear and eye infections, disorders of the eyes 
including blocked tear ducts, conjunctivitis, nasal inflammation and poison ivy 
(Srivastava et al., 2010). The use of German chamomile beverages as medicinal 
preparations has a long tradition in various countries. Infusions and essential oils are used 
in a number of commercial products including soaps, detergents, perfumes, lotions, 
ointments, hair products, baked goods, confections, alcoholic beverages and herbal teas 
(Gupta et al., 2010). Traditionally, German chamomile flowers are prepared as an 
infusion with water, to make an herbal tea (Harbourne et al., 2009). Recent research 
supports this use and shows that these properties are partly due to the phenolic content 
(Maschi et al., 2008; McKay & Blumberg, 2006). 
In fact, different studies dealing with M. recutita flowers are available in literature, 
including reports on antioxidant properties of its methanol extract (Barros et al., 2010; 
Miliauskas et al., 2004), antitumor potential of aqueous and organic extracts (Strivastava 
& Gupta, 2007; Strivastava & Gupta, 2009), and phenolic composition of methanolic 
extracts (Mulinacci et al., 2000; Nováková et al., 2010).  
 
1.2 Fruits of Arbutus unedo, Prunus spinosa, Rosa canina and Rosa micrantha  
1.2.1 Botanical characterization 
The fleshy fruits of several shrubs and small trees are very popular and play a particular 
role in folk medicine and food systems in many regions of the world. Arbutus unedo L. 
(Goméz & Villar, 2004) from the Ericaceae, is a species widely distributed in the 
Mediterranean region and North Africa. Its fruits are a red aggregate drupe generally 
known as strawberry-tree berries. Prunus spinosa L. (Castroviejo et al., 2001), a 
deciduous shrub native to Europe from the Rosaceae family produces purple-blue drupes 
that have also been used as astringent, diuretic and purgative (Lust, 1980). 
Rosa canina L. is a widespread shrub native to Europe and Western Asia. It is a common 
species of dog roses (Rosa sect. Caninae), a section of Rosa most widespread in Central 
Europe (Wissemann et al., 2006). For centuries rose hips of Rosa canina have been used 
for nutrition, medicinal purposes and also for their ornamental value. Hips are rarely eaten 
fresh; usually they are dried and/or processed and consumed in form of herbal tea, nectar, 
wine or marmalade (Uggla et al., 2005; Yildiz & Alpaslan, 2012). Native to Europe and 
Western Asia, in Portugal, Rosa micrantha Borrer ex Sm. is a dense deciduous shrub of 
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the edges of oak forests. Rosa micrantha is a species highly praised in the Northeastern 
Portuguese region due to its characteristic apple scent, even if only skillful users are able 
to distinguish Rosa micrantha from the other roses of the section. Medicinal and 
veterinary are the more mentioned uses of this particular species (Carvalho, 2010). 
In several Portuguese regions, the fruits of Arbutus unedo and of Rosaceae species are 
commonly eaten raw, prepared in jams or macerated with sugar, honey and brandy to 
obtain a digestive and laxative liqueur, which is usually drunk after copious meals (Novais 
et al., 2004; Salgueiro, 2004; Camejo-Rodrigues, 2006; Carvalho, 2010). 
 
1.2.2 Bioactive properties 
Exotic or unusual foods, such as the fruits of Arbutus unedo (strawberry-tree), Prunus 
spinosa (blackthorn), Rosa canina (dog rose) and Rosa micrantha (wild rose) may have 
great potential for food industries as a source of colors and flavors, as well as bioactive 
molecules such as phenolic compounds for dietary supplements or functional foods (e.g. 
Barros et al., 2010; Guimarães et al., 2010; Barros et al., 2011; Barros et al., 2012; Barros 
et al., 2013; Morales et al., 2013). 
Arbutus unedo L. use is very popular in Portugal, particularly made in a kind of strong 
brandy, the ‘aguardente de medronho’. In several Portuguese regions (Trás-os-Montes, 
Alentejo and Algarve) the fruits are eaten raw or made in liqueurs, as well as, bark or 
roots decoctions, are used as anti-inflammatory, laxative, carminative, digestive, 
odontalgic and cardiotonic (Novais et al., 2004; Salgueiro, 2004; Camejo-Rodrigues, 
2006; Carvalho, 2010). Some literature report the traditional use of the leaves as a 
diuretic, urinary antiseptic, antidiarrheal, astringent, depurative, against blenorrhagia, 
diabetes and as antihypertensive (Ziyyat et al., 1997). Experimental investigations have 
already shown that the aqueous extract of the plant exhibited antihypertensive (Ziyyat & 
Boussairi, 1998) and vasorelaxant (Ziyyat et al., 2002) activities.  
There is great interested in the chemical characterization of the mentioned wild fruits 
traditionally consumed in Portugal by their medicinal and edible properties. Recent 
phytochemical studies performed revealed that they have antioxidant properties and 
important antioxidant molecules such as tocopherols and carotenoids (Barros et al., 2010; 
Guimarães et al., 2010).  
Prunus spinosa fruits are commonly eaten raw, prepared in jams or macerated with sugar, 
honey and brandy to obtain a digestive and laxative liqueur, which is usually drunk after 
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copious meals; they have also been used as astringent, diuretic and purgative (Novais et 
al., 2004; Salgueiro, 2004; Camejo-Rodrigues, 2006; Carvalho, 2010). Extracts from the 
flowers have been used as diuretic, anti-inflammatory, spasmolytic and mild laxative and 
‘blood cleansing’ agents (List & Hörhammer, 1971; Borkowski et al., 1994). In 
homeopathy products from fresh flowers are applied for circulatory system disorders 
(Wasilewski & Czelej, 1994; Olszewska & Wolbiś, 2001). 
Moreover, rose hips, i.e. the pomaceous fruit of dog roses, Rosa canina L., have 
prophylactic and therapeutic activities against a wide range of ailments, including the 
inflammatory disorders arthritis (Rein et al., 2004; Kharazmi, 2008), rheumatism, gout, 
and sciatica, as antipyretic, for colds and infectious including influenza, against 
gastrointestinal disorders, to aid digestion, and to prevent gastric mucosa inflammation 
and gastric ulcer, for gallstones, biliary complaints, as a laxative, for disorders of the 
kidney and the lower urinary tract, as a diuretic, for dropsy and as an astringent (Orhan et 
al., 2007).  
Rosa canina fruits are eaten raw as snacks and show prophylactic and therapeutic 
activities against a wide range of ailments, including the inflammatory disorders arthritis, 
rheumatism, gout, colds and gastrointestinal affections (Rein et al., 2004; Orhan et al., 
2007; Carvalho, 2010). Beneficial health and cosmetic properties of R. micrantha fruits 
have been transmitted and tapped by rural people for centuries; they were used to prepare 
homemade remedies that prevented or healed several human disorders and animal 
diseases (Parada et al., 2009; Carvalho, 2010). 
A few works on the phenolic composition of A. unedo fruits are available from Italy 
(Pawlowska et al., 2006), Portugal (Fortalezas et al., 2010; Tavares et al., 2010; Mendes 
et al., 2011) and Spain (Pallauf et al., 2008; Ganhão et al., 2010), P. spinosa from Spain 
(Ganhão et al., 2010) and R. canina from Norway (Hvattum, 2002), Poland (Fecka, 2009), 
Serbia (Tumbas et al., 2012) and Spain (Ganhão et al., 2010). 
 
1.3 Phenolic compounds 
1.3.1 Chemical features and biosyntesis 
Flavonoids belong to a group of natural substances and comprised the three major classes 
of secondary compounds produced higher plants (Winkel-Shirley, 1996). They are 
universally present in fruits, vegetables, legumes, nuts, seeds, herbs, grains, bark, roots, 
steams, flowers, cereals, tea and wine (Middleton, 1998; Kanadaswami et al., 2005), and 
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constitute a relatively diverse family of aromatic molecules (Winkel-Shirley, 2001). More 
than 8.000 varieties of these compounds have been identified. The biosynthetic pathway 
leading to the major classes of flavonoid-derivatives are summarized in  Figure 1 (Dixon 
& Steele, 1999).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All flavonoids are formed from a chalcone precursor, the product of the condensation of 
4-coumaroyl CoA (a product of the central phenylpropanoid pathway) and three 
molecules of malonyl CoA (formed from acetate via a cytoplasmic form of acetyl CoA 
carboxylase) by the enzyme chalcone synthase (CHS) (Dixon & Steele, 1999). The 
flavonoids are phenyl substituted chromones (benzopyran derivatives) consisting of a 15-
carbon basicskeleton (C6-C3-C6) (Kanadaswami et al., 2005). The basic structural feature 
of flavonoid is a 2-phenyl-4H-chromene, consisting of two benzene rings (A and B) 
linked through a heterocyclic pyran ring (C) (Cushine & Lamb, 2005), the benzopyrane 
moiety being a 4H-chromene. Flavonoids occur as aglycones, glycosides and methylated 
Figure 1. The biosynthesis of the major classes of flavonoid derivatives (Dixon & Steele, 1999). 
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derivatives (Kumar & Pandey, 2013). The basic flavonoid structure is aglycone and as 
shown in Figure 2. 
 
 
 
 
 
 
Flavonoids are divided according to the chemical structure into several classes based on 
the degree of the oxidation of the C-ring, the hydroxylation pattern of the ring structure 
and the substitution of the 3-position (Spencer et al., 2009). Depending on their oxidation 
state and functional groups, flavonoids are further divided in six subclasses which general 
structures are shown in Figure 3: -Flavones, e.g. apigenin (5,7-dihydroxy and 4’-
hydroxy) and luteolin (5,7-dihydroxy and 4’-hydroxy); -Flavonols, e.g. quercetin (5,7-
dihydroxy and 3’,4’-dihydroxy), myricetin (5,7-dihydroxy and 3’,4’,5’-trihydroxy) and 
kaempferol (5,7-dihydroxy and 4’-hydroxy); -Flavanones, e.g. naringenin (5,7-
dihydroxy and 3’,4’-dihydroxy) and hesperidin (5-hydroxy-7-O-diglycoside and 3’-
hydroxy,4’-methoxy); -Flavan-3-ols or catechins, e.g. epicatechin (5,7-dihydroxy and 
3’,4’-dihydroxy) and gallocatechin (5,7-dihydroxy and 3’,4’,5’-trihydroxy); Isoflavones, 
e.g. genistein (5,7-dihydroxy and 4’-hydroxy) and Anthocyanidins, e.g. cyanidin (5,7-
hydroxy and 3’,4’-dihydroxy). The position of the aryl substituent divides the flavonoid 
class into flavonoids (at the 2-position) and isoflavonoids (at the 3-position). Flavonols 
differ from flavanones by the hydroxy group at the 3-position and the C2-C3 double bond 
(Narayana et al, 2001). Flavonoids are often hydroxylated in positions 3, 5, 7, 3’, 4’, and 
5’. When glycosides are formed, the glycosidic linkage is normally located in positions 3 
or 7 and the carbohydrates can be ʟ-rhamnose, ᴅ-glucose, glucorhamnose, galactose, or 
arabinose (Middleton, 1984; Kumar & Pandey, 2013). 
 
 
Figure 2. Basic structure of flavonoids: 2-phenyl-4H-chromenes (Cushine & Lambe, 2005). 
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Figure 3. The basic groups of flavonoids (Mladӗnka et al., 2010). 
 
The flavones apigenin and luteolin are common in cereal grains and aromatic herbs (Pietta 
et al., 1995); flavonols quercetin and kaempferol are predominant in vegetables and fruits, 
and are constituents of the beverages green and black teas and red wine (Herrman, 1976). 
The flavanones are mainly found in citrus fruits, the flavan-3-ols (+)-catechin, (-)-
epicatechin, (-)-epigallocatechin, and their gallate esters are widely present in tea leaves. 
Isoflavones are found most often in legumes, including soybeans, black beans, green 
beans, and chick peas. Anthocyanidins and their glycosides (anthocyanins) are natural 
pigments and are abundant in berries and red grapes (Hastam, 1989; Pietta, 2000).  
The biochemical activities of flavonoids and their metabolites depend on their chemical 
structure and the relative position of various moieties on the molecule (Cody, 1988). The 
flavonoids can undergo modifications 
These molecules can suffer moditications on their aromatic cycles, including 
hydroxylations, methylations, or O-glycosylations of hydroxy groups as well as C-
glycosylation directly to carbon atom of the flavonoid skeleton (Stobiecki & Kachlicki, 
2006), hydrogenation, malonylation, sulphation acylations or prenylations, which 
account for the diversity within a compound class (Dixon & Pasinetti, 2010).  
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1.3.2 Bioactive properties 
Flavonoids are plant phytochemicals that cannot be synthesized by humans (Peterson & 
Dwyer, 1998). Flavonoids have many biochemical, physiological and ecological 
functions in plants, and they are important in both plant productivity and animal nutrition 
(Forkmann & Martens, 2001). The function of flavonoids in flowers is to provide colours 
attractive to plant pollinators (Middleton & Chithan, 1993; Harborne & Williams, 2000). 
Flavonoids present in leaves promote physiological survival of plant by protecting it from 
the fungal infections and UV radiations. In addition, flavonoids are involved in 
photosensitization, respiration and photosynthesis control, morphogenesis, sex-
determination and energy transfer (Cushine & Lamb, 2005). They can also function as 
stress protectants in plant cells by scavenging radical oxygen species (ROS) produced by 
the photosynthetic electron transport system (Harborne & Grayer, 1994). Flavonoids have 
antimicrobial properties and act as a deterrent for herbivores by limiting assimilation of 
dietary proteins and inhibiting digestive enzymes (Dixon et al., 2005; Marles et al., 2003; 
Scalbert, 1991). Flavonoids are present in daily human diet and have been reported to 
exert beneficial effects in disease prevention (Upadhyay & Dixit, 2015). Many studies 
have shown that these compounds play important biological, pharmacological, 
physiological, medicinal and epidemiological effects. The biological effects of dietary 
flavonoids include antiinflammatory, antiallergic, antimicrobial, hepatoprotective, 
antiviral, antibacterial, antithrombotic, cardioprotective, capillary strengthening, 
antidiabetic, anticarcinogenic, antineoplastic and vasodilatory actions (Middleton et al., 
2000; Weber et al., 2003; Widlansky et al., 2005; Kanadaswami et al., 2005; Alvesalo et 
al., 2006).  
Flavonoid metabolites may have a higher or lower biological activity than the parent drug, 
and result in a change of the overall cancer protective response (Nielsen et al., 2000). The 
flavonoids have applications as antibiotics, antidiarrheal, antiulcer and antitumorals. As 
anti-inflammatory agents, they have applications in the treatment of diseases such as 
hypertension, vascular fragility, allergies, hypercholesterolemia, and others (Bravo 1998; 
Yao et al., 2004; Ferguson et al., 2004; Ma et al., 2004; Moon et al., 2006). Epidemiologic 
studies suggest a protective role of dietary flavonoids with consumption of fresh fruits 
and vegetables against coronary heart disease (Pietta, 2000). There is increasing evidence 
for the health-protecting function of flavonoid compounds, such as antioxidative and 
antitumor activities (Forkmann & Martens, 2001). The best described property of almost 
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every group of flavonoids is their capacity to act as antioxidants (Kumar & Pandey, 2013). 
The protective effects of flavonoids in biological systems are ascribed to their capacity to 
transfer electrons free radicals, chelate metal catalysts (Ferrali et al., 1997), activate 
antioxidant enzymes (Elliott et al., 1992), reduce alpha-tocopherol radicals (Hirano et al, 
2001) and inhibit oxidases (Cos et al., 1998). Flavonoids are oxidized by radicals (R•), 
resulting in a more stable, less-reactive radical; they stabilize the reactive oxygen species 
by reacting with the reactive compound of the radical. Because of the high reactivity of 
the hydroxy group of the flavonoids, radicals are made inactive, according to the 
following equation: 
 
Flavonoid(OH) + R•            flavonoid(O•) + RH  
 
Selected flavonoids can directly scavenge superoxides, whereas other flavonoids can 
scavenge the highly reactive oxygen derived radical called peroxynitrite (Nijveld et al., 
2001).The antioxidant activity of flavonoids and their metabolites in vitro depends upon 
the arrangement of functional groups about the nuclear structure (Heim et al., 2002). 
Several flavonoids have been reported to quench active oxygen species and inhibit in vitro 
oxidation of low-density lipoproteins and therefore reduce thrombotic tendency (Škerget 
et al., 2005). The antioxidant activity of flavonoids towards free radicals and reactive 
oxygen species, and their potential estrogenic and anticancer activity, such as 
antiproliferation, promotion of differentiation and apoptosis, draws attention to their 
health-protecting role in human diet and animal feed (Forkmann & Martens, 2001). In 
vitro data effectively and consistently demonstrate the antioxidant efficacy of structurally 
diverse flavonoids under many circumstances of oxidative stress (Heim et al., 2002).  The 
chemopreventive properties of flavonoids are generally believed to reflect their ability to 
scavenge endogenous ROS (Galati & O’Brien, 2004). Interestingly, a recent review 
suggests that flavonoids may not act as conventional hydrogen-donating antioxidants but 
may exert modulatory actions in cells through actions at protein kinase and lipid kinase 
signaling pathways (Williams et al., 2004). Due to their capacity to inhibit LDL oxidation, 
flavonoids have demonstrated unique cardioprotective effects (Kondo et al., 1996; Mazur 
et al., 1999),  from the ability to inhibit lipid peroxidation, chelate redox-active metals, 
and attenuate other processes involving ROS (Heim et al., 2002). Flavonoids are 
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extremely safe and associated with low toxicity, making them excellent candidates for 
chemopreventive agents (Moon et al., 2006). The cancer protective effects of flavonoids 
have been attributed to a wide variety of mechanisms, including free radical scavenging, 
modifying enzymes that activate or detoxify carcinogens, and inhibiting the induction of 
the transcription factor activator protein-1 (AP-1) activity by tumor promoters (Canivenc-
Lavier et al., 1996; Shih et al., 2000). Isoflavonoids and flavonoids, have received 
particular attention as putative cancer protective agents in populations with low 
incidences of breast and prostate cancer (Adlercreutz et al., 1991). These compounds have 
been proposed as primary chemopreventive agents mainly due to their abilities to 
specifically inhibit tumor cell proliferation through blockade of signal transduction, their 
anti-oxidant effects and/or their anti-metastatic properties through an inhibition of tumor 
angiogenesis (Ramos, 2007; Pan et al. 2011; Zhao et al, 2009; He et al., 2009). The 
consummation of food products containing high amounts of flavonoids has been reported 
to lower the risk of various cancers and prevention of other diseases (Brusselmans et al., 
2005; Arinç & Ylmaz, 2015). 
 
1.3.3 Human metabolites 
It is now established that polyphenols undergo substantial metabolism after being 
ingested by humans in dietary relevant amount and concentrations of plasma metabolites 
after a normal dietary intake rarely exceed nmol/L (Manach et al., 2005; Donovan et al., 
2006). Polyphenols are extensively altered during first-pass metabolism so that, typically, 
the molecular forms reaching the peripheral circulation and tissues are different from 
those present in foods (Day et al., 2001; Day & Williamson, 2001; Graefe et al., 2001; 
Natsume et al., 2003; Setchell et al., 2003; Zhang et al., 2003). The absorption of dietary 
flavonoids liberated from the food by chewing will depend on its physicochemical 
properties such as molecular size, configuration, lipophilicity, solubility, and pKa. 
Absorption may also depend on dosage, vehicle of administration, antecedent diet, sex 
differences, and microbial population on the colon (Erlund et al., 2001; Kumar & Pandey, 
2013). Importantly it is the chemical structure of polyphenols and not its concentration 
that determines the rate and extent of absorption and the nature of the metabolites 
circulating in the plasma (Pandey & Rizvi, 2009). The flavonoids can be absorved from 
small intestine or have go to the colon before absorption. It may depend upon structure 
of flavonoid, which is whether the glycoside or the aglycone (Erlund et al., 2001; Kumar 
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& Pandey, 2013). There are two major sites of flavonoid metabolism, the colon 
microflora, which (in addition to release aglycones) degrade flavonoids into phenolic 
acids, and in the liver (Rice-Evans, 2001) (Table 1). 
 
 
 
 
The metabolism of flavonoids was initially thought to be mediated by cytochrome P450 
enzymes (CYP P450 demethylates flavonols at the 4’-position and not at the 3’-position) 
(Nielsen et al., 1998; Walle, 2004). 
For example, galangin (5,7-dihydroxyflavonol, Figure 3) is sequentially transformed to 
kaempferol (5,7,4’-trihydroxyflavonol, Figure 3) by the mechanism depending on 
cytochrome P450 reactions among which the CYP1A1 plays the major role (Silva et al., 
1997; Silva et al., 1997). The metabolism of flavonoids starts in lumen of small intestine 
and post-absorption modifications also occur in the liver and other organs (Manach et al., 
2005; Mullen et al., 2006). The degradation of a flavonoid skeleton occurs mainly in the 
gut. Bacterial ring scission of flavonoids results in degradation products, such as various 
phenolic acids. These metabolites can be again absorbed and consequently found in urine 
Table 1.Enzymes involved in polyphenol metabolism. 
Enzyme  Local Function Reference 
CBG-Cytosolic β-glucusidase (EC2.2.1.1) Especially found in liver 
Catalyzes the hydrolysis of 
xenobiotic glycosides 
Gopalan et al., 1992; 
Lamarco & Glew, 
1986 
LPH-Lactase phlorizin hydrolase 
(EC3.2.1.108) 
Small intestine 
Catalyzes the hydrolysis of a wide 
range of polyphenol glucoside 
Day et al., 2000 
COMT- Catechol-O-methyltransferase 
(EC2.1.1.6) 
Variety of tissues Methylates polyphenols Nielsen et al., 1998 
UDP- Glucuronosyl transferase 
(UDPGT/UGT/EC2.4.1.17) 
Endoplasmatic reticulum 
Catalyzes the conjugation of 
polyphenols to glucuronic acid 
Yang et al., 1998; 
Mojarrabi & 
MacKenzie, 1998; 
Strassburg et al., 
1998,1999. 
 UGT1A Intestine, liver, kidney 
 UGT1A1 
Found in liver 
 UGT1A3 
 UGT1A4 
 UGT1A6 
 UGT1A9 Liver, kidney 
 UGT1A8 Liver, colon 
 UGT1A7 
Human gastric epithelium 
 UGT1A10 
P-PST-Phenol 
sulphotransferases (SULT/EC 
2.8.2.1) 
 Cytosolic enzymes  
Coughtrie et al, 1998 SULT1A1 Liver  
SULT1A3 Colon  
Towards antioxidant and antitumor properties of wild medicinal plants traditionally used in Portugal 
15 
  
(Hollman & Katan, 1997; Rice-Evans, 2001). They are absorbed through the gut barrier, 
or, for the non-absorbed fraction and the fraction re-excreted in the bile, by the colon 
microflora. All polyphenols are conjugated to form O-glucuronides, sulphate esters and 
O-methyl ethers (Scalbert, 2002). In 1995 Hollman et al., based on indirect evidence, 
proposed that flavonoid glycosides could be absorved intact in the small intestine, using 
the sodium-dependent glucose transporter 1 (SGLT1) (Hollman et al., 1995). 
Most flavonoids, except for the subclass of catechins, are present in plants bound to sugars 
as β-glycosides. Because mammals lack the appropriate β-glycosidases, most of 
glycosides pass into the large intestine, where they are hydrolyzed by the microflora, in 
to their corresponding free aglycones (Griffiths & Barrow 1972; Bravo 1998). These are 
absorbed through the gut epithelium and methylated and/or conjugated with glucuronic 
acid or sulphate in the liver. This tissue has the capacity to oxidize (introduction of 
hydroxy groups), reduce (carbonyl groups), methylate (creation of O-methyl ethers) or 
conjugate (to form glucuronic- or sulphate-conjugates) flavonoids (Hackett, 1986).    
Due to the conjugation reactions, no free flavonoid aglycones can be found in plasma or 
urine, except for catechins (Hollman, 2004). The flavonoids secreted with bile in intestine 
and those that cannot be absorbed by the small intestine are degraded in the colon by 
microflora, which also break down the flavonoid ring structure (Figure 4). 
 
 
 
 
 
 
 
 
During absorption across the intestinal membrane, flavones, flavonols, isoflavones, and 
catechins are partly transformed in their glucuronides and sulphates (King et al., 1996). 
Figure 4. Compartments involved in the metabolism of flavonoids (Kumar & Pandey, 2013). 
Towards antioxidant and antitumor properties of wild medicinal plants traditionally used in Portugal 
16 
  
Subsequently, this small fraction of the absorbed flavonoids is metabolized by the liver 
enzymes, resulting in more polar conjugates being excreted in the urine or returned to the 
duodenum. However, the major part of ingested flavonoids is not absorbed and is largely 
degraded by the intestinal microflora. The bacterial enzymes catalyze several reactions, 
producing several phenolic acids, depending on the structure of the flavonoid involved, 
as shown in Figure 5 for rutin metabolism (Pietta, 2000). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These phenolic acids can be reabsorbed and subjected to conjugation and O-methylation 
in the liver and then may enter into the circulation (Pietta, 2000). The formation of anionic 
derivatives by conjugation with glucuronides and sulphate groups facilitates their urinary 
and biliary excretion and explains their rapid elimination. Another example of metabolic 
pathways for the conversion of dietary quercetin is shown in Figure 6. 
Figure 5. Metabolic conversion of rutin; (I) 3,4-dihydroxyphenylacetic acid, (II) 3-methoxy-4-
hydroxyphenylacetic acid, (III) 3-methoxy-4-hydroxybenzoic acid, (IV) 3,4-dihydroxybenzoic acid and 
(V) 3-methoxy-4-hydroxyhippuric acid (Pietta, 2000). 
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Figure 6 showed the major metabolic pathways for the conversion of dietary quercetin. 
Quercetin, present in food as glycosides, is absorbed intact by SGLT1 and hydrolyzed by 
β-glucosidase in enterocytes. In addition, dietary glycosides of quercetin can be 
hydrolyzed before absorption by membrane-bound lactase phlorizin hydrolase (LPH). In 
the enterocyte, quercetin aglycone (“free” quercetin) (1) is mostly metabolized to 
quercetin-3-O-glucuronide (4) by UDP- glucuronosyl transferase (UGT) or to quercetin-
3’-O-sulphate (5) by sulphate transferase (ST) and exported into the circulation. In the 
liver, the glucuronides undergo further metabolism, mainly by ST and catechol O-methyl 
transferase (COMT). These processes and enzymes combined are responsible for the 
metabolites detected in plasma and urine. In addition, quercetin may undergo 
enterohepatic circulation by its excretion through bile and subsequent intestinal 
reabsorption (Lotito et al., 2011). 
The metabolism of most other dietary polyphenols in humans are comparable in several 
ways: (a) glycosides are generally not found in plasma or urine in the form ingested, (b) 
Figure 6. Major metabolic pathways for the conversion of dietary quercetin (Lotito et al., 2011). 
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the major forms in plasma and urine are sulphate and glucuronate conjugates of the parent 
aglycones, (c) methylation may occur on polyphenols that contain ortho-hydroxy 
functional groups, and (d) aglycones are absent or constitute only a very small proportion 
of the total amount of polyphenols present, except in green tea catechins, of which 
aglycones can constitute a significant proportion of the total amount in plasma (Hollman 
et al., 1997). 
 
1.4 Objectives of the present study and general overview 
The main objectives of our study were to: 
1. Chemically characterize wild species selected according their empirical relevance in 
traditional medicine and diets such as Chamaemelum nobile, Matricaria recutita, 
Prunus spinosa, Arbutus unedo, Rosa micrantha and Rosa canina. 
2. Evaluate the bioactive properties, including antioxidant, antitumor and 
phosphorylation inhibition of the vascular endothelium growth factor receptor-2 
(VEGFR-2), of methanolic extracts, infusions and decoctions prepared from the 
mentioned species. 
3. Synthesize derivatives/metabolites of some flavonoids present in the studied samples. 
 
The nutritional characterization of C. nobile included the determination of 
macronutrients, free sugars, fatty acids, tocopherols and carotenoids. The herb and its 
decoction and infusion were submitted to a detailed analysis of phytochemicals (phenolic 
compounds and organic acids) and bioactivity evaluation. The antioxidant activity was 
determined by free radicals scavenging activity, reducing power and inhibition of lipid 
peroxidation; the antitumor potential was tested in human tumor cell lines (breast, lung, 
colon, cervical and hepatocellular carcinomas); and their toxicity was evaluated using a 
porcine liver primary cell culture established in our laboratory. Furthermore, the 
antiangiogenic activity (phosphorylation inhibition of VEGFR-2) of C. nobile extracts 
(methanolic extract and infusion) and their main phenolic compounds (apigenin, 
apigenin-7-O-glucoside, caffeic acid, chlorogenic acid, luteolin, luteolin-7-O-glucoside) 
was evaluated through enzymatic assays using the tyrosine kinase intracellular domain of 
VEGFR-2. To better understand the phosphorylation inhibition mechanism of the 
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tyrosine kinase receptor by luteolin, apigenin and apigenin-7-O-glucoside, docking 
studies were performed.  
M. recutita infusion and decoction, the most consumed preparation of this herb, were 
characterized in terms of  organic acids and phenolic composition, and evaluated for their 
bioactive properties (antioxidant and antitumor activities, and toxicity).  
Finally, the in vitro antioxidant and antitumor properties of enriched phenolic extracts 
(non-anthocyanin phenolic compounds enriched extract and anthocyanins enriched 
extract) of A. unedo, P. spinosa, R. micrantha and R. canina wild fruits were evaluated 
and compared in order to clarify anthocyanins contribution for bioactivity and the 
advantageous of using purified/enriched instead of crude phenolic extracts. 
As quercetin is present in all the wild species studied it was chosen to be used in the 
synthesis of some derivatives/metabolites resulting for the human diet. Benzylation and 
methylation reactions in order to protect some hydroxy groups were performed. 
Methylated compounds can also be metabolites. Benzylated and methylated compounds 
were submitted to glucuronidation reactions. 
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Chapter 2. Chemical characterization and bioactive properties of the wild plants: 
Material and Methods 
2.1. Samples of plant materials 
Plant materials used in this study were selected from culturally significant species 
previously inventoried in several ethnobotanical surveys conducted in Portugal (e.g. 
Novais et al., 2004; Salgueiro, 2004; Camejo-Rodrigues, 2006; Carvalho, 2010) and 
reported as widely used for homemade remedies in folk medicine, and for food purposes. 
Accordingly, it has been documented that some edible parts of these species (e.g. flowers 
and fruits) were claimed to have important medicinal properties and empirically 
considered as good sources of vitamins (Carvalho, 2010).  
The selected species and the different types of plant materials collected are described in 
the following subsections. Gathering sites, plant parts or organs and the best period of the 
year to collect each species/material took into account local knowledge. Healers and 
experienced consumers’ criteria were also considered, particularly those criteria 
concerning specific food processing or requirements for safe herbal dosages forms, such 
as infusion and decoction.  
Voucher specimens of all studied species were deposited in the Herbarium of the Escola 
Superior Agrária de Bragança (BRESA). 
 
2.1.1. Chamaemelum nobile  
Chamaemelum nobile L. was gathered during the flowering season (June-July 2010) from 
wild populations located in grasslands in Bragança, Trás-os-Montes, Northeastern 
Portugal. Samples consisted of pieces of about 8 cm, corresponding to terminal soft leafy 
stems and inflorescences with flowers fully open and functional, picked up in plants 
randomly selected in a meadow of about a hectare. Morphological key characters from 
Rothmaler (2007) were used for plant identification. Plant material from different 
specimens was put together in a single final sample for analysis. The final sample was 
lyophilized (FreeZone 4.5, Labconco, Kansas, USA), reduced to a fine dried powder (20 
mesh) and mixed to obtain homogenate sample.  
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2.1.2. Matricaria recutita 
Matricaria recutita L. flower heads and leafy flowering stems of about 15 cm long were 
collected in 2009, in late spring and early summer, in the Natural Park of Montesinho 
territory, Trás-os-Montes, Northeastern Portugal. Plant material was collected from 
different specimens randomly chosen within a wild population. Morphological key 
characters from Rothmaler (2007) were used for plant identification. The sample was 
lyophilized (FreeZone 4.5, Labconco, Kansas, USA), reduced to a fine dried powder (20 
mesh) and mixed to obtain homogenate sample.  
 
2.1.3. Arbutus unedo, Prunus spinosa, Rosa canina and Rosa micrantha 
The fruits of Arbutus unedo L. (strawberry-tree) from Ericaceae, and the Rosaceae species 
Prunus spinosa L. (blackthorn), Rosa canina sl. (dog rose) and Rosa micrantha Borrer ex 
Sm. (similar to eglantine rose) were also gathered in the Natural Park of Montesinho 
territory, in Trás-os-Montes, Northeastern Portugal. From each species, several 
individuals growing in a selected plot of aproximatelly one hectare were casually marked 
in order to collect the mature fruits. Strawberry-tree berries were picked fully ripened in 
November 2008; well matured sloes and dog rose hips were gathered in late September 
2008. R. micrantha overripen hips, that is fleshy and soft dark red fruits, were collected 
in late autumn 2009. The ripeness degree of the fruits was established visually using the 
informant´s criteria of colour and texture, according to growth conditions of the season 
of the year. Considering that the state of ripeness was based in a subjective criterium, in 
order to obtain homogeneity within the samples of the same plant species, the colour of 
the removed ripened fruits from each plant was compared using the Royal Horticultural 
Society Colour Charts Edition V.  
Morphological key characters from the Flora Iberica (Castroviejo et al., 2001; Goméz & 
Villar, 2004) were used for confirming plant identification. The fruits including the seeds 
were lyophilized (Ly-8-FM-ULE, Snijders, Holland) and stored in the deep-freezer at -
20 ºC for subsequent analysis. 
 
2.2. Standards and reagents 
HPLC-grade acetonitrile was obtained from Merck KgaA (Darmstadt, Germany). Formic, 
acetic and trifluoroacetic acid (TFA) were purchased from Prolabo (VWR International, 
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France). Acetonitrile 99.9%, n-hexane 95% and ethyl acetate 99.8% were of HPLC grade 
from Fisher Scientific (Lisbon, Portugal). The fatty acids methyl ester (FAME) reference 
standard mixture 37 (standard 47885-U) was purchased from Sigma (St. Louis, MO, 
USA), as also other individual fatty acid isomers, sugars (ᴅ-(-)-Fructose, ᴅ-(+)-Glucose, 
ᴅ-(+)-Sucrose, ᴅ-(+)-Trehalose), tocopherols (α-, β-, γ-, and δ-isoforms) and trolox (6-
hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) standards. Racemic tocol, 50 
mg/mL, was purchased from Matreya (PA, USA). The phenolic compound standards 
(apigenin-6-C-glucoside; apigenin-7-O-glucoside; caffeic acid; chlorogenic acid; ferulic 
acid; p-coumaric acid; isorhamnetin-3-O-glucoside; kaempferol-3-O-rutinoside; luteolin-
6-C-glucoside; luteolin-7-O-glucoside; myricetin; myricetin-3-O-glucoside; 
protocatechuic acid; quercetin 3-O-glucoside and quercetin-3-O-rutinoside) were from 
Extrasynthese (Genay, France). 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained 
from Alfa Aesar (Ward Hill, MA, USA). Fetal bovine serum (FBS), ʟ-glutamine, Hank’s 
balanced salt solution (HBSS), trypsin-EDTA (ethylenediaminetetraacetic acid), 
nonessential amino acids solution (2mM), penicillin/streptomycin solution (100 U/mL 
and 100 mg/mL, respectively), RPMI-1640 and DMEM media were from Hyclone 
(Logan, USA). Acetic acid, ellipticine, sulforhodamine B (SRB), trypan blue, 
trichloroacetic acid (TCA) and Tris and all organic acids standards (ʟ-ascorbic acis; citric 
acid; fumaric acid; malic acid; shikimic acid; succinic acid; oxalic acid and quinic acid) 
were from Sigma Chemical Co. (Saint Louis, USA). Water was treated in a Milli-Q water 
purification system (TGI Pure Water Systems, USA). 
 
2.3. Nutritional characterization 
2.3.1. Crude composition 
Chamaemelum nobile was analysed for chemical composition (moisture, proteins, fat, 
carbohydrates and ash) using the AOAC procedures (AOAC, 1995). The crude protein 
content (N × 6.25) was estimated by the macro-Kjeldahl method; the crude fat was 
determined by extracting a known weight of powdered sample with petroleum ether, 
using a Soxhlet apparatus; the ash content was determined by incineration at 600 ± 15 ºC. 
Total carbohydrates were calculated by difference. Energy was calculated according to 
the following equation: Energy (kcal) = 4 × (g protein + g carbohydrate) + 9 × (g fat).  
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2.3.2. Sugars composition 
Free sugars of Chamaemelum nobile were determined by a High Performance Liquid 
Chromatography (HPLC) system consisted of an integrated system with a pump (Knauer, 
Smartline system 1000), degasser system (Smartline manager 5000) and auto-sampler 
(AS-2057 Jasco), coupled to a refraction index detector (RI detector Knauer Smartline 
2300) as previously described by the authors (Pereira et al.,2012). Sugars identification 
was made by comparing the relative retention times of sample peaks with standards. Data 
were analyzed using Clarity 2.4 Software (DataApex). Quantification was based on the 
RI signal response of each standard, using the internal standard (IS, raffinose) method 
and by using calibration curves obtained from commercial standards of each compound. 
The results were expressed in g per 100 g of dry weight. 
 
2.3.3. Fatty acids composition 
Fatty acids of Chamaemelum nobile were determined after a transesterification procedure 
as described previously by the authors (Pereira et al., 2012), using a gas chromatographer 
(DANI 1000) equipped with a split/splitless injector and a flame ionization detector (GC-
FID). Fatty acid identification was made by comparing the relative retention times of 
FAME peaks from samples with standards. The results were recorded and processed 
using CSW 1.7 software (DataApex 1.7). The results were expressed in relative 
percentage of each fatty acid. 
 
2.3.4. Tocopherols composition 
Chamaemelum nobile tocopherols were determined following a procedure previously 
optimized and described by the authors (Pereira et al., 2012). Analysis was performed by 
HPLC (equipment described above), and a fluorescence detector (FP-2020; Jasco) 
programmed for excitation at 290 nm and emission at 330 nm. The compounds were 
identified by chromatographic comparisons with authentic standards. Quantification was 
based on the fluorescence signal response of each standard, using the IS (tocol) method 
and by using calibration curves obtained from commercial standards of each compound. 
The results were expressed in mg per 100 g of dry weight. 
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2.3.5. Carotenoids composition 
β-carotene and lycopene of Chamaemelum nobile were determined following a procedure 
previously described by Nagata & Yamashita (1992). A fine dried powder (500 mg) was 
vigorously shaken with 10 mL of acetone–hexane mixture (4:6) for 1 min and filtered 
through Whatman No. 4 filter paper. The absorbance of the filtrate was measured at 453, 
505, 645 and 663 nm. Content of β-carotene and lycopene were calculated according to 
the following equations: 
β-carotene (mg/100mL) = 0.216 × A663 − 1.220 × A645 − 0.304 × A505 + 0.452 × A453;  
Lycopene (mg/100mL) = −0.0458 × A663 + 0.204 × A645 − 0.304 × A505 + 0.452 × A453;  
and further expressed in mg per 100 g of dry weight (dw).  
 
2.4. Preparation of extracts 
2.4.1. Methanolic extracts 
2.4.1.1. Chamaemelum nobile and Matricaria recutita: 
The methanolic extracts were prepared from the lyophilized plant material. Each sample 
(1 g) was extracted by stirring with 25 mL of methanol (25 ºC at 150 rpm) for 1 h and 
subsequently filtered through Whatman No. 4 paper. The residue was then extracted with 
25 mL of methanol (25 ºC at 150 rpm) for 1 h. The combined methanolic extracts were 
evaporated at 40 ºC (rotary evaporator Büchi R-210) to dryness.  
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2.4.1.2. Arbutus unedo, Prunus spinosa, Rosa micrantha and Rosa canina  
2.4.1.2.1. Non-anthocyanin phenolic compounds enriched extract (PE):  
Each sample (1 g) was extracted with 30 mL of methanol:water 80:20 (v/v) at room 
temperature, 150 rpm, for 1 h. The extract was filtered through Whatman nº4 paper. The 
residue was then re-extracted twice with additional 30 mL portions of methanol:water 
80:20 (v/v). The combined extracts were evaporated at 35 ºC (rotary evaporator Büchi R-
210) to remove methanol. For purification, the extract solution was deposited onto a C-
18 SepPak® Vac 3cc cartridge (Phenomenex), previously activated with methanol 
followed by water; sugars and more polar substances were removed by passing through 
10mL of water and phenolic compounds were further eluted with 5mL of methanol. The 
methanolic extract obtained (designated by phenolic extract) was concentrated under 
vacuum and stored at 4 ºC for further use.  
 
2.4.1.2.2. Anthocyanins enriched extract (AE):  
Each sample (1 g) was extracted with 30 mL of methanol containing 0.5% TFA, and 
filtered through a Whatman nº4 paper. The residue was then re-extracted twice with 
additional 30 mL portions of 0.5% TFA in methanol. The combined extracts were 
evaporated at 35 ºC to remove the methanol, and re-dissolved in water. For purification, 
the extract solution was deposited onto a C-18 SepPak® Vac 3cc cartridge (Phenomenex), 
previously activated with methanol followed by water; sugars and more polar substances 
were removed by passing through 10 mL of water and anthocyanin pigments were further 
eluted with 5 mL of methanol:water (80:20, v/v) containing 0.1% TFA. The methanolic 
extract (designated by anthocyanins extract) was concentrated under vacuum, lyophilized 
and stored at 4 ºC for further use. 
 
2.4.1.2.3. Phenolic acids, flavones/ols and flavan-3-ols:  
Each sample (1 g) was extracted with 30 mL of methanol:water 80:20 (v/v) at room 
temperature, 150 rpm, for 1 h. The extract was filtered through Whatman nº4 paper. The 
residue was then re-extracted twice with additional 30 mL portions of methanol:water 
80:20 (v/v). The combined extracts were evaporated at 35 ºC (rotary evaporator Büchi R-
210) to remove methanol. For purification, the aqueous phase was deposited onto a C-18 
SepPak® Vac 3cc cartridge (Phenomenex), previously activated with methanol followed 
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by water; sugars and more polar substances were removed by passing through 10mL of 
water and the purified extract was further eluted with  5 mL of methanol. The methanolic 
extract was concentrated under vacuum, and re-dissolved in 1mL of 20% aqueous 
methanol and filtered through a 0.22 µm disposable LC filter disk for HPLC analysis. 
2.4.2. Aqueous extracts 
2.4.2.1. Decoctions of Chamaemelum nobile and Matricaria recutita 
Each sample (1 g) was added to 200 mL of distilled water, heated (heating plate, VELP 
scientific) and boiled for 5 min. The mixture was left to stand at room temperature for 5 
min more, and then filtered under reduced pressure. The obtained decoctions were frozen 
and lyophilized.  
 
2.4.2.2. Infusions of Chamaemelum nobile and Matricaria. recutita 
Each sample (1 g) was added to 200 mL of boiling distilled water and left to stand at room 
temperature for 5 min, and then filtered under reduced pressure. The obtained infusions 
were frozen and lyophilized. 
 
2.5. Analysis of phytochemicals in the extracts  
2.5.1. Organic acids 
Organic acids were determined in Chamaemelum nobile and Matricaria recutita 
following a procedure previously optimized and described by the authors (Barros,et al., 
2012). Analysis was performed by ultra fast liquid chromatograph (UFLC) coupled to 
photodiode array detector (PDA), using a Shimadzu 20 A series UFLC (Shimadzu 
Corporation). Detection was carried out in a PDA, using 215 nm and 245 nm as preferred 
wavelengths. The organic acids were quantified by comparison of the area of their peaks 
recorded at 215 nm with calibration curves obtained from commercial standards of each 
compound. The results were expressed in g per 100 g of lyophilized methanolic 
extract/decoction/infusion. 
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2.5.2. Phenolic compounds 
2.5.2.1.  In Chamaemelum nobile and Matricaria recutita 
Phenolic compounds were determined by HPLC (Hewlett-Packard 1100, Agilent 
Technologies, Santa Clara, USA) as previously described by the authors (Barros et al., 
2012). Double online detection was carried out in the diode array detector (DAD) using 
280 nm and 370 nm as preferred wavelengths and in a mass spectrometer (API 3200 
Qtrap, Applied Biosystems, Darmstadt, Germany) connected to the HPLC system via the 
DAD cell outlet. The phenolic compounds were characterized according to their UV and 
mass spectra and retention times, and comparison with authentic standards when 
available. For quantitative analysis, calibration curves were prepared from different 
standard compounds. The results were expressed in g per 100 g of lyophilized methanolic 
extract/decoction/infusion. 
 
2.5.2.2. In Arbutus unedo, Prunus spinosa, Rosa micrantha and Rosa canina  
2.5.2.2.1. Phenolic acids and flavones/ols 
The extracts were analysed using a Hewlett-Packard 1100 chromatograph (Agilent 
Technologies) with a quaternary pump and a diode array detector (DAD) coupled to an 
HP Chem Station (rev. A.05.04) data-processing station. A Waters Spherisorb S3 ODS-
2 C18, 3 μm (4.6 mm × 150 mm) column thermostatted at 35 °C was used. The solvents 
used were: (A) 0.1% formic acid in water, (B) acetonitrile. The elution gradient 
established was 10% B to 15% B over 5min, 15–25% B over 5 min, 25–35% B over 
10 min, isocratic 50% B for 10 min, and re-equilibration of the column, using a flow 
rate of 0.5 mL/min. Double online detection was carried out in the DAD using 280 nm 
and 370 nm as preferred wavelengths and in a mass spectrometer (MS) connected to 
HPLC system via the DAD cell outlet. MS detection was performed in an API 3200 
Qtrap (Applied Biosystems, Darmstadt, Germany) equipped with an ESI source and a 
triple quadrupole-ion trap mass analyzer that was controlled by the Analyst 5.1 software. 
Zero grade air served as the nebulizer gas (30 psi) and turbo gas for solvent drying (400 
ºC, 40 psi). Nitrogen served as the curtain (20 psi) and collision gas (medium). The 
quadrupols were set at unit resolution. The ion spray voltage was set at -4500 V in the 
negative mode. The MS detector was programmed for recording in two consecutive 
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modes: Enhanced MS (EMS) and enhanced product ion (EPI) analysis. EMS was 
employed to show full scan spectra, so as to obtain an overview of all of the ions in 
sample. Settings used were: declustering potential (DP) -450 V, entrance potential (EP) 
-6 V, collision energy (CE) -10 V. EPI mode was performed in order to obtain the 
fragmentation pattern of the parent ion(s) in the previous scan using the following 
parameters: DP -50 V, EP -6 V, CE -25 V, and collision energy spread (CES) 0 V. 
Spectra were recorded in negative ion mode between m/z 100 and 1000. The phenolic 
compounds present in the samples were characterised according to their UV and mass 
spectra and retention times compared with standards when available. For the 
quantitative analysis of phenolic compounds, a 5-level calibration curve was obtained 
by injection of known concentrations (2.5-100 μg/mL) of different standards 
compounds: caffeic acid (y = 617.91x – 691.51; R2 = 0.9991); chlorogenic acid (y = 
600.27x –763.62; R2 = 0.9998); p-coumaric acid (y = 884.6x + 184.49; R2 = 0.9999); 
gallic acid (y = 556.94x – 738.37; R2 = 0.9988); isorhamnetin 3-O-glucoside (y = 
262.31x – 9.8958; R2 = 1.000); isorhamnetin 3-O-rutinoside (y = 327.42 x + 313.78; R2 
= 0.9991); kaempferol 3-O-glucoside (y = 190.75x – 36.158; R2 = 1.000); kaempferol 
3-O-rutinoside (y = 175.02x – 43.877; R2 = 0.9999); quercetin 3-O-glucoside (y = 
316.48x – 2.9142; R2 = 1.000); quercetin 3-O-rutinoside (y = 222.79x – 243.11; R2 = 
0.9998), taxifolin (y = 478.06x + 657.33; R2 = 0.9987). The results were expressed in 
mg per 100 g of dry weight (dw). 
 
2.5.2.2.2. Flavan-3-ols and galloyl derivatives 
The extracts were analysed using the HPLC system described above with the following 
conditions thermostatted at 25 °C: (A) 2.5% acetic acid in water, (B) 2.5% acetic 
acid/acetonitrile (90:10, v/v) and (C) HPLC-grade acetonitrile. The elution gradient 
established was 0% to 100% B for 5 min, from 0 to 5% C for 35 min, from 5 to 50 % C 
for 5 min, isocratic 50% C for 5 min, and re-equilibration of the column, using a flow 
rate of 0.5 mL/min. Double online detection was carried out in the DAD using 280 nm 
as preferred wavelength and in a mass spectrometer (MS) connected to HPLC system 
via the DAD cell outlet. The MS using the same equipment described above 
programmed using the following settings: declustering potential (DP) -40 V, entrance 
potential (EP) -7 V, collision energy (CE) -20 V. EPI mode was performed in order to 
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obtain the fragmentation pattern of the parent ion(s) in the previous scan using the 
following parameters: DP -40 V, EP -10 V, CE -25 V, and collision energy spread (CES) 
0 V. Spectra were recorded in negative ion mode between m/z 100 and 1400. The 
proanthocyanidins present in the samples were characterised according to their UV and 
mass spectra and retention times compared with standards when available. For the 
quantitative analysis of phenolic compounds, a 5-level calibration curve was obtained 
by injection of known concentrations (1-100 μg/ml) of different standards compounds: 
catechin (y = 161.23x + 177.26; R2 = 0.9992); ellagic acid (y = 36.81x + 257.13; R2 = 
0.9979); gallic acid (y = 298.26x – 634.14; R2 = 0.9949). The results were expressed in 
mg per 100g of dry weight (dw). 
2.5.2.2.3. Anthocyanins 
The extracts were analysed using the HPLC system described above in the conditions 
described by García-Marino et al., (2010). Separation was achieved on an AQUA® 
(Phenomenex) reverse phase C18 column (5 μm, 150 mm ×4.6 mm i.d) thermostatted at 
35 ºC. The solvents used were: (A) 0.1% TFA in water, and (B) 100% acetonitrile. The 
gradient employed was: isocratic 10% B for 3 min, from 10 to 15% B for 12 min, 
isocratic 15% B for 5 min, from 15 to 18% B for 5 min, from 18 to 30% B for 20 min 
and from 30 to 35% for 5 min, at a flow rate of 0.5 mL/min. Double detection was 
carried out by DAD, using 520 nm as the preferred wavelength, and MS using the same 
equipment described above. Zero grade air served as the nebulizer gas (40 psi) and turbo 
gas (600 ºC) for solvent drying (50 psi). Nitrogen served as the curtain (100 psi) and 
collision gas (high). Both quadrupols were set at unit resolution. The ion spray voltage 
was set at 5000 V in the positive mode. EMS and ESI methods were used for acquisition 
of full scan spectra and fragmentation patterns of the precursor ions, respectively. 
Setting parameters used for EMS mode were: declustering potential (DP) 4 V, entrance 
potential (EP) 7.5 V, collision energy (CE) 10 V, and parameters for EPI mode were: 
DP 41V, EP 7.5 V, CE 10 V, and collision energy spread (CES) 0 V.  The anthocyanins 
present in the samples were characterised according to their UV and mass spectra and 
retention times, and comparison with authentic standards when available. For 
quantitative analysis, a 5-level calibration curve was obtained by injection of known 
concentrations (50 - 0.25 μg/mL) of different standards compounds: cyaniding 3-O-
glucoside (y = 63027x – 153.83; R2 = 0.9995), delphinidin 3-O-glucoside (y = 557274x 
Towards antioxidant and antitumor properties of wild medicinal plants traditionally used in Portugal 
 
33 
  
+ 126.24; R2 = 0.9999) and peonidin 3-O-glucoside (y = 537017x – 71.469; R2 = 0.9997). 
The results were expressed in µg per 100 g of dry weight (dw). 
2.6. Bioactivity evaluation 
2.6.1. General 
The lyophilized methanolic extracts, decoctions and infusions were redissolved in i) water 
and methanol, respectively (final concentration 2.5 mg/mL) for antioxidant activity 
evaluation, or ii) water for antitumor activity evaluation (final concentration 8 mg/mL) 
re-dissolved in DMSO to a final concentration of 400 µg/mL. 
The results were expressed in i) EC50 values (sample concentration providing 50% of 
antioxidant activity or 0.5 of absorbance in the reducing power assay) for antioxidant 
activity, or ii) GI50 values (sample concentration that inhibited 50% of the cell growth) 
for antitumor activity. Water was used as negative control, and trolox and ellipticine were 
used as standards in antioxidant and antitumor activity evaluation assays, respectively. 
 
2.6.2. Antioxidant properties 
DPPH radical-scavenging activity was evaluated by using an ELX800 microplate reader 
(Bio-Tek Instruments, Inc; Winooski, USA), and calculated as a percentage of DPPH 
discolouration using the formula: [(ADPPH-AS)/ADPPH] × 100, where AS is the absorbance 
of the solution containing the sample at 515 nm, and ADPPH is the absorbance of the DPPH 
solution. Reducing power was evaluated by the capacity to convert Fe3+ into Fe2+, 
measuring the absorbance at 690 nm in the microplate reader mentioned above. Inhibition 
of β-carotene bleaching was evaluated though the β-carotene/linoleate assay; the 
neutralization of linoleate free radicals avoids β-carotene bleaching, which is measured 
by the formula: β-carotene absorbance after 2 h of assay/initial absorbance) × 100. Lipid 
peroxidation inhibition in porcine (Sus scrofa) brain homogenates was evaluated by the 
decreasing in thiobarbituric acid reactive substances (TBARS); the colour intensity of the 
malondialdehyde-thiobarbituric acid (MDA-TBA) was measured by its absorbance at 532 
nm; the inhibition ratio (%) was calculated using the following formula: [(A - B)/A] × 
100%, where A and B were the absorbance of the control and the sample solution, 
respectively (Pereira et al., 2012). 
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2.6.3. Antitumor properties 
Five human tumor cell lines were used: MCF-7 (breast adenocarcinoma), NCI-H460 
(non-small cell lung cancer), HCT-15 (colon carcinoma), HeLa (cervical carcinoma) and 
HepG2 (hepatocellular carcinoma). Cells were routinely maintained as adherent cell 
cultures in RPMI-1640 medium containing 10% heat-inactivated FBS (MCF-7, NCI-
H460 and HCT-15) and 2 mM glutamine or in DMEM supplemented with 10% FBS, 2 
mM glutamine, 100 U/mL penicillin and 100 mg/mL streptomycin (HeLa and HepG2 
cells), at 37 ºC, in a humidified air incubator containing 5% CO2. Each cell line was plated 
at an appropriate density (7.5 × 103 cells/well for MCF-7, NCI-H460 and HCT-15 or 1.0 
× 104 cells/well for HeLa and HepG2) in 96-well plates and allowed to attach for 24 h. 
Cells were then treated for 48 h with various extract concentrations. Following this 
incubation period, the adherent cells were fixed by adding cold 10% trichloroacetic acid 
(TCA, 100 µL) and incubated for 60 min at 4 ºC. Plates were then washed with deionized 
water and dried; sulforhodamine B solution (0.1% in 1% acetic acid, 100 µL) was then 
added to each plate well and incubated for 30 min at room temperature. Unbound SRB 
was removed by washing with 1% acetic acid. Plates were air dried, the bound SRB was 
solubilised with 10mM Tris (200 µL) and the absorbance was measured at 540 nm in the 
microplate reader mentioned above. 
 
2.6.4. Hepatotoxicity 
A cell culture was prepared from a freshly harvested porcine liver obtained from a local 
slaughter house, and it was designed as PLP2. Briefly, the liver tissues were rinsed in 
hank’s balanced salt solution containing 100 U/mL penicillin, 100 µg/mL streptomycin 
and divided into 1 × 1 mm3 explants. Some of these explants were placed in 25 cm2 tissue 
flasks in DMEM medium supplemented with 10% fetal bovine serum, 2 mM nonessential 
amino acids and 100 U/mL penicillin, 100 mg/mL streptomycin and incubated at 37 ºC 
with a humidified atmosphere containing 5% CO2. The medium was changed every two 
days. Cultivation of the cells was continued with direct monitoring every two to three 
days using a phase contrast microscope. Before confluence was reached, cells were 
subcultured and plated in 96-well plates at a density of 1.0 × 104 cells/well, and cultivated 
in DMEM medium with 10% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin 
(Abreu et al., 2011). 
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2.6.5. VEGFR-2 phosphorylation inhibition  
Chamaemelum nobile methanolic extract and infusion, and pure phenolic compounds 
(apigenin, luteolin, apigenin-7-O-glucuside, luteolin-7-O-glucuside, caffeic acid and 
chlorogenic acid) were assessed for VEGFR-2 inhibition activity using the Z'-LYTE-
Tyr1 Peptide assay kit (Invitrogen, Cat. PV3190) according to the procedures 
recommended by the manufacturer (Soares et al., 2013). Briefly, assays were performed 
in a total of 20 µL in 384-well plates using fluorescence resonance energy transfer 
technology. A Tyr1 substrate (coumarin-fluorescein double-labeled peptide) at 1 µM was 
incubated for 1 h with 4 µg/mL VEGFR-2, 50 μM ATP and the C. nobile methanolic 
extract/infusion (400 at 6.25 µg/mL) or the pure phenolic compounds (40 at 0.04 µg/mL) 
at room temperature in 50 mM Hepes/NaOH (pH 7.5), 10 mM MgCl2, 2 mM MnCl2, 2.5 
mM DTT, 0.1 mM morthovanadate, and 0.01% bovine serum albumin. The wells were 
incubated at 25 ºC for 1 h and 5 µL development reagents were added to each well. After 
a second incubation of 1 h a stop reagent was added to each well. Using a Biotek FLX800 
micro-plate the fluorescence was read at 445 nm and 520 nm (excitation 400 nm), and 
Gen5™ Software was used for data analysis. Ginestein (Extrasynthese, Genay, France) 
was used as positive control.  
 
2.6.6. Statistical analyses 
For each species, three samples were used and all the assays were carried out in triplicate. 
The results of the chemical compostion and bioactive properties were expressed as mean 
values ± standard deviation (SD). The results of the antiangiogenic activity of the extracts 
were analyzed using a Student´s t-test with α = 0.05, to determine the significant 
difference among the two extracts. The statistical differences in all other results, 
represented by letters, were obtained through one-way analysis of variance (ANOVA) 
followed by Tukey’s honestly significant difference post hoc test with α = 0.05. These 
treatments were carried out using SPSS program (v. 18.0 and 22.0).   
 
2.6.6.1. Docking simulations using AutoDockVina and molecular Dynamics simulation 
Docking simulations: the 2D structure of the compounds apigenin, apigenin-7-O-
glucoside, luteolin and luteolin-7-O-glucoside was constructed using the 
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ACD/ChemSketch Freeware 12.0 software. Open Babel (O’Boylel et al., 2011) was used 
to convert compounds from 2D to 3D and saved in pdb format. A VEGFR-2 crystal 
structure (PDB: 2XIR) was extracted from the Protein Data Bank (PDB) 
(http://www.rcsb.org). The co-crystallized ligand was extracted from the PDB file, and 
AutoDockTools (Sanner, 2005) was used to assign polar hydrogens and Gasteiger charges 
to the compounds and VEGFR-2 protein. All structures were saved in PDBQT file format 
required to use AutoDockVina (Trott & Olson, 2010). AutodockVina was used to perform 
docking in an area of 30 Å by 30 Å by 30 Å, centered on the co-crystallized ligand. The 
docking simulations were performed on a cluster of 6 AMD Opteron 6128 8 core 2.0 GHz 
with using MOLA software (Abreu et al., 2010).  All figures with structure 
representations were prepared using PyMOL (The PyMOL Molecular Graphics System, 
Version 1.3, Schrödinger, LLC. Available at: (http://www.pymol.org/). Accessed on 03 
September, 2012. 
Molecular Dynamics simulation: The Protein Preparation Wizard from Maestro 
(Schrodinger, LLC, Portland, OR) was used to prepare ligand/VEGFR-2 complexes and 
then used to perform explicit solvent molecular dynamics (MD) simulations. The 
parallelized Desmond Molecular Dynamics System v2.2 (D. E. Shaw Research, New 
York, NY) and associated analysis tools, available within the Schrodinger suite 
(Schrodinger, LLC, Portland, OR), were used for this purpose. The protocol used is 
described in Mukherjee et al. (2011). 
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Chapter 3. Chemical characterization and bioactive properties of the wild plants: 
Results and discussion 
3.1. Chamaemelum nobile 
3.1.1. Nutrients composition  
The results of the nutritional characterization of Chamaemelum nobile are shown in Table 
2. Carbohydrates were the most abundant macronutrients, followed by proteins. Ash and 
fat contents were low, and the energetic contribution was 389.88 kcal/100 g dw. The main 
sugar found in this plant material was fructose, followed by glucose and sucrose. 
Trehalose was found in lower amounts. Polyunsaturated fatty acids (PUFA) 
predominated over saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA). 
The FA determined in higher percentages, were linoleic acid (C18:2n6), oleic acid 
(C18:1n9), α-linolenic acid (C18:3n3) and palmitic acid (C16:0). Regarding tocopherols, 
only α- and γ-tocopherols were found in the studied plant material. β-Carotene and 
lycopene were also quantified in the studied sample. 
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Table 2. Nutritional characterization of Chamaemelum nobile (mean ± SD). 
Crude composition (g/100 g dw) Free sugars (g/100 g dw) 
Moisture (g/100 g fw) 67.09 ± 1.02 Fructose 3.37 ± 0.24 
Ash 6.43 ± 0.05 Glucose 1.57 ± 0.13 
Proteins 26.63 ± 1.92 Sucrose 1.08 ± 0.08 
Fat 3.12 ± 0.33 Trehalose 0.60 ± 0.02 
Carbohydrates 63.83 ± 1.66 Total sugars 6.62 ± 0.31 
Energy 389.88 ± 1.32   
Fatty acids (relative %) Tocopherols (mg/100 g dw) 
C16:0 17.89 ± 0.16 α-Tocopherol 1.64 ± 0.02 
C18:0 3.36 ± 0.03 β-Tocopherol Nd 
C18:1n9 23.22 ± 0.22 γ-Tocopherol 0.19 ± 0.01 
C18:2n6 28.89 ± 0.33 δ-Tocopherol Nd 
C18:3n3 18.22 ± 0.11 Total tocopherols 1.83 ± 0.01 
SFA 27.67 ± 0.19 Pigments (mg/100 g)  
MUFA 24.78 ± 0.27 β-carotene 0.95 ± 0.02 
PUFA 47.56 ± 0.46 Lycopene 0.02 ± 0.01 
PUFA/SFA 1.72 ± 0.03   
n6/n3 1.56 ± 0.01   
fw- fresh weight; dw – dry weight. Palmitic acid (C16:0); Stearic acid (C18:0); Oleic acid (C18:1n9c); Linoleic acid 
(C18:2n6c); α-Linolenic acid (C18:3n3). Nineteen more fatty acids were also identified and quantified (total relative 
percentage 8.42%; data not shown).  SFA – saturated fatty acids; MUFA – monounsaturated fatty acids; PUFA – 
polyunsaturated fatty acids. 
 
As far as we know this is the first report on nutritional characterization of C. nobile, that 
proved to be an equilibrated valuable herb rich in carbohydrates and proteins, and poor 
in fat and calories. Moreover it provides tocopherols, carotenoids, essential fatty acids 
(C18:2n6 and C18:3n3), and ratios PUFA/SFA and n-6/n-3 fatty acids higher than 0.45 
and lower than 4.0, respectively (Guil et al., 1996), which are considered good nutritional 
ratios. 
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3.1.2. Phytochemicals in the herb and in its decoction and infusion 
As C. nobile is mostly consumed as decoctions and infusions (aqueous extracts), a 
comparative study of phytochemicals present in the herb and in those preparations was 
performed. Oxalic, quinic, malic, citric and fumaric acids were quantified in all the 
extracts of C. nobile (Table 3), malic acid being the most abundant organic acid. Infusion 
was the preparation with the highest content in organic acids (9.07g/100 g dw), while the 
decoction showed the lowest amount (6.5g/100 g dw). Some of the mentioned compounds 
have shown bioactive properties such as the capacity to chelate metal ions of citric acid 
by forming bonds between the metal and its carboxyl or hydroxyl groups. Citric acid is 
effective in retarding the oxidative deterioration of lipids in foods and is commonly added 
to vegetable oils after deodorization (Hraš et al., 2000). Oxalic acid has a strong chelating 
ability with multivalent cations; nevertheless, it has been considered as an antinutrient 
due to the inhibitory effect on mineral bioavailability and to formative effect on calcium 
oxalate urinary stone (Kayashima & Katayama, 2002). 
 
Table 3. Organic acids composition of Chamaemelum nobile (mean ± SD). 
    In each row different letters mean significant differences (p<0.05) 
 
The main phenolic compounds found in C. nobile herbal material and in its decoction and 
infusion were flavonoids (flavonols and flavones), phenolic acids and derivatives (Table 
4 and 5). 
Organic acid Herb Decoction Infusion 
Oxalic acid 2.02 ± 0.06a 1.74 ± 0.21b 1.99 ± 0.13b,a 
Quinic acid 1.74 ± 0.13b 1.40 ± 0.04b 2.56 ± 0.17a 
Malic acid 3.02 ± 0.07a 2.21 ± 0.19b 3.06 ± 0.05a 
Citric acid 1.33 ± 0.01a 1.23 ± 0.16a 1.46 ± 0.24a 
Fumaric acid 0.02 ± 0.00a 0.01 ± 0.00b 0.01 ± 0.00b 
Total (g/100 g) 8.14 ± 0.28b 6.58 ± 0.28c 9.07 ± 0.01ª 
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Table 4. Retention time (Rt), wavelengths of maximum absorption in the UV-vis region (λmax), pseudomolecular and MS2 fragment ions (in brackets, relative abundances) and 
tentative identification of the phenolic compounds of Chamaemelum nobile.  
Peak Rt (min) λmax (nm) 
Molecular ion 
[M-H]- (m/z) 
MS2 (m/z) Tentative identification 
1 5.11 326 353 191(100), 179(69), 161(7), 135(51) 3-O-Caffeolyquinic acid 
2 5.65 320 515 353(11), 341(6), 323(100), 191(61), 179(6), 161(18), 135* 5-O-Caffeoylquinic acid-hexoside 
3 6.15 262,294 153 109(100) Protocatechuic acid 
4 6.44 326 469 307(8), 179(100),161(37), 135(78) Caffeoyl-hexoside-methylglutarate 
5 7.79 326 353 191(100), 179(11), 173(9), 161(28), 135(8) 5-O-caffeolyquinic acid 
6 9.62 312 453 291*, 163(100), 145(9), 119(51) p-coumaroyl-hexoside-methylglutarate 
7 10.48 332 593 593(100), 473(18), 383(6), 353(12) Apigenin 6-C-glucose-8-C-glucose 
8 11.05 316 453 163(100), 145(8),119(42) p-coumaroyl–hexoside-metylglutarate 
9 11.64 328 469 469(100), 307*, 179(6),161(19), 135(3) Caffeoyl-hexoside-methylglutarate 
10 16.19 320 445 445(100), 427(58), 265(15), 179(8) Caffeic acid derivative 
11 16.53 356 479 317(100) Myricetin 3-O-glucoside 
12 17.15 344 621 487(3), 351(100), 269(14) Apigenin derivative 
13 17.32 320 677 677(100), 515(28), 497(16), 353(65), 335(23), 191 (12), 179(8), 135(3) 1,3,5-O-tricaffeoylquinic acid 
14 18.26 356 477 301(100) Quercetin 3-O-glucuronide 
15 18.52 342 607 269(100) Apigenin O-glucuronylhexoside 
16 18.71 350 579 579(100), 417(26), 285(53) Kaempferol O-pentosylhexoside 
17 19.01 350 593 285(100) Luteolin O-rutinoside 
18 19.12 344 607 545(5), 337(27), 269(100) Apigenin derivative 
19 19.63 350 579 579(100), 447(4), 285(16)  Luteolin O-pentosylhexoside 
20 19.70 350 461 285(100) Luteolin O-glucuronide 
21 20.06 344 593 593(100), 447(5), 285(17) Luteolin O-rhamnosylhexoside 
22 20.11 332 515 515(100), 353(54), 335(16),299(3),203(3),191(16), 179(27), 173(44),135(11) 3,4-O-Dicaffeoylquinic acid 
23 21.14 350 447 285(100) Luteolin O-hexoside 
24 21.75 328 515 353(100), 335(6), 191(85), 179(42), 173(11), 135(16) 3,5-O-Dicaffeoylquinic acid 
25 23.59 370 549 505(100), 301(74) Quercetin 7-O-malonylhexoside 
26ª 24.26 318sh ,348 505 301(100) Quercetin O-acetylhexoside 
26b 24.23 338 445 269(100) Apigenin O-glucuronide 
27 24.52 338 649 605*, 587(5), 515(5), 427(5), 379(29), 361(3), 311(4), 269(100) Apigenin derivative 
28 25.05 332 489 285(100) Luteolin O-acetylhexoside 
29 25.27 334 445 269(100) Apigenin O-glucuronide  
30 27.18 318sh,358 519 315(100) Isorhamnetin O-acetylhexoside 
*abundance ≤ 2; 26b-only found in decoction sample. 
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Table 5. Quantification of phenolic compounds in Chamaemelum nobile (mean ± SD). 
Peak Herb Decoction Infusion 
1 0.07 ± 0.01 nd 0.08 ± 0.01 
2 0.21 ± 0.01 0.04 ± 0.01 0.15 ± 0.02 
3 0.04 ± 0.01 0.06 ± 0.01 0.10 ± 0.0 
4 0.07 ± 0.01 nd 0.05 ± 0.00 
5 1.70 ± 0.00 nd 1.52 ± 0.04 
6 tr nd tr 
7 0.04 ± 0.00 0.03 ± 0.00 0.01 ± 0.00 
8 0.01 ± 0.00 0.02 ± 0.00 0.01 ± 0.00 
9 0.01 ± 0.00 nd 0.01 ± 0.00 
10 0.01 ± 0.00 nd 0.02 ± 0.00 
11 0.01 ± 0.00 nd 0.01 ± 0.00 
12 0.11 ± 0.01 0.17 ± 0.01 0.15 ± 0.01 
13 0.17 ± 0.04 nd 0.13 ± 0.00 
14 0.10 ± 0.00 nd 0.05 ± 0.01 
15 0.06 ± 0.01 0.02 ± 0.00 0.02 ± 0.00 
16 0.04 ± 0.01 0.02 ± 0.00 nd 
17 0.42 ±0.03 nd 0.11 ± 0.00 
18 0.15 ± 0.01 0.50 ± 0.05 0.07 ± 0.01 
19 0.31 ± 0.07 0.18 ± 0.01 0.13 ± 0.00 
20 0.19 ± 0.04 0.07 ± 0.01 0.16 ± 0.00 
21 0.37 ± 0.02 0.12 ± 0.01 nd 
22 0.02 ± 0.00 nd 0.01 ± 0.00 
23 0.37 ± 0.06 0.06 ± 0.00 0.39 ± 0.02 
24 0.37 ± 0.07 nd 0.06 ± 0.02 
25 0.11 ± 0.01 0.01 ± 0.00 0.03 ± 0.00 
26a 0.05 ± 0.01 nd 0.04 ± 0.01 
26b nd 0.06 ± 0.01 nd 
27 0.88 ± 0.05 0.29 ± 0.03 0.76 ± 0.02 
28 0.46 ± 0.07 nd 0.24 ± 0.00 
29 0.12 ± 0.01 nd 0.10 ± 0.0 
30 0.02 ± 0.00 nd 0.11 ± 0.00 
Total flavonol derivatives (g/100g) 0.34 ± 0.03a 0.02 ± 0.00c 0.13 ± 0.01b 
Total flavone derivatives (g/100g) 3.48 ± 0.25a 1.51 ± 0.02c 2.18 ± 0.03b 
Total caffeoylquinic acids (g/100g) 2.54 ± 0.13a 0.04 ± 0.01c 1.94 ± 0.07b 
Total phenolic acid derivatives (g/100g) 0.15 ± 0.02b 0.08 ± 0.01c 0.19 ± 0.00a 
Total phenolic compounds (g/100g) 6.51 ± 0.43a 1.65 ±0.03c 4.44 ± 0.11b 
In each row different letters mean significant differences (p<0.05). tr- traces; nd-not detected. 
 
In general, all the preparations revealed the same chromatographic profile, exemplified 
in Figura 7A for the herbal sample.  
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Up to thirty-one phenolic compounds, including a phenolic acid, eleven hydroxycinnamic 
acid derivatives and nineteen flavonoids were detected in the C. nobile preparations 
(Table 4). Peak 3 was identified as protocatechuic acid by comparison of its UV spectrum 
and retention time with a commercial standard. Six hydroxycinnamic acid derivatives 
(peaks 1, 2, 5, 13, 22 and 24) showed UV spectra with maximum wavelengths around 
320-330 nm and yielded fragment ions at m/z 191 (deprotonated quinic acid) and 179 
(deprotonated caffeic acid) in their MS2 mass spectra, which together with their pseudo 
molecular ions [M-H]- at m/z 353, 515 and 677, allowed their identification as quinic acid 
derivatives containing one, two or three caffeic acid moieties, respectively. Peak 
assignments of the different caffeoylquinic acid isomers were made using the 
recommended IUPAC numbering system (IUPAC, 1976) as also the hierarchical keys 
previously developed by Clifford et al., 2003 and 2005. The majority peak 5 ([M-H]- at 
m/z 353) was positively identified as 5-O-caffeoylquinic acid by comparison with an 
authentic standard. Peak 1 ([M-H]- at m/z 353) was identified as 3-O-caffeoylquinic acid, 
yielding the base peak at m/z 191 and the ion at m/z 179 with an intensity >50% base 
peak. Similar fragmentation pattern was reported by Clifford et al. (2003, 2005) as 
characteristic to distinguish 3-acylchlorogenic acids. Peaks 2, 22, 24 ([M-H]- at m/z 515) 
could be assigned as dicaffeoylquinic acids. Peaks 22 and 24 were assigned to 3,4-O- and 
3,5-O-dicaffeoylquinic acids, respectively, based on their elution order, fragmentation 
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Figure 7. HPLC chromatogram of the phenolic compounds of Chamaemelum nobile recorded at 370 nm 
(A) and UV spectra of peak 27 (B). 
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pattern and relative abundances (Clifford et al., 2003, 2005). MS2 fragmentation of peak 
22 yielded the formation of relatively intense signals corresponding “dehydrated” 
fragments at m/z 335 [caffeoylquinic acid –H-H2O] - and m/z 173 [quinic acid-H-H2O]-, 
characteristic of 4-acyl-caffeoylquinic acids. Furthermore, according to Clifford et al. 
(2005), the intensity of signal at m/z 335 (16% of base peak) is more intense than in 4,5-
O-dicaffeoylquinic (barely detectable, <5% of base peak). These observations allowed 
assigning peak 22 as 3,4-O-dicaffeoylquinic acid. The fragmentation pattern for 3,5-O-
dicaffeoylquinic (peak 24) acid was similar to the one previously reported by Clifford et 
al., 2005. MS2 base peak was at m/z 353, produced by the loss of one of the caffeoyl 
moieties [M-H-caffeoyl]-, and subsequent fragmentation of this ion yielded the same 
fragments as a 5-caffeoylquinic acid at m/z 191, 179 and 135, although in this case with 
a comparatively more intense signal at m/z 179 [caffeic acid-H]-  (<50% base peak). 
Peak 2 showed the same pseudomolecular ion as peaks 22 and 24 but eluted much earlier 
than those dicaffeoylquinic acids and also than 5-O-caffeoylquinic acid. In addition to the 
fragments characteristic of a caffeoylquinic acid, the MS2 spectrum of this compound also 
produced fragments at m/z 353 ([M-H-162]-, loss of a hexose residue) and 341 ([M-H-
174]-, loss of a quinic acid moiety) and its “dehydrated” form at m/z 323. This 
fragmentation pattern pointed to a glycosylated chlorogenic acid, which could correspond 
to 1- or 5-caffeoylquinic-hexoside, according to the mass spectra characteristics and 
intensities of MS2 fragment ions as reported by Clifford et al., 2007. The fact that 5-O-
caffeoylquinic acid was the majority compound in the sample and 1-O-caffeoylquinic 
acid was not detected, permitted its tentative identification as 5-O-caffeoylquinic acid-
hexoside, identity that was coherent with its early elution (greater polarity) compared with 
its parent aglycone. Peak 13 was identified as tricaffeoylquinic acid according to its 
pseudomolecular ion [M-H]- at m/z 677 and diagnostic MS2 fragments at m/z 515 (loss of 
the first caffeoyl), m/z 353 (loss of the second caffeoyl), m/z 191 (loss of the third caffeoyl 
to give quinic acid ion), m/z 179 (caffeic acid ion). The signal observed at m/z 497 can be 
interpreted by the loss of a water molecule from the ion at m/z 515. According to the 
relative intensities of different tricaffeoylquinic acid isomers reported by Lin & Harnly 
(2008), this peak could be assigned as 1,3,5-O-tricaffeoylquinic acid. Peaks 4, 9 and 10, 
with UV spectra similar to caffeic acid with λmax around 326 nm, were also assigned to 
caffeic acid derivatives. All of them presented an MS2 fragment at m/z 179 ([caffeic acid- 
H]-). Peaks 4 and 9 also presented a fragment at m/z 307 (-162 mu, loss of a hexose 
moiety), and the formation of the ion at m/z 179 could be produced by the loss of 162 + 
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128 mu (loss of hexose + methyl-glutarate residues), so that they were tentatively 
identified as caffeoyl-hexoside-methylglutarate. Although they could not be fully 
identified, these compounds could be attributed as derived from the cis and trans isomers 
of caffeic acid. The MS2 analysis of peak 10 yielded signals at m/z 427 ([M-H2O]
-) and 
m/z 265 ([M-18-162]-) pointing out to the presence of a hexose, although no further 
conclusions could be made bout its definite identity. 
Peaks 6 and 8 ([M-H]- at m/z 453) presented a molecular weight 16 units lower than peaks 
4 and 9 but a similar fragmentation pattern, indicating that they could be the 
corresponding coumaroyl derivatives; this assumption was also supported by the 
formation of the MS2 fragment ion at m/z 163 ([coumaric acid-H]-). Thus, they were 
tentatively identified as two p-coumaroyl-hexoside-methylglutarate. Their later elution 
(lower polarity) compared with the caffeoyl counterparts (peaks 4 and 9) was also 
coherent with this identity; similarly, they could be speculated as the respective cis and 
trans isomers. Flavones were the most abundant flavonoids present in the analysed 
samples (Table 5). Peaks 7, 12, 15, 18, 26b, 27 and 29 were identified as apigenin 
derivatives, according to their UV and mass spectra characteristics (Figure 7A). Peak 7 
presented a pseudo molecular ion [M-H]- at m/z 593, releasing three MS2 fragments ions 
at m/z 473 and 383, corresponding to loss of 120 and 90 amu, characteristic of C-hexosyl 
flavones, and at m/z 353 that might correspond to the apigenin aglycone bearing some 
sugar residues [apigenin+83 mu] (Ferreres et al., 2003). The fact that no relevant fragment 
derived from the loss of a complete hexosyl residue (-162 mu) was detected, suggested 
that both sugars were C-attached, which allowed a tentative identification of the 
compound as apigenin 6-C-glucose-8-C-glucose. Peaks 15, 26b and 29 presented pseudo 
molecular ions [M-H]- at m/z 607 and 445 releasing a MS2 fragment ion at m/z 269 ([M-
176-162]- and [M-176]-, corresponding to the loss of glucuronyl-hexoside and glucuronyl 
moieties, respectively), being tentatively identified as apigenin O-glucuronyl-hexoside 
(peak 15) and apigenin O-glucuronides (peaks 26b and 29). Peaks 12, 18 and 27 presented 
pseudomolecular ions [M-H]- at m/z 621, 607 and 649, respectively, that release an MS2 
fragment at m/z 269 (apigenin). They all presented a similar fragmentation pattern, with 
a loss of 270 mu, and peaks 18 and 27 also have a fragment ion at [M-338]-, that could 
correspond to glucuronyl-hexoside or feruloyl-hexoside [M-176-162]. Moreover, peak 27 
presents a difference of 42 mu relatively to peak 18 that may be due to an acyl group. 
Peaks 12 and 18 also presented a difference of 14mu that could correspond to a methyl 
group. However, the fragmentation patterns of these compounds did not allow us to 
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conclude further about their chemical structure, but due to the UV spectra (Figure 7B) 
and the fragmentation mentioned above they were just associated to unknown apigenin 
derivatives. Peaks 17, 19, 20, 21, 23 and 28 were identified as luteolin derivatives. Peaks 
17, 20, 23 and 28 presented pseudomolecular ions [M-H]- at m/z 593, 461, 447 and 489 
releasing a common MS2 fragment at m/z 285 ([M-308]-, [M-176]-, [M-162]- and [M-42-
162], associated to the loss of rutinosyl, glucuronyl, hexosyl and acetylhexoside moieties, 
respectively). They were tentatively identified as luteolin O-rutinoside, luteolin O-
glucuronide, luteolin O-hexoside (the retention time is different from luteolin 7-O-
hexoside) and luteolin O-acetylhexoside. Peaks 19 and 21 showed pseudomolecular ions 
[M-H]- at m/z 579 and 593, both releasing two MS2 fragments at m/z 447 ([M-132]- and 
[M-146]- loss of pentosyl and rhamnosyl moieties, respectively) and 285 ([M-162]-, loss 
of a hexosyl moiety), being tentatively identified as luteolin O-pentosyl-hexoside and 
luteolin O-rhamnosyl-hexoside. 
Flavonols (peaks 11, 14, 16, 25, 26a and 30) were also found in the studied samples 
(Tables 4 and 5). Peak 11 presented a pseudomolecular ion [M-H]- at m/z 479, releasing 
an MS2 fragment at m/z 317 ([M-H-162]-, loss of an hexosyl moiety), corresponding to 
myricetrin, which allowed a tentative identification of the compound as myricetin 3-O-
glucoside, as confirmed by comparison with an authentic standard. Peak 16 showed a 
pseudomolecular ion [M-H]- at m/z 579, releasing two MS2 fragments at m/z 417 ([M-H-
162]-, loss of a hexosyl moiety) and 285 (kaempferol; [M-H-162-132]-, loss of a further 
pentosyl moiety), being tentatively identified as kaempferol pentosyl-glucoside the two 
glycosyl residues are assumed to constitute a disaccharide taking into account that the are 
lost successively and no alternatively, with no fragment corresponding to a  kaempferol-
pentoside being released. Peaks 14, 25 and 26a corresponded to quercetin derivatives. 
Peak 14 presented a pseudomolecular ion [M-H]- at m/z 477, releasing an MS2 fragment 
at m/z 301 ([M-H-176]-, loss of a glucuronyl moiety); this compound was identified as 
quercetin 3-O-glucuronide, by comparison with a standard isolated in our laboratory 
(Dueñas et al., 2008). Peak 25 presented a pseudomolecular ion [M-H]- at m/z 549, 
releasing a MS2 fragments at m/z 301 ([M-H-162-86]-, loss of a malonylhexoside moiety). 
The UV/Vis spectra have long been used for structural analysis of flavonoids. The typical 
flavonoid spectrum consists of two maxima in the range 240–285 nm (Band II), and 300–
550 nm (Band I), which is more specific and useful for obtaining information regarding 
identification. The position and relative intensities of these maxima yield information on 
the nature of the flavonoid and its hydroxylation and substitution patterns (Santos-Buelga 
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et al., 2003). It is known that the introduction of a glycoside on the hydroxyls at positions 
7, 3´ or 4´ has no effect on wavelength maxima or the spectrum shape in relation to the 
aglycone. Thus, quercetin 7-O-glycosides would have λmax in Band I around 370 nm, 
while quercetin 3-O-glycosides are hypsochromically shifted to around 354 nm. Since 
peak 25 presented λmax at 370 nm it was tentatively identified as quercetin 7-O-
malonylhexoside. Peak 26a presented a pseudomolecular ion [M-H]- at m/z 505 releasing 
an MS2 fragment at m/z 301 (quercetin; [M-H-42-162]-, loss of an acetylhexoside moiety), 
and was tentatively identified as quercetin O-acetylhexoside. Peak 30 presented a 
pseudomolecular ion [M-H]- at m/z 519 releasing a MS2 fragment at m/z 315 
(isorhmanetin; [M-H-42-162]-, loss of an acetylhexoside moiety), so that it was 
tentatively identified as isorhamnetin O-acetylhexoside. The amounts of the phenolic 
compounds found varied among the different preparations and some compounds 
disappeared, mostly in decoctions (Table 5). Peak 26a, quercetin O-acetylhexoside that 
appeared in the plant material and infusion preparation, was not present in the decoction 
preparation, being detected at the same retention time another compound (peak 26b) 
associated to an apigenin glucuronide. Tschan, 1996 and Carnat et al., 2004, reported in 
Chamaemelum nobile the presence of chamaemeloside (i.e., apigenin 7-glucoside-6''-(3'''-
hydroxy-3'''-methyl-glutarate), but this compound was not detected in the sample of 
roman camomile studied herein. Carnat et al., 2004, did not report in their study the 
presence in roman camomile of some flavonols described in the present work, such as the 
quercetin, kaempferol and isorhamnetin derivatives, but they only report flavones and 
phenolic acids also detected in this study. 
 
3.1.3. Antioxidant and antitumor activity  
The antioxidant properties were evaluated by four different tests as there is no universal 
method that can measure the antioxidant capacity of all samples accurately and 
quantitatively: DPPH radical scavenging capacity, reducing power and inhibition of lipid 
peroxidation using β-carotene–linoleate model system in liposomes and TBARS assay in 
brain homogenates. 
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Table 6. Antioxidant and antitumor activities of Chamaemelum nobile (mean ± SD). 
*Trolox and ellipticine for antioxidant and antitumor activity assays, respectively. EC50 values correspond to the sample 
concentration achieving 50% of antioxidant activity or 0.5 of absorbance in reducing power assay. GI50 values 
correspond to the sample concentration achieving 50% of growth inhibition in human tumor cell lines or in liver primary 
culture PLP2. In each row different letters mean significant differences (p<0.05). 
 
As it can be observed in Table 6, herbal sample gave the highest β-carotene bleaching 
activity and lipid peroxidation inhibition (lowest EC50 values, Table 6) which can be 
related to its higher content in phenolic compounds (Table 5), while infusion showed the 
highest DPPH scavenging activity (Table 5) which may be related to their higher levels 
in organic acids (Table 3). Both samples showed similar reducing power (Table 6). The 
decoction presented the lowest antioxidant properties, probably due to its lower content 
in phenolic compounds and organic acids.  
The effects of C. nobile extract, decoction and infusion on the growth of five human tumor 
cell lines (MCF-7, NCI-H460, HCT-15, HeLa and HepG2), represented as the 
concentrations that caused 50% of cell growth inhibition (GI50), are also summarized in 
Table 6. The plant material extract was more potent than the infusion sample in all the 
tested cell lines, presenting GI50 values that ranged from 82.52 to 168.40 µg/mL for the 
MCF-7 and HepG2 cells, respectively. Decoction preparation had no antitumor effects at 
the maximal concentration used (400 µg/mL), which could indicate that these effects 
might be related to compounds (including phenolic compounds) that are not extracted or 
affected by the decoction. Nevertheless, none of the C. nobile preparation showed 
 
Herb Decoction Infusion Standard* 
Antioxidant activity 
(EC50 values, µg/mL) 
    
DPPH scavenging activity 621.64 ± 6.84b 1477.30 ± 71.99a 408.46 ± 11.34c 43.03 ± 1.71 
Reducing power 294.90 ± 10.97b 532.62 ± 8.75a 258.89 ± 3.36b 29.62 ± 3.15 
β-carotene bleaching inhibition 443.32 ± 1.47c 680.54 ± 69.06b 1219.64 ± 31.56a 2.63 ± 0.14 
TBARS inhibition 82.33 ± 11.53c 268.55 ± 5.32a 120.41 ± 4.24b 3.73 ± 1.90 
Antitumor activity (GI50 values, µg/mL)     
MCF-7 (breast carcinoma) 82.52±4.57b >400 247.95±5.56a 0.91±0.04 
NCI-H460 (non-small cell lung cancer) 82.75±8.14b >400 226.65±7.42a 1.42±0.00 
HCT-15 (colon carcinoma) 91.23±3.13b >400 150.24±5.47a 1.91±0.06 
HeLa (cervical carcinoma) 85.01±6.39b >400 233.06±7.36a 1.14±0.21 
HepG2 (hepatocellular carcinoma) 168.40±2.23b >400 250.30±0.55a 3.22±0.67 
PLP2 >400 >400 >400 >32.5 
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hepatotoxicity in the porcine liver primary cell culture (non-tumor cells; PLP2) (Table 
6). Overall, C. nobile is an equilibrated valuable species rich in carbohydrates and 
proteins, and poor in fat, providing tocopherols, carotenoids and essential fatty acids 
(C18:2n6 and C18:3n3). Moreover, the herb and its infusion are a source of phenolic 
compounds and organic acids that showed antioxidant and antitumor activities, without 
hepatotoxicity. Some bioactive compounds are affected by in C. nobile decoction, leading 
to a lower antioxidant potential and absence of antitumor potential. The plant bioactivity 
could be explored in the medicine, food, and cosmetic industries.  
 
3.1.4. Antiangiogenic activity of the extracts and phenolic compounds 
According to previous studies of the authors, Roman chamomile is an equilibrated 
valuable species rich in carbohydrates and proteins, and poor in fat, providing 
tocopherols, carotenoids and essential fatty acids (C18:2n6 and C18:3n3). Moreover, the 
herb and its infusion are a source of phenolic compounds and organic acids with a high 
bioactive potential (Guimarães et al., 2013). Herein, methanolic extract, infusion and 
phenolic compounds of Roman chamomile were evaluated for their ability to interact with 
the VEGFR-2 tyrosine kinase domain, using an enzymatic fluorescence resonance energy 
transfer (FRET-based assay). The results are given in Table 7.  
 
Table 7. VEGFR-2 phosphorylation inhibition activity of Chamaemelum nobile extracts and phenolic 
compounds (mean ± SD). 
Chamaemelum nobile VEGFR-2 IC50, μg/mL 
Methanolic extract 269.26 ± 8.74 
Infusion 301.09 ± 13.07 
t-Students test; p-value <0.001 
Phenolic compound VEGFR-2 IC50, μM 
Luteolin 2.10 ± 0.32c,* 
Apigenin 4.78 ± 0.27b 
Apigenin-7-O-glucoside 44.47 ± 3.96a 
Luteolin-7-O-glucoside >40 
Caffeic acid >40 
Chlorogenic acid >40 
Genistein 1.04 ± 0.06 
IC50- concentration that provided 50% of VEGFR-2 inhibition. *Different letters mean significant 
differences between compounds (p<0.05). 
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The methanolic extract showed a lower IC50 value than the infusion, 269 and 301 μg/mL, 
respectively. These results are in agreement with the higher phenolic compounds amount, 
antioxidant and antitumor activities also previously reported for the methanolic extract. 
(Guimarães et al., 2013). Regarding individual molecules, apigenin, apigenin-7-O-
glucoside, caffeic acid, chlorogenic acid, luteolin and luteolin-7-O-glucoside were chosen 
because these compounds were the ones used to quantify all the phenolic compounds 
identified in Roman chamomile (Guimarães et al., 2013). Phenolic acids (caffeic and 
chlorogenic acids) and luteolin-7-O-glucoside did not show VEGFR-2 phosphorylation 
inhibition activity (IC50 values higher than 40 µg/mL), whereas apigenin-7-O-glucoside 
gave VEGFR-2 phosphorylation inhibition activity with IC50 value = 19.21 µg/mL. A 
drastically increase in the VEGFR-2 phosphorylation inhibition activity was observed for 
the corresponding aglycones (compounds without the glycosyl group) of the mentioned 
flavonoids: luteolin and apigenin (IC50 values = 0.60 and 1.29 µg/mL, respectively). The 
active concentrations, corresponding to the last IC50 values, are easily provided by the 
Roman chamomile infusion, which contains 8.42 µg/mL and 9.28 µg/mL of luteolin and 
apigenin derivatives (compounds with glycosyl groups: luteolin7-O-glucoside and 
apigenin-7-O-glucoside), respectively (values calculated from the ones reported 
previously by the authors and taking into account the extraction yields) (Guimarães et al., 
2013). It should be highlighted that the methanolic extract prepared from the herb would 
provide even higher amounts of those derivatives (21.31 and 13.50 µg/mL, respectively, 
Guimarães et al., 2013. The possible VEGFR-2 phosphorylation inhibition mechanism of 
luteolin, apigenin and apigenin-7-O-glucoside (Figure 8) was predicted using docking 
tools. 
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Figure 8. Chemical structures of luteolin, apigenin and apigenin-7-O-glucoside. 
 
A careful analysis of the predicted docking poses showed that apigenin and luteolin 
probably interacts with VEGFR-2 ATP binding site with a similar binding pose, stabilized 
by three predicted hydrogen bonds (Figure 8): one H-bond between the CYS919 
backbone and the carbonyl group in position 3 of the benzopyrone moiety; a second H-
bond between CYS919 backbone and the hydroxy  group in position 5 of the benzopyrone 
moiety; and a third H-bond between the amino group of LYS868 side chain and the 
hydroxy group in position 4 of the benzene ring. The higher VEGFR-2 phosphorylation 
inhibition capacity of luteolin compared to apigenin can probably be explained with a 
better occupation of the ATP binding site, accomplished by the lutein extra hydroxyl 
group occupation of a small pocket located inside the Figure 9. 
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Furthermore, comparing the docking poses of apigenin and apigenin-7-O-glucoside, it 
was possible to observe that the presence of the glucoside moiety shifts the compound 
slightly away from the ATP binding site. This shift probably weakens the described H-
bonds, explaining the lower VEGFR-2 phosphorylation inhibition capacity of apigenin-7-
O-glucoside. Moreover, the inability of AutodockVina to predict a binding pose of 
luteolin-7-O-glucoside similar to luteolin, apigenin and apigenin-7-O-glucoside, seems 
to indicate that luteolin-7-O-glucoside probably cannot interact with the ATP binding site. 
This was experimentally proved by the high IC50 value obtained in the enzymatic assay 
(>100 µM). MD (Molecular Dynamics) simulation were performed using the most active 
compounds, luteolin and apigenin, to verify if both predicted docking poses remain stable 
in a more physiologically relevant setting.  The docking posed of both complexes were 
the starting points for 5 ns MD simulations, and the overall stability of each MD 
simulation was evaluated by plotting the receptor backbone (VEGFR-2) and ligands 
RMSD (Root Mean Square Deviation) as a function of time (Figure 10).  
Figure 9. Surface representation of VEGFR-2 ATP binding site docked with apigenin (green line), luteolin 
(blue line) and apigenin-7-O-glucoside (magenta line). Apigenin and luteolin hydrogen bonds are 
represented at yellow dash, and apigenin-7-O-glucoside hydrogen bonds at red dash. 
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After small adjustments in the first ns of the MD simulation, both apigenin and luteolin 
structures remained stable thought-out the duration of the MD simulation with average 
RMSD of 0.37 and 0.57 Å, respectively (Figure 10). This is an indication that the 
predicted docking pose is reliable and is probably close to the experimental VEGFR-2 
binding pose. In both MD simulations, the RMSD values for the VEGFR-2 backbone 
structure was also analyzed and it was observed that, after a normal adjustment of around 
2 ns, the RMSD values also remained stable thought-out the rest of the MD simulation. 
This is the expected MD simulation behavior of the protein backbone indicating that the 
VEGFR-2 structure used is suitable for this type of molecular modeling studies. 
In general the MD simulations performed give us further assurance that the predicted 
docking pose probably corresponds closely to the experimental binding pose although 
Figure 10. RMSD values obtained during the 5 ns MD simulation timeframe for: a) VEGFR-2/Apigenin 
and b)VEGFR-2/Luteolin complexes. 
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this can only be completely established by the elucidation of the VEGFR-2/apigenin or 
VEGFR2/luteolin complex structures, usually performed by X-ray crystallography. 
The antiangiogenic effect of apigenin on tumor cells was already reported but related to 
a reduction in the expression of VEGF (Osada et al., 2004) and not with an inhibition of 
VEGFR activity, such it was demonstrated in the present work. Regarding luteolin, as far 
as we know this is the first report on antiangiogenic activity, being only reported its 
anticarcinogenic effects mainly by induction of apoptosis and cell cycle arrest by action 
on critical molecular targets for cell survival such as p53, p21, cyclin dependent kinases 
and caspases in liver (Stagos et al., 2012) and non-small cell lung (Cai et al., 2011) cancer 
cells.   
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3.2. Matricaria recutita 
3.2.1. Antioxidant and antitumor activity  
The antioxidant activity was determined by free radicals scavenging activity, reducing 
power and inhibition of lipid peroxidation in brain cell homogenates, the antitumor 
potential was tested in human tumor cell lines (breast, lung, colon, cervical and 
hepatocellular carcinomas), and the hepatotoxicity was evaluated using a porcine liver 
primary cell culture. The results are shown in Table 8. 
 
 
Table 8. Antioxidant and antitumor activities, and hepatotoxicity of wild Matricaria recutita (mean ± SD) 
 Infusion Decoction Plant methanol extract* Positive control** 
Extraction yield (%)  16.25 ± 0.59 19.37 ± 1.09 16.09 ± 0.77 - 
Antioxidant activity (EC50 values, µg/mL)     
DPPH scavenging activity  394.97 ± 44.31b 344.02 ± 18.65b 800.36 ± 49.09a 43.03 ± 1.71 
Reducing power  316.61 ± 2.46a 318.75 ± 3.01a 232.49 ± 26.19b 29.62 ± 3.15 
β-carotene bleaching inhibition  422.72 ± 92.91b 497.34 ± 107.67b 661.11 ± 21.93a 2.63 ± 0.14 
TBARS inhibition  511.01 ± 17.28a 508.44 ± 4.43a 183.48 ± 3.52b 3.73 ± 1.90 
Antitumor activity (GI50 values, µg/mL) Infusion Decoction Plant methanol extract Positive control** 
MCF-7 (breast carcinoma) >400 >400 >400 0.91±0.04 
NCI-H460 (non-small lung cancer) >400 >400 >400 1.42±0.00 
HCT-15 (colon carcinoma) 298.23±11.58a >400 250.24±18.38b 1.91±0.06 
HeLa (cervical carcinoma) 277.67±9.04a >400 259.36±7.57b 1.14±0.21 
HepG2 (hepatocellular carcinoma) >400 >400 >400 3.22±0.67 
Hepatotoxicity (GI50 value, µg/mL)     
PLP2 >400 >400 >400 2.06±0.03 
*Results reported in Barros et al., 2010. **Trolox and ellipticine for antioxidant and antitumor activity assays, respectively. EC50 values 
correspond to the sample concentration achieving 50% of antioxidant activity or 0.5 of absorbance in reducing power assay. GI50 values 
correspond to the sample concentration achieving 50% of growth inhibition in human tumor cell lines or in liver primary culture PLP2. In 
each row different letters mean significant differences (p<0.05). 
 
The infusion and decoction lyophilized samples gave similar antioxidant activity 
properties and were better than the plant methanol extract in the radical scavenging assays 
(DPPH and β-carotene bleaching inhibition). Otherwise, the plant methanol extract gave 
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higher reducing power and lipid peroxidation inhibition measured by TBARS assay 
(lowest EC50 values). The mechanisms involved in the assays used to evaluate antioxidant 
activity are different and, therefore, each plant preparation can have different compounds 
with specific capacities to participate in those mechanisms. 
Trolox and ellipticine were used as positive controls of antioxidant and antitumor 
activities evaluation assays, but should not be considered as standards and the comparison 
with extracts/oral preparations results should be avoided, because they are individual 
compounds and not mixtures. 
Regarding antitumor effects, M. recutita infusion and plant methanol extract showed to 
be selective for HCT-15 and HeLa, since no activity was observed against the other cell 
lines: MCF-7, NCI-H460 and HepG2. Nevertheless, none of the M. recutita preparations 
showed hepatotoxicity in the porcine liver primary cell culture (non-tumor cells; PLP2) 
(Table 8). The plant methanol extract was slightly more potent than the infusion sample 
in HCT-15 and HeLa human cell lines. Decoction preparation had no antitumor effects at 
the maximal concentration used (400 µg/mL). The results obtained are in agreement with 
other authors that reported minimal growth inhibitory effects in normal cells, but a 
significant reduction in cell viability in various human cancer cell lines, mainly from 
methanolic fractions rather than aqueous ones (Srivastava & Gupta, 2007, 2009). The 
absence of antitumor activity in decoction of another chamomile species, C. nobile 
(Roman chamomile), was previously reported by us (Guimarães et al., 2013). 
It should be highlighted that M. recutita has been included in commercial mixtures for 
different pharmacological applications such as i) TBS-101 (a mixture of seven 
standardized botanical extracts) that showed an outstanding safety profile with significant 
anticancer activity against androgen-refractory human prostate cancer PC-3 cells, both in 
vitro and in vivo (Evans et al., 2009); ii) STW 5 (a mixture of nine standardized botanical 
extracts) for treatment of gastrointestinal disorders, with a mechanism of action related to 
their antioxidant properties (Schempp et al., 2006). Nevertheless, chemical 
characterization and bioactivity evaluation of M. recutita infusion and decoction, the most 
consumed preparations of this herb, have been discarded being addressed herein.  
 
3.2.2. Organic acids and phenolic compounds  
Oxalic, quinic, malic, citric and succinic acids were quantified in all the extracts of M. 
recutita, oxalic acid being the most abundant organic acid (Table 9).  
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Table 9. Identification and quantification of organic acids in wild Matricaria recutita (mean ± SD). 
Organic acid Infusion Decoction Plant (control) 
Oxalic acid 8.45 ± 0.32ª 8.60 ± 0.47ª 3.24 ± 0.05b 
Quinic acid 0.24 ± 0.00b 0.88 ± 0.19ª 0.17 ± 0.00c 
Malic acid 2.26 ± 0.06ª 1.97 ± 0.03b 0.39 ± 0.02c 
Shikimic acid 0.02 ± 0.00 0.02 ± 0.00 tr 
Ascorbic acid nd nd tr 
Citric acid 6.44 ± 0.85ª 6.14 ± 0.14ª 1.55 ± 0.00b 
Succinic acid 7.00 ± 0.21ª 5.74 ± 0.13b 1.94 ± 0.05c 
Fumaric acid 0.01 ± 0.00 0.01 ± 0.00 tr 
Total (g/100 g dw) 24.42 ± 1.32a 23.35 ±0.65ª 7.30 ± 0.03b 
In each row different letters mean significant differences (p<0.05); tr- traces; nd-not detected; dw- dry 
weight. 
 
Shikimic and fumaric acids were present in low or vestigial amounts. Ascorbic acid was 
not detected neither in infusion nor decoction, and was present in traces in the plant 
extract. Infusion and decoction gave similar contents in organic acids, and higher than the 
plant extract.  
Organic acids might have antioxidant properties, such is the case of citric and oxalic acids 
(Hraš et al., 2000; Kayashima & Katayama, 2002), which may contribute for the 
antioxidant activity of the samples studied herein. 
The main phenolic compounds found in M. recutita plant and in its decoction and infusion 
were phenolic acids and derivatives, as also flavonoids such as flavonols and flavones 
(Tables 10 and 11). The chromatographic profile of the three plant preparations can be 
observed in Figure 11. Up to twenty phenolic compounds, including phenolic acids and 
flavonoids were detected in the M. recutita preparations (Table 10). 
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Table 10. Retention time (Rt), wavelengths of maximum absorption in the UV-vis region (λmax), pseudomolecular and MS2 fragment ions (in brackets, relative abundances) and 
tentative identification of the phenolic compounds of wild Matricaria recutita. 
Peak Rt (min) 
λmax 
(nm) 
Molecular ion 
[M-H]- (m/z) 
MS2 
(m/z) 
Tentative identification 
1 7.69 328 353 191(100), 179(53), 173(5), 161(5), 135(48) 3-O-caffeolyquinic acid 
2 8.24 294 153 109(100) Protocatechuic acid 
3 9.75 320 515 515(100),353(5), 191(33), 179(6), 161(13) 1,5-Dicaffeolyquinic acid 
4 10.84 326 353 191(75), 179(84), 173(100), 161(11), 135(77) 4-O-Caffeolyquinic acid 
5 11.34 326 353 191(100), 179(7), 173(3), 161(4), 135(2) cis-5-O-Caffeolyquinic acid 
6 11.57 326 353 191(100), 179(15), 173(8), 161(15), 135(7) trans-5-O-Caffeolyquinic acid 
7 12.24 312 355 193(100), 179(13), 149(80) cis-Ferulic acid  hexoside 
8 12.39 312 355 193(100), 179(13), 149(81) trans-Ferulic acid hexoside 
9 14.85 328 367 193(16), 191(100), 173(19), 134(8) 5-O-Feruloylquinic acid 
10 15.18 354 479 317(100) Myricetin O-hexoside 
11 15.45 322 711 549(3), 355(36), 193(100), 149(84) Ferulic acid  hexoside dímer 
12 15.81 322 677 
515(100), 497(2), 353(17), 335(7), 191(4), 179 (7), 173 (1), 
135 (3) 
1,3,5-O or 1,4,5-O-Tricaffeolyquinic 
13 16.54 340 651 489(96), 447(55), 285(45) Luteolin acetylhexoside hexoside 
14 17.11 330 515 
515 (100),353(66), 
335(25),299(2),255(3),203(3),191(26),179(53),173(68), 161(9) 
3,4-O-Dicaffeolyquinic acid 
15 17.68 340 447 285(100) Luteolin-7-O-glucoside 
16 18.09 330 515 
353(100),335(8),191(89),179(75),173(11),161(7), 
155(2),135(28) 
3,5-O-Dicaffeolyquinic acid 
17 18.54 372 505 343(8), 301(100) Quercetin 7-O-acetylhexoside 
18 18.64 343 489 327(5), 285(64) Luteolin O-acylhexoside 
19 18.81 328 515 
353(100),335(4),299(5),255(5),203(3),191(30),179(67), 
173(95), 161(2),155(3),135(24) 
4,5-O-Dicaffeoylquinic acid 
20 19.10 296(sh),336 489 327(5), 285(64) Luteolin O-acylhexoside 
Towards antioxidant and antitumor properties of wild medicinal plants traditionally used in Portugal 
 
60 
  
Compound 2 was identified as protocatechuic acid by comparison of its UV spectrum and 
retention time with a commercial standard. Thirteen hydroxycinnamic acid derivatives 
(peaks 1, 3-9, 11, 12, 14, 16 and 19) were detected, ten being quinic acid derivatives (1, 
3-6; 9, 12, 14, 16 and 19), whose identities were assigned based on their MS spectra and 
fragmentation patterns. These compounds released characteristic MS2 fragment ions at 
m/z 191 (deprotonated quinic acid), 179 (deprotonated caffeic acid) or 193 (deprotonated 
ferulic acid), which together with their pseudo molecular ions [M-H]- at m/z 353, 515, 
677 or 367 allowed their identification as quinic acid derivatives containing one, two or 
three caffeic acid moieties or one ferulic acid moiety, respectively. The assignments of 
the different caffeoylquinic acid isomers were made using the recommended IUPAC 
numbering system, as also the hierarchical keys previously developed by Clifford, 2003 
and Clifford et al., 2005.  
Compound 6 was positively identified as 5-O-caffeoylquinic acid by comparison with an 
authentic standard, as also to its MS fragmentation pattern. Compound 5 was tentatively 
assigned as the corresponding cis isomer of 5-O-caffeoylquinic acid based on its 
fragmentation pattern and lower levels compared with peak 6. Furthermore, 
hydroxycinnamoyl cis derivatives would be expected to elute before the corresponding 
trans ones, as observed after UV irradiation (366 nm, 24 h) of hydroxycinnamic acids in 
our laboratory. 
Compound 1 ([M-H]- at m/z 353) was identified as 3-O-caffeoylquinic acid, yielding the 
base peak at m/z 191 and the ion at m/z 179 with an intensity >55% base peak, 
characteristic of 3-acylchlorogenic acids as reported by Clifford et al. (2003, 
2005).  Compound 4 was easily distinguished from the other two isomers by its base peak 
at m/z 173 [quinic acid-H-H2O]
-, accompanied by a secondary fragment ion at m/z 179 
with approximately 84% abundance of base peak, which allowed identifying it as 4-O-
caffeoylquinic acid according to the fragmentation pattern described by Clifford et al. 
(2003, 2005). Compound 9 was tentatively identified as 5-O-feruloylquinic acid taking 
into account its fragmentation pattern and relative intensities similar to 5-O-
caffeoylquinic acid. 
Compounds 3, 14, 16 and 19 ([M-H]- at m/z 515) could be assigned as dicaffeoylquinic 
acids and were assigned to 1,5-O-, 3,4-O-, 3,5-O- and 4,5-O- dicaffeoylquinic acids, 
respectively, based on their elution order, fragmentation pattern and relative abundances 
(Clifford et al., 2003, 2005). MS2 fragmentation of compound 14 yielded the formation 
of signals corresponding to “dehydrated” fragment ions at m/z 335 [caffeoylquinic acid –
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H-H2O]
- and m/z 173 [quinic acid-H-H2O]
-, characteristic of 4-acyl-caffeoylquinic acids. 
Furthermore, according to Clifford et al., 2005, the intensity of signal at m/z 335 (25% of 
base peak) is more intense than in 4,5-O-dicaffeoylquinic (barely detectable, 4% of base 
peak). These observations allowed assigning compound 14 as 3,4-O-dicaffeoylquinic 
acid. The fragmentation pattern for 3,5-O-dicaffeoylquinic (compound 16) acid was 
similar to the one previously reported by Clifford et al., 2005. MS2 base peak was at m/z 
353, produced by the loss of one of the caffeoyl moieties [M-H-caffeoyl]-, and subsequent 
fragmentation of this ion yielded the same fragments as 5-caffeoylquinic acid at m/z 191, 
179 and 135, although in this case with a comparatively more intense signal at m/z 179 
[caffeic acid-H]-  (75% base peak). Compound 19 was assigned to 4,5-O- dicaffeoylquinic 
acid since its fragmentation was identical to those previously reported by Clifford et al., 
2005. In this case, the signal at m/z 335 was barely detectable (<5 % of base peak) and 
the intense signal at m/z 173, is characteristic for an isomer substituted at position 4, which 
indicated that whereas 3,4-O-dicaffeoylquinic acid initially loses the caffeoyl moiety at 
position 3, in the case of 4,5-O-dicaffeoylquinic acid would initially lose that at position 
5. Compound 3 was assigned as 1,5-O-dicaffeoylquinic acid, following the criteria the 
reported by Clifford et al., 2005, the weak ions at m/z 335 and 179 (<10 % of base peak).  
Compound 12 was identified as tricaffeoylquinic acid according to its pseudomolecular 
ion [M-H]- at m/z 677 and diagnostic MS2 fragments at m/z 515 (loss of the first caffeoyl), 
m/z 353 (loss of the second caffeoyl), m/z 191 (loss of the third caffeoyl to give quinic 
acid ion), m/z 179 (caffeic acid ion). The signal observed at m/z 497 can be interpreted by 
the loss of a water molecule from the ion at m/z 515. According to the relative intensities 
of different tricaffeoylquinic acid isomers reported by Lin & Harnly (2008), this 
compound could be assigned as 1,3,5-O-tricaffeoylquinic acid or 1,4,5-O-
tricaffeoylquinic acid.  
Compounds 7 and 8 with MS2 fragments at m/z 193 ([ferulic acid-H]-) resulting from the 
loss of a hexosyl moiety, -162 mu, and 176 ([ferulic acid-H-H2O]
-) was tentatively 
assigned as a ferulic acid hexoside. Compound 7 presented similar UV and mass spectra 
characteristics as peak 8 but an earlier retention time, taking into account the observation 
above it was tentatively identified as cis ferulic acid hexoside. Similarly, compound 11 
was tentatively identified as ferulic acid hexoside dimer.  
Flavones were the most abundant flavonoids present in the samples analysed (Tables 11 
and 12).  
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Table 11. Quantification of phenolic compounds in wild Matricaria recutita (mean ± SD). 
Peak Infusion Decoction Plant (control) 
3-O-caffeolyquinic acid 0.15 ± 0.01a 0.12 ± 0.00b 0.07 ± 0.00c 
Protocatechuic acid 0.07 ± 0.01a 0.05 ± 0.01b nd 
1,5-Dicaffeolyquinic acid nd tr 0.02 ± 0.00 
4-O-Caffeolyquinic acid 0.21 ± 0.00b 0.13 ± 0.00c 0.24 ± 0.00a 
cis 5-O-Caffeolyquinic acid 0.17 ± 0.04a 0.15 ± 0.00a nd 
trans 5-O-Caffeolyquinic acid 0.26 ± 0.04b 0.22 ± 0.01b 1.02 ± 0.02a 
cis Feruloyl hexoside acid 0.32 ± 0.02a 0.28 ± 0.01b nd 
trans  Feruloyl hexoside acid 0.46 ± 0.01b 0.38 ± 0.01c 1.02 ± 0.00a 
5-O-Feruloylquinic acid 0.03 ± 0.00a 0.02 ± 0.00b nd 
Myricetin O-hexoside nd nd 0.05 ± 0.00 
Feruloyl hexoside acid dímer 0.59 ± 0.00b 0.55 ± 0.01c 0.91 ± 0.00a 
1,3,5-O or 1,4,5-Tricaffeolyquinic 0.03 ± 0.00b 0.02 ± 0.00c 0.06 ± 0.00a 
Luteolin acetylhexoside hexoside 0.02 ± 0.00c 0.03 ± 0.00b 0.11 ± 0.01a 
3,4-O-Dicaffeolyquinic acid 0.73 ± 0.03a 0.33 ± 0.01b 0.35 ± 0.00b 
Luteolin-7-O-glucoside 0.17 ± 0.01a 0.09 ± 0.00b 0.06 ± 0.00c 
3,5-O-Dicaffeolyquinic acid 0.26 ± 0.07a 0.16 ± 0.00b 0.10 ± 0.00b 
Quercetin 7-O-acetylhexoside nd nd 0.10 ± 0.00 
Luteolin O-acylhexoside 0.09 ± 0.01b 0.06 ± 0.00c 0.19 ± 0.01a 
4,5-O-Dicaffeoylquinic acid 0.17 ± 0.03a 0.13 ± 0.01b nd 
Luteolin O-acylhexoside 1.29 ± 0.12b 0.81 ± 0.04c 2.10 ± 0.00a 
Total phenolic acids (g/100 g dw) 3.43 ± 0.22b 2.53 ± 0.02c 3.99 ± 0.02a 
Total flavonoids (g/100 g dw) 1.56 ± 0.12b 0.98 ± 0.04c 2.59 ± 0.01a 
Total phenolic compounds (g/100 g dw) 5.00 ± 0.33b 3.51 ± 0.06c 6.58 ± 0.03a 
In each row different letters mean significant differences (p<0.05); tr- traces; nd-not detected; dw- dry weight. 
 
 
Compounds 13, 15, 18 and 20 were identified as luteolin derivatives. Compounds 15, 18 
and 20 presented a pseudomolecular ions [M-H]- at m/z 447 and 489 releasing a common 
MS2 fragment at m/z 285 ([M-H-162]- and [M-H-42-162]-, loss of hexosyl and 
acetylhexoside moieties, respectively). They were tentatively identified as luteolin 7-O-
glucoside (retention time compared with a commercial standard), and two luteolin O-
acetylhexoside (compound 18 and 20), respectively. Compound 13 presented a 
pseudomolecular ion [M-H]- at m/z 651 releasing three MS2 fragments at m/z 489, 447 
and 285 (loss of hexosyl, acetylhexosyl and acetyldihexosyl moieties, respectively), being 
tentatively identified as luteolin acetylhexoside hexoside. 
Flavonols (compounds 10 and 17) were also found in the studied samples (Table 11). 
Compound 10 presented a pseudomolecular ion [M-H]- at m/z 479, releasing an MS2 
fragment at m/z 317 ([M-H-162]-, loss of an hexosyl moiety), corresponding to myricetin, 
which allowed a tentative identification of the compound as myricetin O-hexoside. 
Compound 17 corresponded to a quercetin derivative presenting a pseudomolecular ion 
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[M-H]- at m/z 505 releasing an MS2 fragment at m/z 301 (quercetin; [M-H-42-162]-, loss 
of an acetylhexoside moiety). It is known that the introduction of a glycoside on the 
hydroxyls at positions 7, 3´ or 4´ has no effect on wavelength maxima or the spectrum 
shape in relation to the aglycone (Mabry et al., 1970). Thus, quercetin 7-O-glycosides 
would have λmax in Band I around 370 nm, while quercetin 3 O-glycosides are 
hypsochromically shifted to around 354 nm. Since this compound presented λmax at 372 
nm it was tentatively identified as quercetin 7-O-acetylhexoside. 
The amounts of the phenolic compounds found varied among the different preparations 
and flavonols decreased in infusions and decoctions, but otherwise cis isomer of 
caffeoylquinic and ferulic acids derivatives appeared in these preparations (Table 11 and 
Figure 11).  
 
 
 
 
(A) 
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Figure 11. HPLC chromatogram of the phenolic compounds of Matricaria recutita recorded at 280 nm 
(A) plant methanol extract (control; 1:2 v/v); (B) infusion and (C) decoction. 
 
The plant methanol extract (control) presented the highest amounts of phenolic acids 
(3.99g/100 g dw) and flavonoids (2.59g/100 g dw) as also total phenolic compounds 
(6.58g/100 g dw), followed by infusion (5.00g/100 g dw) and decoctions (3.51g/100 g 
dw). The same was observed in C. nobile (Roman chamomile) in a previously work of 
our research group (Guimarães et al., 2013). 
The major compound found in the herbal plant and in the preparations was luteolin O-
acylhexoside (compound 20). Mulinacci et al. (2000), Nováková et al. (2010), Harbourne 
et al., (2009) and Srivastava & Gupta, (2009) reported the presence of apigenin 7-O-
glucoside and other apigenin derivatives, but these compounds were not detected in our 
(B) 
(C) 
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samples. Furthermore, Mulinacci et al. (2000) revealed the presence of different 
flavonoids, such as patuletin and other quercetin derivatives. In relation to the 
quantification, no comparison can be made, due to the fact that those authors only 
presented percent area measured at 335 nm of the main phenolic compounds found.    
Nováková et al. (2010) presented the phenolic profile of methanolic extracts of M. 
recutita herbal flowers and infusions, demonstrating also lower values in infusions 
preparation when compared to the herbal plant methanolic extract. These authors also 
found a dissimilar profile than the one obtained in this study, finding other flavonoids, 
such as kaempferol, isorhamnetin and different quercetin derivatives in their samples. The 
quantification was expressed in µmol/L, being difficult to compare with the results of M. 
recutita obtained herein.  
Overall, it was observed a decrease in the amount of phenolic compounds in the plant 
infusion or decoction, compared to the methanol extract; the same was not observed for 
organic acids, which indicates that these compounds are better extracted with hot water 
than with methanol. The decoction had no antitumor effects which could indicate that 
these effects might be related to compounds (including phenolic compounds) that were 
not extracted or that were affected by the decoction procedure. Both plant methanol 
extract and infusion showed inhibitory activity of the growth of colon and cervical 
carcinoma cell lines, without toxicity for hepatocyte normal cells. Therefore, wild 
German chamomile (M. recutita) may be considered a source of important 
phytochemicals with bioactive properties to be explored in the medicine, food, and 
cosmetic industries 
 
3.3. Arbutus unedo, Prunus spinosa, Rosa canina and Rosa micrantha fruits 
3.3.1. Phenolic compounds  
The characterization of the phenolic compounds present in the wild fruits was performed 
by HPLC-DAD-MS analysis, and data of the retention time, λmax, pseudomolecular ion, 
main fragment ions in MS2, tentative identification and quantification of phenolic acids, 
flavone/ols, flavan-3-ols, and anthocyanins are presented in Tables 12-14. 
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Table 12. Retention time (Rt), wavelengths of maximum absorption in the UV-vis region (λmax), pseudomolecular and MS2 fragment ions (in brackets, relative abundances), 
tentative identification and quantification of the phenolic acids and flavone/ols of wild fruits. 
 
Peak 
Rt 
(min) 
λmax 
(nm) 
Molecular 
ion  
[M-H]- 
(m/z) 
MS2 
(m/z) 
Tentative identification Identification type 
Quantification 
(mg/100g) 
Arbutus unedo 
1 18.7 354 615 615(100),463(18),301(18) 
Quercetin galloylhexoside 
derivative 
DAD/MS 
0.57 ± 0.03 
2 18.9 352 615 615(100),463(36),301(29) 
Quercetin  galloylhexoside 
derivative 
DAD/MS 
1.31 ± 0.00 
3 19.2 - 463 317(100) Myricetin rhamnoside DAD/MS 0.23 ± 0.01 
4 19.5 348 609 301(100) Quercetin 3-O-rutinoside  Standard/DAD/MS 1.70 ± 0.02 
5 19.9 354 447 285(100) Kaempferol hexoside DAD/MS 0.84 ± 0.14 
6 20.4 348 463 301(100) Quercetin 3-O-glucoside Standard/DAD/MS 2.34 ± 0.01 
7 20.8 352 463 317(100) Myricetin rhamnoside DAD/MS 0.45 ± 0.01 
8 23.7 352 433 301(100) Quercetin pentoside DAD/MS 1.32 ± 0.04 
9 24.7 350 447 301(100) Quercetin rhamnoside DAD/MS 2.10 ± 0.04 
     Total  10.86 ± 0.24 
Prunus spinosa  
1 5.2 326 353 191(100),179(98),161(14),135(75) 3-O-caffeoylquinic acid 
Clifford et al. 2003 and 2005/ 
DAD/MS 
22.09 ± 0.11 
2 7.1 312 337 191(36),163(100),155(8),119(75) 
3-p-coumaroylquinic acid Clifford et al. 2003 and 2005/ 
DAD/MS 
0.80 ± 0.01 
3 7.5 324 353 191(74),179(94),173(100),161(8),135(75) 
4-O-caffeoylquinic acid Clifford et al. 2003 and 2005/ 
DAD/MS 
3.41 ± 0.03 
4 8.2 326 367 193(100),191(16),173(14),149(25) 
3-O-feruloylquinic acid Clifford et al. 2003 and 2005/ 
DAD/MS 
1.76 ± 0.04 
5 8.5 340 401 269(100) Apigenin pentoside DAD/MS 1.32 ± 0.03 
6 11.1 312 337 191(3),173(100),163(43),155(12),119(21) 
4-p-coumaroylquinic acid Clifford et al. 2003 and 2005/ 
DAD/MS 
0.64 ± 0.00 
7 14.3 346 739 625(100),607(7),501(9),475(7),317(14),299(24) Myricetin derivative DAD/MS 1.06 ± 0.05 
8 15.1 328 335 179(20),161(100),135(49) Caffeoyl hexoside DAD/MS 1.07 ± 0.00 
9 18.9 350 595 301(100) Quercetin pentosyl-hexoside DAD/MS 1.36 ± 0.04 
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Peak 
Rt 
(min) 
λmax 
(nm) 
Molecular 
ion  
[M-H]- 
(m/z) 
MS2 
(m/z) 
Tentative identification Identification type 
Quantification 
(mg/100g) 
10 19.5 356 609 301(100) Quercetin rhamnosyl-hexoside DAD/MS 2.22 ± 0.03 
11 19.8 356 609 301(100) Quercetin 3-O-rutinoside Standard/DAD/MS 15.63 ± 0.33 
12 20.3 352 595 301(100) Quercetin pentosyl-hexoside DAD/MS 6.83 ± 0.29 
13 20.7 356 463 301(100) Quercetin 3-O-glucoside Standard/DAD/MS 1.36 ± 0.02 
14 21.2 354 463 301(100) Quercetin hexoside DAD/MS 4.70 ± 0.50 
15 22.9 350 593 285(100) Kaempferol 3-O-rutinoside Standard/DAD/MS 1.90 ± 0.05 
16 23.8 354 609 447(4),301(100) Quercetin hexosyl-rhamnoside DAD/MS 7.17 ±0.42 
17 24.0 354 433 301(100) Quercetin pentoside DAD/MS 8.84 ± 0.26 
18 24.4 358 623 315(100) Isorhamnetin 3-O-rutinoside Standard/DAD/MS 0.87 ± 0.03 
19 25.1 348 447 301(100) Quercetin rhamnoside DAD/MS 1.30 ± 0.02 
20 25.8 356 505 463(5),301(100) Quercetin acetylhexoside DAD/MS 1.90 ± 0.05 
21 29.8 348 651 609(15),301(100) Quercetin acetylrutinoside DAD/MS 1.00 ± 0.01 
     Total phenolic acids  29.78±0.17 
     Total flavone/ols  57.48±0.74 
     Total   87.25 ± 0.91 
Rosa canina 
1 15.9 292 435 303(24),285(100) Taxifolin pentoside DAD/MS 1.18 ± 0.03 
2 16.9 294 449 287(20),269(100),225(2),209(2),151(27)   Eriodictyol hexoside  DAD/MS 0.15 ± 0.00 
3 17.6 290 449 449(100),287(44),269(64),225(14),209(14),151(55)   Eriodictyol hexoside  DAD/MS 0.50 ± 0.01 
4 19.6 356 609 301(100) Quercetin 3-O-rutinoside Standard/DAD/MS 0.47 ± 0.00 
5 20.0 352 477 301(100) Quercetin glucuronide DAD/MS 0.24 ± 0.01 
6 20.4 290 435 303(26),285(100) Taxifolin pentoside DAD/MS 0.83 ± 0.00 
7 20.5 358 463 301(100) Quercetin 3-O-glucoside Standard/DAD/MS 0.66 ± 0.01 
8 20.9 352 463 301(100) Quercetin hexoside DAD/MS 0.78 ± 0.00 
9 23.8 352 433 301(100) Quercetin pentoside DAD/MS 0.10 ± 0.01 
10 24.2 346 623 315(100) Isorhamnetin 3-O-rutinoside Standard/DAD/MS 0.02 ± 0.01 
11 24.6 350 447 301(100) Quercetin rhamnoside DAD/MS 0.46 ± 0.01 
12 35.4 348 593 285(100) 
Kaempferol rhamnosyl-
hexoside 
DAD/MS 
0.09 ± 0.00 
     Total  5.50 ± 0.05 
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Peak 
Rt 
(min) 
λmax 
(nm) 
Molecular 
ion  
[M-H]- 
(m/z) 
MS2 
(m/z) 
Tentative identification Identification type 
Quantification 
(mg/100g) 
Rosa micrantha 
1 5.7 278 345 183(100),168(10) Methyl gallate hexoside DAD/MS 2.45 ± 0.02 
2 16.0 294 435 303(54),285(100) Taxifolin pentoside DAD/MS 2.68 ± 0.01 
3 17.1 296 449 449(100), 287(10),269(85),225(12),209(12),151(7)   Eriodictyol hexoside  DAD/MS 0.22 ± 0.01 
4 17.8 290 449 449(100),287(44),269(66),225(12),209(25),151(44)   Eriodictyol hexoside  DAD/MS 0.63 ± 0.02 
5 19.8 354 609 301(100) Quercetin 3-O-rutinoside Standard/DAD/MS 0.32 ± 0.00 
6 20.3 358 477 301(100) Quercetin glucuronide DAD/MS 0.10 ± 0.01 
7 20.6 292 435 303(53),285(100) Taxifolin pentoside DAD/MS 1.92 ± 0.00 
8 20.7 352 463 301(100) Quercetin 3-O-glucoside Standard/DAD/MS 0.97 ± 0.01 
9 21.2 352 463 301(100) Quercetin hexoside DAD/MS 0.90 ± 0.01 
10 24.1 352 433 301(100) Quercetin pentoside DAD/MS 0.21 ± 0.00 
11 24.4 352 623 315(100) Isorhamnetin 3-O-rutinoside Standard/DAD/MS tr 
12 25.1 346 447 301(100) Quercetin rhamnoside DAD/MS 0.71 ± 0.01 
13 35.7 348 593 285(100) 
Kaempferol rhamnosyl-
hexoside 
DAD/MS 
0.05 ± 0.00 
     Total  11.16 ± 0.04 
tr-traces 
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Table 13. Retention time (Rt), wavelengths of maximum absorption in the UV-vis region (λmax), pseudomolecular and MS2 fragment ions (in brackets, relative abundances), 
tentative identification and quantification of flavan-3-ols and galloyl derivatives in wild fruits. 
Peak 
Rt 
(min) 
λmax 
(nm) 
Molecular 
ion [M-H] 
(m/z) 
MS2 
(m/z) 
Tentative identification Identification type 
Quantification 
(mg/100g) 
Arbutus unedo 
1 9.9 274 343 191 (100),169 (13) Galloylquinic acid 
Pawlowska et al., 2006/ Mendes 
et al., 2011 and Tavares et al., 
2010/DAD/MS 
8.65 ± 0.00 
2 11.3 278 331 169 (100) Galloylhexoside acid DAD/MS 1.02 ± 0.03 
3 12.5 276 593 423(75),407(25),305 (100) PA dimer (GC+C)b DAD/MS 1.07 ± 0.00 
4 12.9 276 325 169 (100) Galloyl shikimic acid 
Pawlowska et al., 2006/ Mendes 
et al., 2011 and Tavares et al., 
2010/DAD/MS 
3.61 ± 0.01 
5 15.7 274 577 451(17),425(26),407(100), 289(78), 287(7) B1 dimer DAD/MS 8.56 ± 0.31 
6 16.4 280 865 
865(100),739(9), 713(9), 695(17), 577(9), 575(9), 425(12), 407(17), 
289(12),287(12) 
B-type procyanidin 
trimer 
DAD/MS 4.11 ± 0.14 
7 17.5 278 865 
865(100),739(3), 713(3), 695(2), 577(11), 575(3), 425(4), 407(5), 
289(9),287(7) 
B-type procyanidin 
trimer 
DAD/MS 2.76 ± 0.07 
8 18.3 278 289 245 (70), 205 (33), 151 (21), 137 (33) (+)-catechin Standard/ DAD/MS 13.51 ± 0.93 
9 18.4 278 495 343(42),191(100) Digalloylquinic acid 
Pawlowska et al., 2006/ Mendes 
et al., 2011 and Tavares et al., 
2010/DAD/MS 
3.49 ± 0.42 
10 19.4 278 1153 865 (7), 577 (8), 289 (100) 
B-type procyanidin 
tetramer 
DAD/MS 2.94 ± 0.07 
11 22.4 278 577 451(17),425(75),407(100), 289(58), 287(17) 
B-type procyanidin 
dimer 
DAD/MS 3.35 ± 0.06 
12 22.9 276 477 325(100),169(29) 
Digalloylquinic shikimic 
acid 
Pawlowska et al., 2006/ Mendes 
et al., 2011 and Tavares et al., 
2010/DAD/MS 
1.81 ± 0.04 
13 23.9 270 633 633(100),463(12),301(70),275(5) Strictinin ellagitannin 
Pawlowska et al., 2006/ Mendes 
et al., 2011 and Tavares et al., 
2010/DAD/MS 
3.54 ± 0.01 
14 28.3 270 477 325(100),169(54) 
Digalloylquinic shikimic 
acid 
Pawlowska et al., 2006/ Mendes 
et al., 2011 and Tavares et al., 
2010/DAD/MS 
2.51 ± 0.00 
     Total flavan-3-ols  36.30 ± 0.70 
     Total galloyl derivatives  24.63 ± 0.42 
     Total  60.93 ± 0.27 
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Peak 
Rt 
(min) 
λmax 
(nm) 
Molecular 
ion [M-H] 
(m/z) 
MS2 
(m/z) 
Tentative identification Identification type 
Quantification 
(mg/100g) 
Rosa canina 
1 11.5 280 1351 1019(9),899(26),675(100),451(96),287(9) PA trimer triglycoside DAD/MS 0.77 ± 0.00 
2 12.3 280 1189 1189(100), 898(23),739(17),575(10),449(17),289(7) PA trimer diglycoside DAD/MS 1.37 ± 0.00 
3 12.9 280 819a 739(100),674(2),289(15) PA tetramer triglycoside Salminen et al., 2005/DAD/MS 0.69 ± 0.04 
4 13.5 274 819a 739(38),674(2),289(100) PA tetramer triglycoside Salminen et al., 2005/DAD/MS 1.21 ± 0.07 
5 14.9 280 739 449(18),425(29),407(100),289(47) 
PA dimer 
monoglycoside 
DAD/MS 3.27 ± 0.10 
6 15.6 280 451 289(100) (+)-catechin-hexoside DAD/MS 1.62 ± 0.06 
7 15.9 272 577 451(4),425(52),407(100),289(69) Procyanidin dimer  B1 DAD/MS 1.68 ± 0.09 
8 16.3 278 577 425(31), 407(100), 289(25) Procyanidin dimer  B3 DAD/MS 1.50 ± 0.13 
9 17.7 282 865 865(100),695(10), 577(50), 449(15), 407(25), 287(35) 
B-type procyanidin 
trimer 
DAD/MS 0.74 ± 0.08 
10 17.9 280 739 739(100),449(11),425(11),407(48),289(22) 
Procyanidin dimer 
monoglycoside 
DAD/MS 1.32 ± 0.02 
11 18.7 278 289 289(100),245(29), 205(8), 179(7), 137(4) (+)-catechin Standard/ DAD/MS 3.59 ± 0.17 
12 30.1 280 865 865(100),739(14),577(21),575(21),425(14),407(14),289(21) 
B-type procyanidin 
trimer 
DAD/MS 2.14 ± 0.08 
     Total flavan-3-ols  19.90 ± 0.51 
Rosa micrantha 
1 11.3 280 1351 1019(23),899(26),675(100),451(73),287(10) PA trimer triglycoside DAD/MS 2.32 ± 0.05 
2 12.1 280 1189 898(37),739(19),575(14),449(22),289(100) PA trimer diglycoside DAD/MS 2.02 ± 0.04 
3 12.7 280 819a 819(100),739(18),674(4),289(35) PA tetramer triglycoside Salminen et al., 2005/DAD/MS 0.88 ± 0.07 
4 13.2 280 819a 739(18),674(27),289(100) PA tetramer triglycoside Salminen et al., 2005/DAD/MS 2.52 ± 0.06 
5 13.8 280 1351 1019(13),899(13),675(50),451(100),287(14) PA trimer triglycoside DAD/MS 0.49 ± 0.01 
6 14.5 280 739 739(100),449(27),425(13),407(63),289(43) 
PA dimer 
monoglycoside 
DAD/MS 4.93 ± 0.06 
7 15.3 280 451 289(100) (+)-catechin-hexoside DAD/MS 2.64 ± 0.14 
8 15.6 274 577 451(15),425(55),407(100),289(91) Procyanidin dimer B1 DAD/MS 1.69 ± 0.04 
9 17.6 280 739 739(100),449(25),425(15),407(47),289(22) 
Procyanidin dimer 
monoglycoside 
DAD/MS 0.94 ± 0.08 
10 18.4 278 289 289(100),245(72), 205(32), 179(16), 137(18) (+)-catechin Standard/ DAD/MS 2.90 ± 0.06 
11 19.8 284 819a 819(100),739(33),674(11),289(67) PA tetramer triglycoside Salminen et al., 2005/DAD/MS 1.54 ± 0.07 
12 19.9 280 865 865(100),739(15),577(3),575(5),425(2),407(5),289(9) 
B-type procyanidin 
trimer 
DAD/MS 0.68 ± 0.12 
13 21.6 280 851 
851(100),739(6), 671(4), 561(62), 537(17), 407(10), 381(33), 357(6), 
289(12) 
PA trimer (2C+A)b DAD/MS 1.80 ± 0.06 
Towards antioxidant and antitumor properties of wild medicinal plants traditionally used in Portugal 
 
71 
  
Peak 
Rt 
(min) 
λmax 
(nm) 
Molecular 
ion [M-H] 
(m/z) 
MS2 
(m/z) 
Tentative identification Identification type 
Quantification 
(mg/100g) 
14 25.9 282 739 739(100),449(11),425(33),407(11),289(33) 
PA dimer 
monoglycoside 
DAD/MS 1.98 ± 0.11 
15 26.8 280 851 
851(100),739(6), 671(6), 561(71), 537(18),407(12),381(65), 357(12), 
289(12) 
PA trimer (2C+A)b DAD/MS 1.40 ± 0.08 
16 28.8 280 1027 1027(100),900(4),737(3),575(4),407(15),287(7) 
PA trimer 
monoglycoside 
DAD/MS 0.96 ± 0.34 
17 29.9 282 865 865(100),739(6),577(25),575(31),425(13),407(25),289(25) 
B-type procyanidin 
trimer 
DAD/MS 1.63 ± 0.03 
18 35.6 276 577 451(14),425(51),407(71),289(100) 
B-type procyanidin 
dimer 
DAD/MS 1.31 ± 0.03 
     Total  flavan-3-ols  32.62 ± 0.70 
a [M-H]2- ; b C: (epi)catechin, A: (epi)afzelechin, GC: (epi)gallocatechin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Towards antioxidant and antitumor properties of wild medicinal plants traditionally used in Portugal 
 
72 
  
Table 14. Retention time (Rt), wavelengths of maximum absorption in the UV-vis region (λmax), pseudomolecular and MS2 fragment ions (in brackets, relative abundances), 
tentative identification and quantification of the anthocyanins of wild fruits. 
Peak 
Rt 
(min) 
λmax 
(nm) 
Molecular ion  
[M+H]+ (m/z) 
MS2 
(m/z) 
Tentative identification Identification type 
Quantification 
(µg/100g dw) 
Arbutus unedo  
1 18.0 518 465 303(100) Delphinidin 3-O-glucoside Standard/DAD/MS 0.91 ± 0.01 
2 22.4 518 449 287(100) Cyanidin 3-O-glucoside Standard/DAD/MS 11.40 ± 0.03 
3 25.9 518 419 287(100) Cyanidin 3-O-pentoside Standard/DAD/MS 1.45 ± 0.02 
     Total   13.77 ± 0.01 
 Prunus spinosa 
1 23.1 518 449 287(100) Cyanidin 3-O-glucoside Standard/DAD/MS 19.83 ± 0.05  
2 24.4 518 595 449(6), 287(100) Cyanidin 3-O-rutinoside Standard/DAD/MS 31.12 ± 0.11 
3 30.9 518 463 301(100) Peonidin 3-O-glucoside Standard/DAD/MS 10.73 ± 0.16  
4 31.4 520 609 463(3), 301(100)  Peonidin 3-O-rutinoside Standard/DAD/MS 34.47 ± 0.03 
5 32.2 518 419 287(100) Cyanidin 3-O-pentoside Standard/DAD/MS 1.49 ± 0.12 
6 37.4 520 433 301(100) Peonidin 3-O-pentoside Standard/DAD/MS 0.26 ± 0.03 
7 38.2 520 491 287(100) Cyanidin 3-O-acetylglucoside DAD/MS 1.77 ± 0.01 
8 42.3 520 505 301(100) Peonidin 3-O-acetylglucoside DAD/MS 0.73 ± 0.05 
     Total   100.40 ± 0.47 
 Rosa canina 
1 22.6 516 449 287(100) Cyanidin 3-O-glucoside Standard/DAD/MS 0.68 ± 0.01 
 Rosa micrantha 
1 22.5 516 449 287(100) Cyanidin 3-O-glucoside Standard/DAD/MS 1.19 ± 0.03 
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As an example, the HPLC profiles of flavonols (A), flavan-3-ols (B) and anthocyanins 
(C) of A. unedo fruits, recorded at 370, 280 and 520 nm, respectively, can be observed in 
Figure 12.  
 
 
 
 
(A) 
(B) 
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Figure 12. HPLC phenolic profiles of Arbutus unedo obtained at 370 nm (A), 280 nm (B) and 520 nm (C) 
used for recording flavone/ols, flavan-3-ols and galloyl derivatives, and anthocyanins, respectively. Note 
that different chromatographic conditions were used in each case. 
 
3.3.1.1. Phenolic acids and flavone/ols 
Prunus spinosa fruits were the only ones that presented phenolic acids, all belonging to 
the hydroxycinnamic acid derivative sub-group, among them, five compounds (peaks 1-
4 and 6) were quinic acid derivatives identified according to their UV spectra (λmax at 
314-330 nm) and pseudo molecular ions [M-H]- (m/z at 337, 353 and 367, all of them 
yielding a product ion at m/z 191, due to the deprotonated quinic acid). Peak assignments 
of the different hydroxycinnamoylquinic acid isomers were made using the recommended 
IUPAC numbering system (IUPAC, 1976) and the hierarchical keys previously 
developed by Clifford et al., (2003) and Clifford et al., (2005). Peak 1, the major phenolic 
compound found in P. spinosa fruits, and peak 2 were identified as 3-O-caffeoylquinic 
acid and 3-p-coumaroylquinic acid, respectively, as peak 1 yielded deprotonated quinic 
acid (m/z at 191) as base peak and another majority ion corresponding the 
hydroxycinnamic acid residue at m/z 179 [caffeic acid-H]-, and peak 2 presented m/z 163 
[p-coumaric acid-H]- as base peak, a fragmentation pattern characteristic of 3-
acylchlorogenic acids (Clifford et al., 2003, 2005). Similarly, peak 4, with a major ion at 
m/z 193 [p-ferulic acid-H]-, was tentatively identified as 3-O-feruloylquinic acid taking 
into account its pseudomolecular ion and fragmentation pattern. Peaks 3 and 6 were easily 
distinguished from its base peak at m/z 173 ([quinic acid-H-H2O]
-), in the case of peak 3, 
(C) 
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accompanied by a secondary fragment ion at m/z 179 with approximately 94% abundance, 
which allowed their identification as 4-O-caffeoylquinic and 4-p-coumaroylquinic acids 
according to the fragmentation patterns described by Clifford et al. (2003, 2005). Peak 8 
presented a UV spectra similar to caffeic acid, with λmax around 328 nm, and a pseudo 
molecular ion [M-H]- at m/z 335, releasing a fragment at m/z 179 [caffeic acid-H]- (-162 
mu, loss of a hexosyl moiety); it was tentatively identified as a caffeoyl hexoside. In all 
the studied samples, quercetin derivatives (λmax around 354 nm, and an MS2 fragment at 
m/z 301) were particularly abundant (Table 13). Quercetin 3-O-rutinoside (peaks: 4- A. 
unedo, 11- P. spinosa, 4- R. canina and 5- R. micrantha in Table 13) and quercetin 3-O-
glucoside (peaks: 6- A. unedo, 13- P. spinosa, 7- R. canina and 8- R. micrantha), were 
found in all the studied fruits. Both were positively identified according to their retention, 
mass and UV-vis characteristics by comparison with commercial standards. Quercetin 
pentoside and quercetin rhamnoside ([M-H]- at m/z 433 and 447, respectively) were also 
found in all the samples (peaks: 8 and 9- A. unedo; 17 and 19- P. spinosa; 9 and 11- R. 
canina; 10 and 12- R. micrantha). A quercetin hexoside ([M-H]- at m/z 463) was also 
found in P. spinosa (peak 14), R. canina (peak 8) and R. micrantha (peak 9) fruits. Other 
detected quercetin glycosides were peaks 9 and 12 in P. spinosa, both assigned to 
quercetin pentosyl-hexosides ([M-H]- at m/z 595); peaks 10 and 16 in P. spinosa ([M-H]- 
at m/z 609), tentatively identified as quercetin rhamnosyl-hexoside and quercetin hexosyl-
rhamnoside; peaks 20 and 21 in P. spinosa, which were assigned to a quercetin 
acetylhexoside (pseudomolecular ion [M-H]- at m/z 505) and quercetin acetylrutinoside 
(pseudomolecular ion [M-H]- at m/z 651); and peaks 5 and 6 in R. canina and R. 
micrantha ([M-H]- at m/z 477), respectively, identified as quercetin glucuronides. Peaks 
1 and 2 in A. unedo fruits were assigned to two quercetin galloylhexoside derivatives. 
Their identities were assigned based on their pseudomolecular ions and MS2 spectra, 
releasing fragments corresponding to quercetin (m/z at 301) and to distinct losses of 
hexosyl (-162 mu), pentosyl (-132 mu), rhamnosyl (-146 mu), glucuronide (-176 mu), 
rutinoside (-308 mu), acetyl (-42 mu) and galloyl (-152 mu) moieties. In none of them the 
identity of the sugar and positions of location of the substituent could be established. 
Other detected flavonols corresponded to kaempferol, isorhamnetin and myricetin 
derivatives. Kaempferol 3-O-rutinoside (peak 15 in P. spinosa) and isorhamnetin 3-O-
rutinoside (peaks: 8- P. spinosa, 10- R. canina and 11- R. micrantha) were identified in 
accordance with their retention, mass spectra and UV-vis characteristics by comparison 
with commercial standards. Peak 5 in A. unedo ([M-H]- at m/z 447) was identified as a 
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kaempferol hexoside, and peaks 12 and 13 in R. canina and R. micrantha, respectively, 
were identified as kaempferol rhamnosyl-hexosides ([M-H]- at m/z 593). Two myricetin 
rhamnosides ([M-H]- at m/z 463) were also found in A. unedo (peaks 3 and 7) releasing 
an MS2 fragment at m/z 317 ([M-H-146]-, myricetin, loss of a rhamnosyl moiety).  
Peak 7 in P. spinosa fruits presented a λmax around 346 nm, which could be associated to 
a flavonol, and a pseudo molecular ion [M-H]- at m/z 739, presenting a fragment at m/z 
317 that could correspond to myricetin, so that it was tentatively identified as a myricetin 
derivative. Peak 5 in this fruit was assigned to a flavone, apigenin pentoside ([M-H]- at 
m/z 401), releasing an MS2 fragment at m/z 269 ([M-H-132]-, apigenin, loss of a pentosyl 
moiety).  
Other flavonoids detected in R. canina and R. micrantha were identified as taxifolin 
(flavanonol) and eriodictyol (flavanone) derivatives, λmax around 290 nm. Peaks 1 and 6 
in R. canina and 2 and 7 in R. micrantha presented a pseudo molecular ion [M-H]- at m/z 
435, releasing a fragment at m/z 303 [taxifolin-H]- (-132 mu, loss of a pentosyl moiety) 
and were tentatively identified as taxifolin pentosides. Peaks 2 and 3 R. canina and 3 and 
4 in R. micrantha presented a pseudo molecular ion [M-H]- at m/z 449, releasing a 
fragment at m/z 287 [eriodictyol-H]- (-162 mu, loss of a hexosyl moiety) and were 
tentatively identified as eriodictyol hexosides. 
Prunus spinosa fruits presented the highest concentration in phenolic acids (29.78mg/100 
g), especially due to 3-O-caffeoylquinic acid, the most abundant phenolic acid, and 
flavone/ols (57.48mg/100 g), in which quercetin 3-O-rutinoside (15.63mg/100 g) was the 
main compound. Arbutus unedo fruits presented quercetin 3-O-glucoside as the majority 
flavonol (2.34mg/100 g).  
Taxifolin pentoside was the majority flavanonol derivative in R. canina and R. micrantha 
(1.18 and 2.68mg/100 g, respectively). Rosa micrantha (11.16mg/100 g) presented higher 
amount of total flavonoids (flavonols, flavanone and flavanonol) compared to R. canina 
(5.50mg/100 g).  
 
3.3.1.2. Flavan-3-ols and galloyl derivatives 
Flavan-3-ols (i.e., catechins and proanthocyanidins) were other relevant flavonoids found 
in A. unedo, R. canina and R. micrantha fruits. Peak 8 in A. unedo, peak 11 in R. canina 
and peak 10 in R. micrantha were identified as (+)-catechin by comparison of its UV 
spectra and retention time with a commercial standard. Peak 6 in R. canina and Peak 7 in 
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R. micrantha presented a pseudomolecular ion [M-H]- at m/z 451, releasing an MS2 
fragment at m/z 289 ([M-H-162]-, loss of an hexosyl moiety), corresponding to a catechin 
monomer. This compound was tentatively identified as (+)-catechin-O-hexoside, identity 
that was coherent with its earlier elution (higher polarity) compared with its parent 
aglycone. Peak 5 in A. unedo, peak 7 in R. canina and peak 8 in R. micranta were 
identified as procyanidin dimer B1 by comparison of its UV spectra and retention time 
with a standard available in the laboratory. Similarly, peak 8 in R. canina was identified 
as procyanidin dimer B3. Other signals at m/z 577, 865 and 1153, in A. unedo (peaks 6, 
7, 10 and 11), R. canina (peaks 9 and 12) and R. micrantha (peaks 12, 17 and 18) can be 
respectively associated to B-type procyanidin dimers, trimers and tetramers (i.e., 
(epi)catechin units with C4-C8 or C4-C6 interflavonoid linkages). Peak 3 in A. unedo 
(pseudomolecular ion [M-H]- at m/z 593) was coherent with a proanthocyanidin dimer 
consisting of one (epi)gallocatechin unit and one (epi)catechin unit. Peaks 13 and 15 in 
R. micrantha ([M-H]- at m/z 851) were coherent with proanthocyanidin trimers formed 
by two (epi)catechin units and one (epi)afzelechin unit. Pseudomolecular ions [M-H]- at 
m/z 739, 1027, 1189 and 1351 in R. canina (peaks 1, 2, 5 and 10) and in R. micrantha 
(peaks 1, 2, 5, 6, 9 and 16) could correspond to procyanidin dimers or trimers having one 
to three sugar units attached to them. Also, peaks corresponding to double-charged 
deprotonated ions [M-2H]2- at m/z 819 were detected in R. canina (peaks 3 and 4) and R. 
micrantha (peaks 4, 5 and 11), which could be interpreted as procyanidin tetramers 
bearing three hexosyl residues in accordance with previous observations by Salminen et 
al. (2005). Other compounds detected in the chromatograms obtained for flavan-3-ol 
analysis were identified as different galloyl derivatives according to their 
pseudomolecular ions and MS2 fragmentation behaviour (Table 13). Peaks 1, 2, 4, in A. 
unedo presented pseudomolecular ions [M-H]- at m/z 343, 331 and 325, respectively, 
releasing a fragment at m/z 169 [gallic acid–H]- (-174, -162 and -156 mu, losses of quinic 
acid, hexosyl and shikimic acid moieties). These compounds were tentatively identified 
as galloylquinic acid, galloylhexoside and galloylshikimic acid. Other signals at m/z 495 
and 477 in A. unedo (peaks 9, 12 and 14) can be respectively associated to digalloylquinic 
and digalloylquinic shikimic acids, respectively. These galloyl derivatives were already 
described in A. unedo by by Pawlowska et al. (2006), Mendes et al. (2011) and Tavares 
et al. (2010). Peak 13 in A. unedo showed a spectra UV similar to ellagic acid, and was 
identified as an ellagitannin. This compound was assigned as strictinin ellagitannin 
according to its pseudomolecular ion ([M-H]- at m/z 633) and fragmentation pattern as 
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described by Fortalezas et al. (2010), Tavares et al. (2010) and Mendes et al. (2011). Peak 
1 in R. micrantha (Table 12) presented λmax around 278 nm and was identified as methyl 
gallate hexoside ([M-H]- at m/z 345). A similar compound was already reported in rose 
hip extracts by Hvattum (2002) and further identified by Fecka (2009) as methylgallate 
3-O-β-glucoside. (+)-Catechin was the most abundant flavan-3-ol found in A. unedo 
(13.51mg/100 g) and R. canina (3.59mg/100 g), and also was a prominent compound in 
R. micrantha (2.90mg/100 g), although a glycosylated proanthocyanidin dimer (peak 6, 
4.93mg/100 g) was the most abundant flavan-3-ol in this fruit. A. unedo fruits presented 
the highest concentration in proanthocyanidins (36.30mg/100 g dw).  
 
3.3.1.3. Anthocyanins 
The anthocyanin profile obtained for P. spinosa fruits, consisting of eight compounds, 
was more complex that those found in the other fruits. Only one anthocyanin was detected 
in R. canina and R. micrantha fruits, whereas three anthocyanins were detected in A. 
unedo fruits. The analytical characteristics, identities and concentrations of the 
anthocyanins found in the different samples are presented in Table 14. Cyanidin 3-O-
glucoside, peonidin 3-O-glucoside and delphinidin 3-O-glucoside were positively 
identified by comparison with standards. The identity of cyaniding 3-O-rutinoside and 
peonidin 3-O-rutinoside were also confirmed by comparison of their chromatographic 
and UV and mass spectral characteristics with data in our library. Peaks 5 and 6 of P. 
spinosa and peak 3 of A. unedo were assigned as cyaniding 3-O-pentoside and peonidin 
3-O-pentoside, respectively, based on their mass spectra, which showed an MS2 signal at 
m/z 287 (cyanidin; [M-132]+, loss of a pentosyl moiety) and m/z 301 (peonidin; [M-132]+, 
loss of a pentosyl moiety). Peaks 7 and 8 presented pseudomolecular ions [M-H]+ at m/z 
491 and 505 releasing MS2 fragments at m/z 287 and 301 (cyanidin and peonidin, 
respectively; [M-H-42-162]+, loss of an acetylhexoside moiety), and were tentatively 
identified as cyaniding 3-O-acetylglucoside and peonidin 3-O-acetylglucoside, 
respectively. Cyanidin 3-O-glucoside was found in all the samples, being the major 
anthocyanin in most of them, with exception of P. spinosa fruits in which cyaniding 3-O-
rutinoside and peonidin 3-O-rutinoside were the major anthocyanins. These fruits also 
presented the highest anthocyanin concentrations, which was coherent with their higher 
pigmentation.  
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3.3.2. Comparison with literature results 
The chemopreventive effect of polyphenols has often been associated with their 
antioxidant activity. For example, chlorogenic acids are responsible for beneficial roles 
of some medicinal plants in the prevention of certain oxidative diseases (Morishita & 
Ohnishi, 2001). Quercetin is also a very efficient antioxidant (Pietta, 2000) and appears 
to be active in many diseases such as cancer (Choi et al., 2001), cardiovascular 
(Yoshizumi et al., 2001), and neurodegenerative (Schroeter et al., 2001) disorders. 
Derivatives of both these compounds were abundant in the studied fruits. A range of 
health related properties are also reported for flavon-3-ols namely antiviral (Shahat et al., 
2002), insulin-like (Anderson et al., 2004), antitumor (Miura et al., 2008), anti-
inflammatory (Terra et al., 2007), and antioxidant (Maldonado et al., 2005) activities. B-
type trimer showed higher antioxidant activity compared to higher oligomers (Shahat et 
al., 2002). Compared to resveratrol and ascorbic acid, an A-type procyanidin dimer and 
trimer had similar or better radical scavenging abilities (Maldonado et al., 2005). Thus, 
both A- and B-type procyanidins have been reported to exert antioxidant activity. 
Anthocyanins have demonstrated that, in addition to their colorful characteristics, they 
possess some positive therapeutic effects, mainly linked with their strong antioxidant 
properties (Wang et al., 1997). Cyanidin-3-O-glucoside (kuromanin) has been found to 
have the highest oxygen radical absorbance capacity (Wang et al., 1997). This compound 
is the most ubiquitous and it represents the main anthocyanin in the edible parts of several 
plants (Dugo et al., 2001), being also found in the four fruits studied herein.  The highest 
phenolic acids (29.78mg/100 g), flavone/ols (57.48mg/100 g) and anthocyanins 
(100.40µg/100 g) contents were found in Prunus spinosa fruits, despite no flavan-3-ols 
compounds were detected in this sample. As far as we know, there is no information on 
the phenolic composition of R. micrantha fruits; our group has already characterized the 
phenolic compounds of flowers from this species (Barros et al., 2013). The total amounts 
of each phenolic group has been reported for P. spinosa fruits from Spain (Ganhão et al., 
2010), but the individual profile of this species has not been previously described. Ganhão 
et al. (2010) also analysed total phenolic compounds in A. unedo and R. canina. 
Otherwise, for A. unedo and R. canina, there are a few publications on their individual 
profile of phenolic composition but from other countries (Hvattum, 2002; Pawlowska et 
al., 2006; Pallauf et al., 2008; Fecka, 2009; Fortalezas et al., 2010; Tavares et al., 2010; 
Mendes et al., 2011; Tumbas et al., 2012).  R. canina fruits from Portugal presented some 
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similarities in the phenolic composition to samples from Norway, Poland and Serbia 
(Hvattum, 2002; Fecka, 2009; Tumbas et al., 2012). Tumbas et al. (2012) identified in the 
Serbian sample different phenolic acids (gallic, protocatechuic, caffeic, syringic, 
coumaric, vanillic, ferulic and ellagic acids) and flavonoid aglycones, such as quercetin, 
kaempferol and myricetin. In the Portuguese sample these types of flavonols were found 
but all of them were glycosylated; this could be due to the fact that the extract studied by 
Tumbas et al. (2012) was an infusion of rosehips, and hydrolyses of the sugar moieties 
could have occurred. The sample from Serbia presented a lower concentration in phenolic 
compounds and quercetin (296.5µg/kg of rosehip tea) was the major compound. As for 
the samples studied herein, (+)-catechin (3.59mg/100 g dw) was the major phenolic 
compound found. Samples of R. canina from Poland (Fecka, 2009) presented a higher 
concentration of phenolic compounds than the one studied here, being methylgallate-3-
O-β-glucoside and catechin the main phenolic compounds. Furthermore, Fecka (2009) 
identified the presence of ellagitannins such as tellimagrandin I and II and rugosin A, B, 
D and E, which were not detected in our study. No quantitative information was provided 
in the study described by Hvattum (2002) regarding phenolic compounds of R. canina 
sample from Norway. Nevertheless, its phenolic profile was similar to the Portuguese 
sample here analysed, despite some differences in the identification of flavan-3-ols. For 
A. unedo fruits there are three different studies on the individual phenolic profile of 
samples from Italy, Spain and Portugal (Pawlowska et al., 2006; Pallauf et al., 2008; 
Fortalezas et al., 2010; Tavares et al., 2010; Mendes et al., 2011) and they were all very 
similar to the one obtained in this work, with exception of Italian A. unedo fruits 
(Pawlowska et al., 2006), for which only gallic acid derivatives and anthocyanins were 
reported, but not flavonols. The comparison of phenolic compounds quantification was 
not possible, due to the fact that these authors only quantified the anthocyanins, 
expressing the results in fresh weight. However, the amounts obtained for Spanish A. 
unedo fruits (Pallauf et al., 2008) were very similar to ours. Mendes et al., 2011, Tavares 
et al., 2010 and Fortalezas et al., 2010 studied a different sample from Portugal, but did 
not present any type of quantification.   
Previous in vitro chemical and biochemical assays demonstrated that the studied fruits 
have a high antioxidant activity and that this could be correlated to their phenolic 
composition (Barros et al., 2010; Guimarães et al., 2010; Barros et al., 2011). Overall, 
Prunus spinosa fruits presented the highest concentration in phenolic acids and 
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flavone/ols, being 3-O-caffeoylquinic acid and quercetin 3-O-rutinoside the major 
compounds. (+)-Catechin was the most abundant compound in Arbutus unedo and Rosa 
canina fruits. A. unedo fruits presented the highest concentration in flavan-3-ols. 
Cyanidin 3-O-glucoside was found in all the studied fruits, being the major anthocyanin 
in most of them, with the exception of P. spinosa, were cyaniding 3-O-rutinoside and 
peonidin 3-O-rutinoside predominated. All in all, P. spinosa presented the highest levels 
of phenolic acids and flavonoids, including anthocyanins, flavonols and flavones, 
although no flavan-3-ols could be identified in its fruits. The present study represents a 
contribution to the chemical characterization of phenolic extracts from wild fruits with 
reported antioxidant activity and traditionally used for several medicinal applications. 
The studied fruits may have great potential for food industries as a source of colors and 
flavors, as well as bioactive molecules such as phenolic compounds for dietary 
supplements or functional foods. 
 
3.3.3. Antioxidant and antitumor activity  
The results of antioxidant activity, determined by free radicals scavenging activity, 
reducing power and inhibition of lipid peroxidation in brain cell homogenates, are shown 
in Table 15. 
 
Table 15. Antioxidant activitya of different phenolic enriched extracts from four wild fruits (mean ± SD).  
 
 
DPPH scavenging 
Activity 
Reducing 
Power 
β-carotene 
bleaching inhibition 
TBARS 
inhibition 
PE     
Arbutus unedo 60.89±1.74d 36.69 ± 1.82c 432.08±19.37c 7.21 ± 0.35c 
Prunus spinosa 64.98 ± 6.19c 42.08 ± 0.66b 641.11 ± 80.69b 7.39 ± 0.20c 
Rosa canina 75.78 ± 4.10a 47.38 ± 0.93a 852.20 ± 147.67a 10.02±0.29a 
Rosa micrantha 69.58 ± 3.37b 47.80 ± 1.19a 755.39 ± 82.25b 8.89 ± 0.26b 
 
DPPH scavenging 
Activity 
Reducing 
Power 
β-carotene 
bleaching inhibition 
TBARS inhibition 
AE     
Arbutus unedo 93.75 ± 2.26b 75.41±0.53b 950.96 ± 38.71a 23.13±3.21b 
Prunus spinosa 99.37 ± 2.36a 83.30 ± 0.46a n.a. 25.29 ± 0.85a 
Rosa canina 81.21±2.26d 72.75±2.38c 893.57±29.19b 12.39 ± 0.18c 
Rosa micrantha 86.33±1.69c 75.25±0.12b 904.08±55.50b 22.52±0.36b 
Trolox  43.03 ± 1.71 29.62 ± 3.15  2.63 ± 0.14  3.73 ± 1.90 
aEC50 values (µg/mL) corresponding to the sample concentration achieving 50% of antioxidant activity or 0.5 of 
absorbance in reducing power assay. n.a. It was not possible to obtain EC50 value for this extract. PE- Non-anthocyanin 
phenolic compounds enriched extract; AE- Anthocyanins enriched extract. In each column, and for each extract, 
different letters mean significant differences (p<0.05). 
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The studied extracts were chemically characterized in a previous work of our research 
group (Guimaraes et al., 2013). Herein, two different enriched phenolic extracts were 
prepared, in order to evaluate and compare their bioactivity: a non-anthocyanin phenolic 
compounds enriched extract (PE; with phenolic acids, flavones/ols, flavan-3-ols and 
galloyl derivatives) and a separate anthocyanins enriched extract (AE).  
Regarding PE of the studied wild fruits, A. unedo presented the highest antioxidant 
activity in all the in vitro assays, which could be related to the presence of galloyl 
derivatives (exclusively in A. unedo PE) and/or to the presence of higher levels of flavan-
3-ols. The second one with highest antioxidant effects was P. spinosa, in which the main 
contributors seemed to be phenolic acids (exclusive in P. spinosa PE) and flavones/ols, 
present in this PE in higher amounts. The studied Rosa species revealed the lowest 
antioxidant activity, presenting similar phenolic compounds profile (flavan-3-ols and 
flavones/ols); the higher levels of these compounds found in R. micrantha comparatively 
to R. canina, might explain the higher antioxidant activity observed in the first case 
(Table 15, Figure 13).  
 
 
 
Figure 13. Concentrations of phenolic compounds present in the wild fruits, determined by HPLC-DAD-
MS/ESI according to reference (Guimarães et al., 2013). 
 
Concerning AE, a pro-oxidant effect of anthocyanins seemed to occur, since the samples 
with the highest amounts revealed the lowest antioxidant activity (Table 15, Figure 13). 
For that reason, P. spinosa gave the lowest antioxidant activity (in β-carotene-bleaching 
inhibition assay it was not possible to determine EC50 value due, in our opinion, to pro-
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oxidant effects of anthocyanins), while R. canina showed the highest antioxidant 
effects.     
PE gave higher antioxidant properties than the corresponding AE, and according to their 
chemical characterization, those prperties seem to be related to galloyl derivatives, 
flavan-3-ols, phenolic acids and flavones/ols. In general, PE and AE presented higher 
antioxidant activity than the methanolic extracts (crude extracts) of the same fruits 
previously studied by us (Barros et al., 2010; Guimaraes et al., 2010). It seems that 
purified/ enriched extracts (such as the cases herein presented) are more suitable than 
crude extracts, in wich antagonistic effects between the compounds presente could be 
observed, conducting to a decrease in the antioxidant activity. The only exception was for 
de β-carotene bleaching inhibition assay (higher capacity in crude extracts); in this case, 
other molecules rather than the ones previously mentioned are probably involoved and 
the might bring synergistic effects.  
The antitumor potential was tested in human tumor cell lines (breast, lung, colon, cervical 
and hepatocellular carcinomas), and the hepatotoxicity was evaluated using a porcine 
liver primary cell culture. All the extracts inhibited the growth of tumor cell lines, except 
R. canina PE and AE, P. spinosa AE and R. micrantha AE for MCF-7 (breast carcinoma). 
A.unedo, followed by P. spinosa, PE gave the best antitumor inhibition (Table 16), which 
could be correlated as mentioned above for antioxidante activity (similar behaviour), to 
the phenolic groups present in each of the wild fruits (Figure 13), i.e, exclusive presence 
of galloyl derivatives and the highest levels of flavan-3-ols for A. unedo PE, and the 
exclusive presence of phenolic acids and the highest levels of flavones/ols for P. spinosa 
PE. Regarding AE, samples with the highest amounts of anthocyanins (P. spinosa and A. 
unedo) revealed the highest antitumor effects, except in the case of MCF-7 that was not 
inhibited by P. spinosa AE. None of the samples showed toxicity for non-tumor liver 
primary culture.
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Table 16. Antitumor activity and hepatotoxicitya of different phenolic enriched extracts from four wild fruits (mean ± SD).  
PE 
MCF-7  
(breast carcinoma) 
NCI-H460 
(non-small lung cancer) 
HCT-15 
(colon carcinoma) 
HeLa 
(cervical carcinoma) 
HepG2  
(hepatocellular carcinoma) 
PLP2  
(non-tumor liver  
primary culture) 
Arbutus unedo 153.08±10.34d 37.68±5.02d 93.36±5.98c 143.36±9.07d 128.51±7.47d >400 
Prunus spinosa 270.65±9.25c  154.25±6.35c 220.44±2.89b 193.62±11.05c  169.56±6.39c >400 
Rosa canina >400a 254.69±3.91a 243.67±4.65a 253.03±11.03a 281.79±5.78a >400 
Rosa micrantha 374.11±8.69b 226.04±7.56b 223.25±4.23b  226.34±13.81b 255.31±9.01b  >400 
AE 
MCF-7 
(breast carcinoma) 
NCI-H460 
(non-small lung cancer) 
HCT-15 
(colon carcinoma) 
HeLa  
(cervical carcinoma) 
HepG2  
(hepatocellular carcinoma) 
PLP2 
(non-tumor liver  
primary culture) 
Arbutus unedo 238.11±6.74 227.43±4.09c 121.95±7.15b 149.88±8.46d 168.40±7.29c >400 
Prunus spinosa >400a 282.92±4.28b  234.59±6.29a  224.58±14.09c  231.31±9.24b >400 
Rosa canina >400a 305.97±4.23a 243.51±8.24a 311.16±10.18a 266.53±10.95a >400 
Rosa micrantha >400a 307.68±6.05a 264.04±3.08a 252.07±11.01b 270.5±9.24a >400 
Ellipticine 0.91±0.04 1.42±0.00 1.91±0.06 1.14±0.21 3.22±0.67 2.06±0.03 
aGI50 values (µg/mL) corresponding to the sample concentration achieving 50% of growth inhibition in human tumor cell lines or in liver primary culture PLP2. PE- Non-anthocyanin phenolic 
compounds enriched extract; AE- Anthocyanins enrichedextract. In each column, and for each extract, different letters mean significant differences (p<0.05). 
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As far as we know, thisb is the first study regarding antitumor effects of A. unedo, R. 
micrantha and P. spinosa wild fruits. In the case of R. canina, the antitumor effects of na 
aqueous extract from its hips were studied in mouse melanoma cells (Fujii et al., 2011), 
and similarly to the herein studied PE, the higher contributors are proanthocyanidins 
(flavan-3-ols). Otherwise, the flavonoids fraction from R. canina tea showed higher 
antiproliferative activity in HeLa cell line (IC50  = 80.63 µg/mL; Tumbas et al., 2012) than 
the one observed in the present study for PE (GI50 = 253.03 µg/mL), contrarily to the 
observed result (no activity up to 400 ug/mL), those authors reported effects against 
MCF-7 cell line (IC50 = 248.03 µg/mL).  
Overall, the bioactivity of the studied wild fruits proved to be more related to phenolic 
compounds profile than to the amounts present in each extract being PE more bioactive 
than AE. It should be highlighted the high capacity of A. unedo PE to inhibit lipid 
peroxidation in animal brain homogenates (IC50 = 7.21 µg/mL), as also its antitumor 
potential against NCI-H460 human cell line (non-small lung cancer; GI50 = 37.68 µg/mL).  
Regarding chemical characterization of the mentioned sample, the presence of galloyl 
derivatives exclusively in A. unedo wild fruits could be related to its higher bioactivity. 
Further studies are needed in order to confirm the specific role of these compounds in 
antioxidante and antitumor effects. Due to the observed bioactive properties, the 
mentioned species could be considered in the design of new formulations of dietary 
supplements or functional foods. 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4. 
Chemical Synthesis 
 
Towards antioxidant and antitumor properties of wild medicinal plants traditionally used in Portugal 
 
88 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Towards antioxidant and antitumor properties of wild medicinal plants traditionally used in Portugal 
 
89 
  
Chapter 4. Chemical Synthesis 
 
Flavonoids are present in a great variety of food and especially in fruit and vegetables. 
Quercetin is the flavonoid most swallowed every day (between 10 and 100/mg per day 
according food habits) (Kajjout & Rolando, 2011). Moreover, it was identified in the 
studied plant species. Quercetin is a very efficient antioxidant (Pietta, 2000) and appears 
to be active in many diseases (Choi et al., 2001; Yoshizumi et al., 2001; Schoroeter et al., 
2001). In blood, quercetin is mainly found in conjugated forms. The main metabolic 
pathways in humans and mammals for this flavonol are methylation, sulphation, and 
glucuronidation (Manach et al., 1998; Day et al., 2001; Justino et al., 2004; Van der 
Woude et al., 2004; Mullen et al., 2008). The relative amount of metabolites varies either 
in their chemical nature or in their position on the quercetin ring, according to the species 
and the metabolism phase (Kajjout & Rolando, 2011). Some studies using plasma 
samples containing sulphate or glucuronide conjugates or both and methylated forms 
showed that the biological activities of these metabolites were rather different from the 
quercetin (Koga & Meydani, 2001). 
In humans quercetin 3-O-β-ᴅ-glucuronide and quercetin 3’-O-sulphate are the most 
abundant quercetin metabolites and have even more potent biological activities than 
quercetin 1 (Chao et al., 2009). Plasma analyses of pig fed with quercetin rich diets 
showed that there is no quercetin left but only methylated metabolites, such us 3’-O-
methylquercetin (isorhamnetin) and 4’-O-methylquercetin (tamarixetin) along with the 
3’-dehydroxylated quercetin (kaempferol), most of being conjugated as glucuronide or 
sulphate (Ader et al., 2000). However, quercetin metabolism in humans is still 
controversial as the different relative abundance of metabolites depends of the diet habits 
and the quercetin content (Graefe et al., 1999; Graefe et al., 2001; Manach et al., 1998; 
Moon et al., 2001). In order to evaluate the bioactivity of some of flavonoids 
derivatives/human metabolites we tried the synthetic approach. 
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4.1. Benzylation reactions 
The literature mentions some possible methods of synthesis for flavonoid derivatives, 
especially for the most common, quercetin, using the protection of hydroxy group 
approach. Our work started with the benzylation of the hydroxy groups. The benzyl group 
was chosen as protecting group because it is easily introduced by reaction with a benzyl 
halide and also easily removed by hydrogenolysis (Kajjout & Rollando, 2011). Following 
the conditions of the Kajjout & Roland 2011, a solution of quercetin 1, in DMF, was 
reacted with benzyl bromide and potassium carbonate under argon atmosphere, at room 
temperature (Scheme 1; Experiment 1, Section 4.4.1.1).  
 
 
Scheme 1. Benzylation reaction of quercetin 1.  
 
After the work-up procedure, the crude residue was analyzed by 1H-NMR spectroscopy 
(results not shown). The spectrum showed that the reaction should have formed a mixture 
of products with different protection degrees namely O-tri- (2), O-tetra- (3) and 
pentabenzylated quercetin (4) (Scheme 1), in good agreement with the results reported in 
the literature (Kajjout & Rolando, 2011). Unfortunately, it was not possible to separate 
the products by column chromatography, probably due to their very similar solubilities. 
In view of these results it was decided to study this reaction with temperature control. 
Thus, all the reagents were mixed at 0 ºC, under stirring and the temperature was kept for 
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2 h, followed by 14 h at room temperature (to obtain a good temperature adjustment, the 
reaction was carried out in a Cooled Incubator MIR-154), following the conditions of 
Bouktaib et al., 2002 to obtain the compound 3 (Scheme 2, Experiment 2, Section 
4.4.1.2). 
 
 
Scheme 2. Attempt to obtain 3,7,3’4’-O-tretrabenzylated quercetina 3. 
 
Once again, the 1H-NMR spectrum of the crude residue showed that the formation of 
products with different degree of protection had occurred (results not shown). The 
purification by column chromatography, using CH2Cl2 as eluent, was not well succeeded, 
and the expected product 3 (Bouktaib et al., 2002) was not isolated. 
Following these results, it was decided to investigate the introduction of the same 
protecting group using different amounts of the alkylating agent (BnBr) and of the base 
(K2CO3) (Table 17, Experiments 3-14, section 4.4.1.3 and 4.4.1.4).  
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Table 17. Benzylation of quercetin using different amounts of alkylating agent (BnBr).  
Exp. Solvent (dried) BnBr (equiv.) K2CO3 (equiv.) 
3 
DMF 
 
3.5 
1.5 
4 1.75 
5 2.0 
6 3.0 
7 3.25 
8 3.5 
9 4.0 
10 4.0 4.0 
11 
 
4.5 
 
4.0 
12 4.1 
13 4.5 
14 DMSO 4.5 4.5 
 
All reactions afforded a variety of products, but the mixtures from reactions 13 and 14 
(Table 17), showed mainly one or two products by 1H-NMR. Experiment 13 gave mainly 
the 3,7,3’,4’-O-tetrabenzylated quercetin 3 (Scheme 3), while experiment 14, using 
DMSO, gave the 3,7,4’-O-tribenzylated quercetin 2 (Scheme 4).   
 
 
Scheme 3. Synthesis of 3,7,3’,4’-O-tetrabenzylated quercetina 3 using Bouktaib et al., 2002 conditions, 
but 4.5 equiv of BnBr and of  K2CO3. 
 
The 1H-MNR spectrum of the reaction (Scheme 3, Experiment 13, Section 4.4.1.3) 
residue shows the presence of a major O-tetrabenzylated derivative with several other 
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benzylated derivatives with different protection degrees. This residue was washed with 
methanol, allowing the solubilization of the polar components and precipitation of the 
less polar compound. The solid isolated by filtration was identified by 1H-NMR as the O-
tetrabenzylated quercetin derivative 3 in a quite pure form (Figure 14), in 49.3% yield. 
 
 
Figure 14. 1H-NMR (400 MHz, CDCl3) spectrum of 3 (Experiment 13, Section 4.4.1.3). 
 
Considering the protection reactivity order 4’>7>3>3’>5 referred by Shi et al., 2012, the 
structure 3 is proposed  for the O-tetrabenzylated derivative of quercetin obtained 
(Scheme 3), which 1H-NMR spectrum data are similar to the ones presented in the 
literarture by Bouktaib et al., 2002 and Kajjout & Rolando, 2011 (Section 4.4.1.3). 
The experiment 14 is presented in Scheme 4 (Table 17). 
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Scheme 4. Synthesis of 3,7,4’-O-tribenzylated quercetin 2 in DMSO (Experiment 14). 
 
The 1H-NMR spectrum of the impure residue obtained from this experiment 14 showed 
that the mixture was less complex than those obtained before. This residue was mainly 
formed by a O-tribenzylated and a O-tetrabenzylated derivative in a 76:24 ratio, 
respectively, by 1H-NMR, along with traces of other non identified benzylated 
derivatives. The residue was purified by recrystallization from dichloromethane:hexane 
and led to a yellow solid (Experiment 14, Section 4.4.1.4) which was identified by 1H-
NMR (Figure 15). Based on the different reactivity of the hydroxy groups of quercetin 
claimed by Shi et al., in 2012, 4’>7>3>3’>5, the structure 2 is proposed for the O-
tribenzylated quercetin obtained, which 1H-NMR spectrum data are similar to the ones 
presented in the literature by Bouktaib et al., 2002 and Shi et al., 2012 (Experiment 14, 
Section 4.4.1.4). In the ESI mass spectrum at low resolution a peak m/z 595.20 (M++Na, 
17%) was observed. 
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Figure 15. 1H-NMR (400 MHz, CDCl3) spectrum of recrystallized compound 2 (Experiment 14, Section 
4.4.1.4). 
 
In order to obtain the 5,7,3’,4’-O-tetrabenzylated quercetin 6, it was decided to prepare it  
from rutin 4  using the method described by Kajjout et al. 2011.  This reaction was carried 
out in two steps outlined in Scheme 5: (1) the four free hydroxy groups of rutin 4 were 
benzylated affording compound 5; 
(2) the hydrolysis of compound was performed  giving the desired  compound 6 (Scheme 
5, Experiment 15, Section 4.4.1.5).  
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Scheme 5. Synthesis of the 5,7,3’,4’-O-tetrabenzylated quercetina 6 from rutin 4. 
 
The crude residue obtained from step 1 was identified by 1H-NMR as the O-
tetrabenzylated derivative of rutin 5 according to Kajjout et al., 2011. It was used with no 
further purification in step 2, where a solid was formed and identified by 1H-NMR 
spectroscopy as compound 6 in almost pure form, Figure 16. The NMR data are similar 
to those found in the literature, Kajjout et al., 2011. 
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Figure 16. 1H-NMR (400 MHz, CDCl3) spectrum of the compound 6 (Experiment 15, Section 4.4.1.5). 
 
In this work it was possible to obtain one O-tribenzylated quercetin 2, with free hydroxy 
groups in positions 5 and 3’, and two O-tetrabenzylated quercetins 3 and 6, with free 
hydroxy groups at 5 or 3 positions, respectively using different synthetic strategies.  
 
4.2. Methylation reactions 
In face of the results obtained in the reactions involving the benzyl group as the protective, 
it was decided to investigate the protection of the hydroxy groups of quercetin with 
methyl group, a less bulky group. As mentioned before, it is known that one of the 
metabolic pathways in humans and mammals, for quercetin, involves its methylation. The 
O-tetramethylated quercetin 7 was obtained by reacting compound 1 with dimethyl 
sulphate and potassium carbonate, in acetone (Scheme 6, Experiment 16, Section 
4.4.2.1) in 49% yield as a yellow solid. 
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Scheme 6. Synthesis of 3,7,3’,4’-O-tetramethylated quercetina 7. 
 
The 1H-NMR spectrum of compound 7 is presented in Figure 17. 
 
 
Figure 17. 1H-NMR (400 MHz, CDCl3) spectrum of the compound 7 (Experiment 16, Section 4.4.2.1). 
 
Rao et al. in 1976, have shown that the methylation occurs gradually according to the 
sequential order of the positions: 4’>7>3>3’>5, the less reactive hydroxy group being 
that of the 5 position. Based on this reactivity order, structure 7 is proposed for the O-
tetramethylated quercetin derivative obtained (Scheme 6). As far as our knowledge this 
compound is not be described in the literature, see experiment 16.  
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4.3. Glucuronidation reactions 
As previously mentioned, in human plasma quercetin usually appears as glucuronides. 
Therefore, in this work the glucuronidation of quercetin derivatives 2 (3,7,4’-O-
tribenzylated), 3 (3,7,3’,4’-O-tetrabenzylated) and 6 (5,7,3’,4’-O-tetrabenzylated) was 
attempted by their reactions with acetobromo-α-ᴅ-glucuronic acid methyl ester 8, 
according to schemes 7, 8 and 9 (Experiments 17, 18 and 19, section 4.3.1.1), 
respectively. 
 
 
 
 
Scheme 7. Glucuronidation reaction of compound 2. 
 
 
Scheme 8. Glucuronidation reaction of compound 3 
 
In each case the separation of these compounds (scheme 7 and 8) was attempted by 
column chromatography in order to obtain the desired glucuronide derivative in a pure 
form. Unfortunately, none of these two reactions were well succeeded. The 1H-NMR 
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spectrum of the crude residue obtained in the reaction displayed in Scheme 7 showed a 
complex mixture of compounds. The starting materials 2 and 8(1), were present and the 
compound 9 expected as a β-anomer (Scheme 7) seemed to be present only in a small 
amount, based on a doublet at 5.78 ppm with J = 8.0 Hz (data not shown). The formation 
of this compound was corroborated by the mass spectrum obtained by ESI that showed a 
peak m/z 911.42 (M++Na, 7.4%) (data not shown).  
The reaction displayed in Scheme 8 afforded also a very complex crude residue and the 
fractions collected after column chromatography were not possible to identify.  
Starting from compound 6, the glucuronidation reaction was attempted in order to obtain 
the glucuronide derivative 11 (Scheme 9).    
 
 
 
Scheme 9. Glucuronidation reaction of compound 6. 
 
The 1H-NMR spectrum of the crude residue of experiment 19 showed a complex mixture 
of compounds. It was possible to identify three major signals of acetyl groups along with 
several other minor signals. None of them was attributed to acetyls of compound 8. The 
expected β-anomer was associated with the doublet at 5.78 ppm with a coupling constant 
J = 8.0 Hz (data not shown). Compound 11 was effectively formed, although in a small 
amount, as it was confirmed by mass spectrometry analysis. The mass spectrum obtained 
by ESI showed a peak of m/z 1001.40 as the base peak (100%) which corresponds to 
M++Na. 
The glucuronidation of 7 (3,7,3’,4’-O-tetramethylated quercetin) was attempted using the 
experimental conditions presented in Scheme 10 (Experiment 20, Section 4.4.3.2). 
                                                          
(1) 1H NMR (400 MHz, CDCl3): 2.06, 2.07 and 2.11 (9H, 3s, 3 × OAc); 3.77 (3H, s, COOMe); 4.59 (1H, 
dd, 10.0 Hz, H-5); 4.86 (1H, dd, J = 10.0 and 4.0 Hz, H-2); 5.25 (1H, dd, J = 10.4 and 9.6 Hz, H-3); 5.62 
(1H, apparent t, J = 9.6 Hz, H-4); 6.65 (1H, d, J = 4.0 Hz, H-1);  
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Scheme 10. Glucuronidation reaction of compound 7. 
 
The 1H-NMR spectrum of the crude residue of experiment 20, revealed that a very 
complex mixture was formed. The presence of some signals and their multiplicity could 
suggest that glucuronidation had occurred although in a small extent. In fact it was 
possible to find a doublet at 5.77 ppm with a coupling constant J = 7.6 Hz (data not 
shown), that was attributed to the anomeric proton of a β-anomer. It was also found a 
great number of signals attributed of different acetyls and none of them correspond to the 
ones of starting material 8. It was also possible to see the presence of several singlets of 
methyl groups. Nevertheless, this residue was submitted to column chromatography but 
it was not possible to separate the products.  
In conclusion, these reactions of glucuronidation did not give the expected compounds in 
a pure form and therefore we could not study their biological activity. 
 
4.4 Synthesis of flavonoid derivatives: Experimental Section 
 
The numbers of the compounds are related to the ones presented in Chapter 4. 
General procedure: The starting material flavonoids and acetobromo-α-ᴅ-glucuronic acid 
methyl ester, were purchased at Sigma Aldrich. Melting points (ºC) were determined in 
STUART SMP3 and are uncorrected. 1H and 13C NMR spectra were recorded on a Bruker 
Avance III at 400 MHz. DEPT 135º experiments were used to differentiate the different 
type of carbons. Heteronuclear correlations 1H–13C, HSQC and HMBC were performed 
to attribute some signals. The mass spectra were obtained on a LXQ Finnigan by Electro 
Spray Ionization (ESI). 
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4.4.1 Benzylation experiments 
4.4.1.1 Experiment 1 (Section 4.1, Scheme 1) 
 
To a solution of quercetin 1 (0.200 g, 0.660 mmol) in DMF (3 mL), potassium carbonate 
(0.320 g, 2.32 mmol, 3.5 equiv.) and BnBr (0.276 mL, 2.32 mmol, 3.5 equiv.) were added 
under argon. The reaction mixture was vigorously stirred at room temperature for 16 h. 
The resulting mixture was diluted with ethyl acetate (80 mL) and washed with water 
(3x50 mL).  The organic layer was dried (MgSO4) and evaporated, affording a complex 
mixture (by TLC and 1H-NMR spectrum). This mixture was submitted to flash column 
chromatography (silica gel, dichloromethane), giving products 2, 3, and 4, identified in 
the 1H-NMR spectrum (Scheme 1, Section 4.1), according to Kajjout & Rolando 2011, 
but were not possible to separate.  
 
4.4.1.2 Experiment 2 (Section 4.1, Scheme 2) 
 
To a solution of quercetin 1 (0.200 g, 0.660 mmol) in DMF (3 mL), potassium carbonate 
(0.320 g, 2.32 mmol, 3.5 equiv.) and BnBr (0.276 mL, 2.32 mmol, 3.5 equiv.) were added 
under argon. After vigorous stirring at 0 ºC for 2 h, the reaction mixture was allowed to 
warm to room temperature and the stirring was maintained for 14 h. The resulting mixture 
was diluted with iced water (50 mL), extracted with ethyl acetate (3 x 50 mL). The organic 
layer was washed with water (3 x 80 mL), dried (MgSO4) and evaporated, affording a 
complex mixture that was submitted to flash column chromatography (silica gel, 
dichloromethane), but the products formed was not possible to be separated (Scheme 2, 
Section 4.1).  
 
4.4.1.3 Experiments 3-13 (Section 4.1) 
All these experiments were carried out under the experimental conditions described in the 
Experiment 2, changing the equivalents of benzyl bromide and/or potassium carbonate as 
shown in the Table 17 (Chapter 4, Section 4.1).  
In Experiment 13 the washing up of the residue with methanol allowed the solubilization 
of more polar compounds and the precipitation of the less polar. This solid was isolated 
by filtration (0.225 g, 49.3 % yield) and as a yellow solid identified as 3 (Section 4.1, 
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Scheme 3). MP 137–139 ºC [140-142 ºC – Bouktaib et al., 2002 and Kajjout & Rolando, 
2011]. 1H NMR (400 MHz, CDCl3): δ = 5.01 (s, 2H, 3’-OCH2Ph), 5.06 (s, 2H, 3-
OCH2Ph) 5.14 (s, 2H, 7-OCH2Ph), 5.26 (s, 2H, 4’-OCH2Ph), 6.45 (d, J = 2.0 Hz, 1H, H-
6), 6.48 (d, J = 2.0Hz, 1H, H-8), 6.98 (d, J = 8.8 Hz, 1H, H-5’), 7.25-7.49 (m, 20H, 4 x 
Ph), 7.57 (dd, J = 8.4 and 2.0 Hz, 1H, H-6’), 7.73 (d, J = 2.0 Hz, 1H, H-2’), 12.72 (1H, 
broad s, OH) ppm. 13C NMR (100.6 MHz, CDCl3): δ = 70.40 (7-OCH2Ph), 70.82 (4’-
OCH2Ph), 71.05 (3’-OCH2Ph), 74.31 (3-OCH2Ph), 93.01 (C8), 98.53 (C6), 106.12 (C5a), 
113.63 (C5’), 115.24 (C2’), 122.58 (C6’), 123,40 (C1’), 127.15 (CH), 127.31 (CH), 
127.43 (CH), 127.87 (CH), 127.99 (CH), 128.25 (CH), 128.33 (CH), 128.47 (CH), 128.58 
(CH), 128.71 (CH), 128.76 (CH), 135.75 (C), 136.40 (C), 136.61 (C), 136.86 (C), 137.42 
(C3), 148.19 (C3’), 151.06 (C4’), 156.27 (C2), 156.64 (C8a), 162.03 (C5), 164.42 (C7), 
178.78 (C=O) ppm. ESI m/z (%): 685.26 (M++Na, 47%), 453.28 (100%).  
The NMR spectroscopy data are similar to those found in the literature by Kajjout et al., 
2002 and Kajjout & Rolando, 2011. 
 
4.4.1.4  Experiment 14 (Section 4.1, Scheme 4) 
 
To a solution of quercetin 1 (0.200 g, 0.660 mmol) in DMSO (3 mL), potassium carbonate 
(0.411 g, 2.97 mmol, 4.5 equiv.) and BnBr (0.355 mL, 2.97 mmol, 4.5 equiv.) were added 
under argon. The reaction mixture was stirred at room temperature for 14 h. The resulting 
mixture was diluted with iced water (50 mL), extracted with ethyl acetate (3 x 50 mL). 
Then, the organic layer was washed with water (3 x 80 mL), dried (MgSO4) and 
evaporated, affording a complex mixture that was submitted to flash column 
chromatography (silica gel, dichloromethane). The crude residue was purified by 
crystallization from dichloromethane-hexane, affording a compound 2 as a yellow solid, 
0.257 g, in 35.1% yield (Scheme 4, Section 4.1). MP 147-149 ºC [150-152 ºC - Bouktaib 
et al., 2002; 149-150 ºC -Z-H Shi et al., 2012]. 1H NMR (400 MHz, CDCl3): δ = 5.08 (s, 
2H, 3-OCH2Ph), 5.14 (s, 2H, 7-OCH2Ph), 5.20 (s, 2H, 4’-OCH2Ph), 6.45 (d, J = 2.0 Hz, 
1H, H-6), 6.51 (d, J = 2.4 Hz, 1H, H-8), 6.96 (d, J = 9.2 Hz, 1H, H-5’), 7.28-7.30 (m, 3H 
+ OH), 7.35-7.47 (m, 13H, aromatic H), 7.6305 (d, J = 2.0 Hz, 1H, H-2’), 7.631 (dd, J = 
9.2 and 2.0 Hz, 1H, H-6’) ppm. 13C NMR (100.6 MHz, CDCl3): δ = 70.40 (CH2), 71.10 
(CH2), 74.22 (CH2), 92.98 (C8), 98.63 (C6), 106.18 (C5a), 111.53 (C5’), 114.86 (C6’), 
121.86 (C2’), 123.92 (C2), 127.44 (CH), 127.85(CH), 128.17 (CH), 128.25 (CH), 128.32 
(CH), 128.65 (CH), 128.72 (CH), 128.77 (CH), 128.82 (CH), 135.63 (C), 135.77 (C), 
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136.40 (C), 137.58 (C), 145.55 (C3’), 147.81(C4’), 156.31 (C), 156.71 (C8a), 161.99 
(C5), 164.44 (C7), 178.81 (C=O) ppm. 
ESI m/z (%): 595.20 (M++Na+, 13%), 611.17 (100%), 453.27 (30%), 368.59 (33%).  
The NMR spectroscopy data are similar to those found in the literature by Kajjout et al., 
2002 and Shi et al., 2012. 
 
4.4.1.5 Experiment 15 (Section 4.1, Scheme 5) 
 
Step 1: The four free hydroxyl groups of rutin 4 were benzylated using an excess of 
benzyl bromide (8 equiv.) and potassium carbonate (8 equiv.) in DMF, during 16 h at 
room temperature. The resulting mixture was diluted with ethyl acetate (100 mL) and 
washed with water (3 x 75 mL). The organic layer was dried (MgSO4) and evaporated. 
The residue was obtained as a beige syrup (1.046g, 93.6%) that was identified as 5 (Step 
1, Scheme 5, Section 4.1). 1H NMR (400 MHz, DMSO-D6) inter alia 5.14, 5.17, 5.24 
and 5.25 (PhCh2O) ppm. Step 2: The hydrolysis of the glycosidic bond of the O-
tetrabenzylated rutin 5 was performed using a mixture of MeOH/HCl (98:2) at reflux (65 
ºC) which led to the desired product 5,7-bis(benzyloxy)-2-[3’,4’-bis(benzyloxy)phenyl]-
3-hydrixy-4H-chromen-4-one (6) and as a light yellow powder (210 mg, 46.1% yield), 
(Scheme 5, Section 4.1). This NMR spectroscopy data are similar to those found in the 
literature to Kajjout et al., 2011. MP: 169-171 ºC. 1H NMR (400 MHz, CDCl3): δ = 5.12 
(s, 2H, 7-OCH2Ph), 5.22 (s, 2H, 5-OCH2Ph) 5.24 (s, 2H, 4’-OCH2Ph), 5.26 (s, 2H, 3’-
OCH2Ph), 6.47 (d, J = 2.0 Hz, 1H, H-6), 6.58 (d, J = 2.0 Hz, 1H, H-8), 7.03 (d, J = 8.8 
Hz, 1H, H-5’), 7.32 -7.62 (m, 20H, 4 x Ph), 7.77 (dd, J = 8.8 and 2.0 Hz, 1H, H-6’), 7.90 
(d, J = 2.4 Hz, 1H, H-2’) ppm.(*) 13C NMR (100.6 MHz, CDCl3): δ = 70.52 (7-OCH2Ph), 
70.64 (5-OCH2Ph), 70.89 (4’-OCH2Ph), 71.48 (3’-OCH2Ph), 93.62 (C8), 97.51 (C6), 
106.62 (C5a), 114.14 (C2’), 121.22 (C6’), 124.19 (C2), 126.59 (CH), 127.15 (CH), 
127.50 (CH), 127.62 (CH), 127.75 (CH), 127.84 (CH), 127.87 (CH), 128.45 (CH), 128.52 
(CH), 128.62 (CH), 128.74 (CH), 135.55 (CH), 136.12(C), 136.79 (C), 137.10 (C), 
137.63 (C4’), 141.98 (C3), 148.53 (C1’), 150.14 (C3’), 158.60 (C8a), 159.29 (C5), 
163.20 (C7), 171.64 (C=O) ppm. ESI m/z (%): 685.34 (M++Na, 59.34%), 663.31 
(49.2%), 368.58 (100%). (*) the proton of the OH was not detected in the proton 1H-NMR 
spectrum. 
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4.4.2 Methylation reaction 
4.4.2.1 Experiment 16 (Section 4.2, Scheme 6) 
 
2-(3’4’-dimethoxyphenyl)-5-hydroxy-3,7-dimethoxy-4H-chromen-4-one: A mixture of 
quercetin 1 (0.200 g, 0.660 mmol), dimethyl sulphate (0.124 µL, 1.32 mmol), potassium 
carbonate (0.366 g, 2.65 mmol) in acetone (30 mL) was stirred at 45-50 ºC for 18 h, to 
afford the O-tetramethylated quercetin 12. The solvent was removed under vacuum. The 
residue was suspended in ammonium solution (70:10 v/v) and extracted with ethyl acetate 
(3 x 50 mL). The organic layer was dried (MgSO4), evaporated and the residue obtained 
was a yellow solid that was identified as 12, 116 mg in 49% yield. MP: 95-97 ºC. 1H 
NMR (400 MHz, CDCl3): δ = 3.88 (s, 3H, OMe), 3.89 (s, 3H, OMe), 3.978 (s, 3H, OMe), 
3.984 (s, 3H, OMe), 6.38 (d, J = 2.4 Hz, 1H, H-6), 6.46 (d, J = 2.4 Hz, 1H, H-8), 7.00 (d, 
J = 8.4 Hz, 1H, H-5´), 7.70 (d, J = 2.4 Hz, 1H, H-2´), 7.75 (dd, J= 8.4, 2.0 Hz, 1H, H-6´), 
12.62 (1H, broad s, OH) ppm. 13C NMR (100.6 MHz, CDCl3): δ = 55.73 (OCH3), 55.90 
(OCH3), 55.97 (OCH3), 60.08 (OCH3), 92.09 (C8), 97.74 (C6), 105.91 (C5a), 110.77 
(C5’), 111.16 (C2’), 122.09 (C6’), 122.80 (C1’), 138.86 (C3), 148.67 (C3’), 151.29 (C4’), 
155.71 (C4), 156.60 (C8a), 161.89 (C5), 165.35 (C7), 176.62 (C=O) ppm.  
 
4.4.3 Glucuronidation reactions  
4.4.3.1 Experiments 17,18 and 19 (Section 4.3, Scheme 7, 8 and 9) 
 
O-tribenzylated 2 (Experiment 17) and O-tetrabenzylated 3 (Experiment 18) derivatives 
of quercetin were reacted with potassium carbonate (2 equiv.) and glucuronic acid 
derivative 8 (2 equiv.) in DMF, at room temperature, under argon. The mixtures were 
stirred for 24 h. Each reaction mixture was diluted with EtOAc (30 mL) and was washed 
with water (3 x 30 mL), dried (MgSO4) and evaporated, affording a complex mixture that 
was submitted to flash column chromatography (silica gel; dichloromethane:ethyl acetate, 
85:15) but the compounds formed were not possible to be separated,: (Scheme 7 and 8, 
Section 4.3). The residue obtained from experiment 17 showed in the 1H-NMR spectrum 
several compounds including starting materials. In experiment 18, also a very complex 
mixture was obtained in the 1H-NMR spectrum of the residue, and the fractions collected 
after column chromatography were not possible to identify. 
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A mixture of O-tetrabenzylated quercetin 6 (experiment 19) (0.200 g, 0.300 mmol), 
potassium carbonate (0.084 g, 0.600 mmol), acetobromo-α-ᴅ-glucuronic acid methyl 
ester 8 (0.240 g, 0.600 mmol) were dissolved in DMF (3 mL) under argon and the solution 
was stirred at room temperature for 20 h. The reaction mixture was diluted with ethyl 
acetate (50 mL) and washed with water (3 x 30 mL). The organic layer was dried (MgSO4) 
and the solvent evaporated. The 1H-NMR spectrum of the crude residue showed a 
complex mixture of compounds.  
In all the experiments 17, 18 and 19, only a small amount of the  β-anomer expected 9, 
10 and 11, seemed to be formed based on the presence of a doublet at 5.78 ppm, J = 8.0 
Hz, that appears in the corresponding 1H-NMR spectrum mixtures.  
 
 
4.4.3.2 Experiment 20 (Section 4.3, Scheme 10) 
 
A mixture of the O-tetramethylated quercetin 7 (0.100 g, 0.280 mmol), potassium 
carbonate (0.076 g, 0.550 mmol) and acetobromo-α-ᴅ- glucuronic acid methyl ester 8 
(0.220 g, 0.550 mmol) was dissolved in DMF (3 mL) under argon and the solution was 
stirred for 20 h at room temperature (RT). The reaction mixture was diluted with ethyl 
acetate (50 mL) and washed with water (3 x 30 mL). The organic layer was dried (MgSO4) 
and the solvent evaporated. The residue obtained gave a very complex mixture in 1H-
NMR and was submitted to a column chromatography using silica gel 60A (60-200 µm) 
and a mixture of dichloromethane/ethyl acetate (85:15) was used as eluent, but the 
products were not possible to be separated. In this experiment the β-anomer of compound 
13 seemed to be formed in a small amount, based on the presence of doublet at 5.77 ppm, 
J = 7.6 Hz, that appears in the corresponding 1H-NMR spectrum mixture. 
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Chapter 5. Conclusions and Future perspectives 
 
The nutritional characterization of Roman chamomile (C. nobile) was performed and 
carbohydrates were the most abundant macronutrients, followed by proteins. The sugars 
fructose, glucose, sucrose and trehalose were identified and quantified in this wild 
chamomile, being fructose the predominant sugar found. In lipidic fraction the 
predominant compounds were linoleic and oleic acids, and polyunsaturated fatty acids 
(PUFA) predominated over saturated fatty acids (SFA). Regarding tocopherols, only α- 
and γ- tocopherols were found in this wild chamomile. Different types of preparations, 
infusion, decoction and hydroalcoholic extract of this wild chamomile were evaluated for 
the antioxidant activity and submitted to a detailed analysis of phytochemicals (organic 
acids and phenolic compounds). Oxalic, quinic, malic, citric and fumaric acids were 
quantified in the three preparations of C. nobile. Malic acid was the most abundant 
organic acid in the three preparations, and infusion showed the highest content in organic 
acids. The phenolic profile of the different preparations was identical, varying only in the 
concentrations found. Thirty different phenolic compounds were detected in the three 
preparations, including phenolic acids (hydroxycinnamic derivatives mainly, 
caffeoylquinic acids), flavonols (quercetin, kaempferol and myricetin derivatives) and 
flavones (apigenin and luteolin derivatives). The most abundant compounds in infusion 
and hydroalcoholic extract were 5-O-caffeoylquinic acid and an apigenin derivative. A 
degradation of the compounds was observed in both infusion and decoction preparations, 
mainly in the last one. This could be related with the higher thermical impact applied to 
obtain this type of preparation, when compared to the infusion. The hydroalcoholic 
extract gave the highest antioxidant activity in the β-carotene bleaching activity and 
TBARS inhibition assays (which can be related to its higher content in phenolic 
compounds). The highest radical scavenging activity and reducing power were observed 
in the infusion. Otherwise, decoctions presented the lowest antioxidant potential 
(probably due to its lower content in phenolic compounds and organic acids). Antitumor 
properties of C. nobile hydroalcoholic extract, decoction and infusion were evaluated on 
five human tumor cell lines (MCF-7, NCI-H460, HCT-15, HeLa and HepG2). The 
hydroalcoholic extract presented the highest growth inhibitory activity for all the cell 
lines, and decoction preparation had no antitumor effects at the maximal concentration 
used.  
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The antiangiogenic activity of C. nobile hydroalcoholic extract and infusion, and its main 
phenolic compounds: apigenin, apigenin-7-O-glucoside, caffeic acid, chlorogenic acid, 
luteolin, luteolin-7-O-glucoside were evaluated for their ability to interact with the 
VEGFR-2 tyrosine kinase domain, using an enzymatic assay. The hydroalcoholic extract 
showed higher phosphorylation inhibition than the infusion, what is in agreement with 
the higher phenolic compounds amount, antioxidant and antitumor activities also 
previously reported for hydroalcoholic extract. Regarding phenolic compounds, luteolin 
and apigenin were the most potent in inhibiting VEGFR-2 phosphorylation, leading us to 
believe that these compounds are involved in the antiangiogenic activity revealed by the 
hydroalcoholic extract. 
The antioxidant properties of German chamomile (M. recutita) infusion and decoction 
were similar, and showed better results than the hydroalcoholic extract in the DPPH and 
β-carotene bleaching inhibition assays. The hydroalcoholic extract of this wild 
chamomile gave the best results for reducing power and TBARS assays. Antitumor 
effects of M. recutita infusion and hydroalcoholic extract showed to be selective only for 
HCT-15 and HeLa cell lines, but none of the three preparations showed hepatotoxicity 
for PLP2 cells. Once again, decoction had no antitumor activity at the maximal 
concentration used.  Phenolic acids and derivatives, and flavonoids such as flavonols and 
flavones were found in M. recutita. Twenty phenolic compounds were detected. Luteolin-
O-acylhexoside was the most abundant compound identified in the three preparations and 
the hydroalcoholic extract was the preparation that presented the highest quantity of this 
compound. Protocatechuic acid, cis 5-O-caffeolyquinic acid, 5-O-feruloyquinic acid and 
4,5-O-dicaffeoylquinic acid were only detected in infusion and decoction, and myricetin-
O-hexoside, quercetin 7-O-acetylhexoside and 1,5-dicaffeolyquinic acid were only found 
in the hydroalcoholic extract. 
Wild fruits of Arbutus unedo, Prunus spinosa, Rosa canina and Rosa micrantha are rich 
in a variety of phenolic compounds, and the present study represents a contribution to the 
phenolic characterisation of these wild fruits with acknowledged antioxidant activity and 
traditionally used for several folk medicinal applications. These compounds have potent 
antioxidant properties, which have been related to anticancer activity. P. spinosa fruits 
were the only ones that presented phenolic acids, all belonging to the hydroxycinnamic 
acid derivative sub group. The major phenolic compound found in this wild fruit was 
identified as 3-O-caffeoylquinic acid. In all the studied samples of the wild fruits, 
quercetin 3-O-rutinoside and quercetin 3-O-glucoside were found. Quercetin pentoside 
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and quercetin rhamnoside were also found in all samples. Quercetin hexoside was only 
found in P. spinosa, R. canina and R. micrantha. Other detected flavonols, corresponding 
to kaempferol, isorhamnetin and myricetin derivatives were found in these fruits. Two 
myricetin rhamnosides were found in A. unedo. Taxifolin (flavanonol) and eriodictyol 
(flavanone) derivatives were identified in R. canina and R. micrantha wild fruits. P. 
spinosa was the fruit that presented the highest concentration in phenolic acids. A. unedo 
fruits presented quercetin 3-O-glucoside as the main flavonol. In R. canina and R. 
micrantha wild fruits taxifolin pentoside was the major flavananol derivative quantified, 
and R. micrantha presented the highest amount of total flavonoids. Catechins and 
proanthocyanidins (flavan-3-ols) were other relevant class of flavonoids found in 
A.unedo, R. canina and R. micrantha fruits. (+)-Catechin was the most abundant flavan-
3-ol found in A. unedo and R. canina. It was also a prominent compound in R. micrantha, 
besides a glycosylated proanthocyanidin dimer. A. unedo presented the highest 
concentration in proanthocyanidins. Flavan-3-ols were not detected in P. spinosa, and A. 
unedo was the only wild fruit studied that presented galloyl derivatives. Proanthocyanidin 
dimer monoglycoside was the most abundant flavan-3-ol present in R. canina and R. 
micrantha fruits. The anthocyanin profile obtained for P. spinosa, was more complex that 
those found in other fruits. For R. canina and R. micrantha only one anthocyanin was 
detected, namely cyanidin-3-O-glucoside. Three differents anthocyanins were identified 
in A. unedo, cyanidin 3-O-glucoside, cyanidin 3-O-pentoside and delphinidin-3-O-
glucoside, but the most abundant was cyanidin 3-O-glucoside. Cyanidin 3-O-glucoside 
was found in all the samples, being the major anthocyanin in most of them, with exception 
of P. spinosa in which cyanidin 3-O-rutinoside and peonidin 3-O-rutinoside were the 
main anthocyanins. The highest phenolic acids, flavonols and anthocyanins contents were 
found in P. spinosa, despite no flavan-3-ols were detected in this sample. The 
comparative study of the bioactivity of different enriched phenolic extracts of wild fruits 
(PE- non-anthocyanin phenolic compounds enriched extract) gave higher antioxidant 
properties than the corresponding AE (anthocyanins enriched extracts), and in accordance 
with their chemical characterization. A. unedo presented the highest antioxidant activity 
in all the preformed assays. The second one with the highest antioxidant effects was P. 
spinosa, while Rosa species revealed the lowest antioxidant activity. The antitumor 
potential of all fruit extracts were tested in breast, lung, colon, cervical and hepatocellular 
cell lines. Hepatotoxicity was evaluated using a porcine liver primary cell culture. All the 
extracts inhibited the growth of tumor cell lines, except R. canina PE and AE, P. spinosa 
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AE and R. micrantha AE for the breast carcinoma (MCF-7). A. unedo, followed by P. 
spinosa PE gave the best antitumor potential. None of the samples showed toxicity for 
non-tumor liver primary cell culture. Regarding the chemical characterization of the 
metionated samples, the presence of galloyl derivatives exclusively in A. unedo wild fruits 
could be related to its higher bioactivity. The studied fruits may have great potential for 
food industries as a source of colours and flavours. The bioactivity of the studied wild 
fruits proved to be more related with the phenolic compounds profile than with the 
amounts present in each extract, and could be considered in the design of new 
formulations of dietary supplements or functional foods.  
The chemical synthesis of metabolites/derivatives of quercetin proved to be quite 
difficult. The protection of the hydroxy groups present in quercetin was done following 
the literature, using the protection model described by Bouktaib et al (2002) and Kajjout 
& Rolando (2011). Both authors used benzyl as a protecting group because it is easily 
introduced by reaction with a benzyl halide and also easily removed by hydrogenolysis. 
Nevertheless, we have used different reaction conditions, because we were unable to 
reproduce the literature results. Thus, several benzylated derivatives of quercetin were 
obtained, but their separation by chromatographic column was not possible using the 
mixtures of eluents suggested by both research groups, probably due to the formation of 
more benzylated derivatives in our reactions. From two of our benzylation attemps it was 
possible to obtain the 3,7,3’,4’-O-tetrabenzylated derivative in one case, and the 3,7,3´-
O-tribenzylated derivative in other case, which were identified by 1H and 13C NMR and 
comparing with the spectroscopic data of the literature. The 5,7,3’,4’-O-tetrabenzylated 
quercetin was obtained from benzylation of rutin (a 3-O-disaccharide of quercetin) 
followed by 3-O-deglycosylation. The glucuronidation of O-tri- and of the two O-
tetrabenzylated quercetin derivatives was attempted by reacting them with acetobromo-
α-ᴅ-glucuronic acid methyl ester, giving mixtures of various compounds including a 
small amount of the expected glucurodinated β-anomers.  
In face of the results obtained in the reactions involving benzyl protection followed by 
glucuronidation, it was decided to investigate the use of methylation, to protect the 
hydroxyls with a less bulky group, the methoxylated compounds are also known as 
flavonoids metabolites. The 3,7,3’4’-O-tetramethylated quercetin was obtained according 
to the reactivity described in the literature by Shi et al. 2012 and it was characterized by 
melting point (Mp), 1H and 13C NMR. As far as our knowledge it is not described in the 
literature. The glucuronidation of this tetramethylated quercetin did not work. The crude 
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residue revealed that a very complex mixture was formed, and it was not possible to 
obtain the expected 5-O-glucuronide-3,7,3’,4’-O-tetramethylated quercetin. 
Further studies, are needed in the glucuronidation reaction of flavonoids to avoid the 
formation of complex mixtures that prevented us to get the glucuronide derivatives 
wanted, in higher amounts and in a pure form.. 
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